Ars.els-cdn.com



Online Table 1.??Selected Relevant Published Studies That Have Used Echo Prior to or During Chemotherapy in Risk Stratification for the Development of CTRCD.?First Author, Year (Ref. #)MethodSample Size, Age (years)?Cancer/TreatmentPrediction Threshold of Cardiac Events?Wang et al., 2015PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5XYW5nPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj

TnVtPjQzPC9SZWNOdW0+PERpc3BsYXlUZXh0PigxKTwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVj

LW51bWJlcj40MzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9

InpkOWZmeHJzMjJkcGViZTVmdHFwNXcyajB4c2YyMjByZGRzciIgdGltZXN0YW1wPSIxNTEwNzc4

MTIzIj40Mzwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGlj

bGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+V2FuZywgTC48

L2F1dGhvcj48YXV0aG9yPlRhbiwgVC4gQy48L2F1dGhvcj48YXV0aG9yPkhhbHBlcm4sIEUuIEYu

PC9hdXRob3I+PGF1dGhvcj5OZWlsYW4sIFQuIEcuPC9hdXRob3I+PGF1dGhvcj5GcmFuY2lzLCBT

LiBBLjwvYXV0aG9yPjxhdXRob3I+UGljYXJkLCBNLiBILjwvYXV0aG9yPjxhdXRob3I+RmVpLCBI

LjwvYXV0aG9yPjxhdXRob3I+SG9jaGJlcmcsIEUuIFAuPC9hdXRob3I+PGF1dGhvcj5BYnJhbXNv

biwgSi4gUy48L2F1dGhvcj48YXV0aG9yPldleW1hbiwgQS4gRS48L2F1dGhvcj48YXV0aG9yPkt1

dGVyLCBJLjwvYXV0aG9yPjxhdXRob3I+U2NoZXJyZXItQ3Jvc2JpZSwgTS48L2F1dGhvcj48L2F1

dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5DYXJkaWFjIFVsdHJhc291bmQgTGFi

b3JhdG9yeSwgRGl2aXNpb24gb2YgQ2FyZGlvbG9neSwgRGVwYXJ0bWVudCBvZiBNZWRpY2luZSwg

TWFzc2FjaHVzZXR0cyBHZW5lcmFsIEhvc3BpdGFsLCBIYXJ2YXJkIE1lZGljYWwgU2Nob29sLCBC

b3N0b24sIE1hc3NhY2h1c2V0dHMuJiN4RDtJbnN0aXR1dGUgZm9yIFRlY2hub2xvZ3kgQXNzZXNz

bWVudCwgTWFzc2FjaHVzZXR0cyBHZW5lcmFsIEhvc3BpdGFsLCBIYXJ2YXJkIE1lZGljYWwgU2No

b29sLCBCb3N0b24sIE1hc3NhY2h1c2V0dHMuJiN4RDtDYXJkaW8tT25jb2xvZ3kgUHJvZ3JhbSwg

RGl2aXNpb24gb2YgQ2FyZGlvbG9neSwgRGVwYXJ0bWVudCBvZiBNZWRpY2luZSwgTWFzc2FjaHVz

ZXR0cyBHZW5lcmFsIEhvc3BpdGFsLCBIYXJ2YXJkIE1lZGljYWwgU2Nob29sLCBCb3N0b24sIE1h

c3NhY2h1c2V0dHMuJiN4RDtDZW50ZXIgZm9yIEx5bXBob21hLCBNYXNzYWNodXNldHRzIEdlbmVy

YWwgSG9zcGl0YWwgQ2FuY2VyIENlbnRlciwgSGFydmFyZCBNZWRpY2FsIFNjaG9vbCwgQm9zdG9u

LCBNYXNzYWNodXNldHRzLiYjeEQ7Q2VudGVyIGZvciBCcmVhc3QgQ2FuY2VyLCBNYXNzYWNodXNl

dHRzIEdlbmVyYWwgSG9zcGl0YWwgQ2FuY2VyIENlbnRlciwgSGFydmFyZCBNZWRpY2FsIFNjaG9v

bCwgQm9zdG9uLCBNYXNzYWNodXNldHRzLiYjeEQ7Q2FyZGlhYyBVbHRyYXNvdW5kIExhYm9yYXRv

cnksIERpdmlzaW9uIG9mIENhcmRpb2xvZ3ksIERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIE1hc3Nh

Y2h1c2V0dHMgR2VuZXJhbCBIb3NwaXRhbCwgSGFydmFyZCBNZWRpY2FsIFNjaG9vbCwgQm9zdG9u

LCBNYXNzYWNodXNldHRzOyBDYXJkaW8tT25jb2xvZ3kgUHJvZ3JhbSwgRGl2aXNpb24gb2YgQ2Fy

ZGlvbG9neSwgRGVwYXJ0bWVudCBvZiBNZWRpY2luZSwgTWFzc2FjaHVzZXR0cyBHZW5lcmFsIEhv

c3BpdGFsLCBIYXJ2YXJkIE1lZGljYWwgU2Nob29sLCBCb3N0b24sIE1hc3NhY2h1c2V0dHMuIEVs

ZWN0cm9uaWMgYWRkcmVzczogbWFyaWVsbGVAY3Jvc2JpZS5jb20uPC9hdXRoLWFkZHJlc3M+PHRp

dGxlcz48dGl0bGU+TWFqb3IgQ2FyZGlhYyBFdmVudHMgYW5kIHRoZSBWYWx1ZSBvZiBFY2hvY2Fy

ZGlvZ3JhcGhpYyBFdmFsdWF0aW9uIGluIFBhdGllbnRzIFJlY2VpdmluZyBBbnRocmFjeWNsaW5l

LUJhc2VkIENoZW1vdGhlcmFweTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BbSBKIENhcmRpb2w8

L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbSBKIENh

cmRpb2w8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz40NDItNjwvcGFnZXM+PHZvbHVt

ZT4xMTY8L3ZvbHVtZT48bnVtYmVyPjM8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QW50aHJh

Y3ljbGluZXMvKmFkdmVyc2UgZWZmZWN0cy90aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdv

cmQ+Q2FyZGlvdmFzY3VsYXIgRGlzZWFzZXMvY2hlbWljYWxseSBpbmR1Y2VkLypkaWFnbm9zdGlj

IGltYWdpbmcvZXBpZGVtaW9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkVjaG9jYXJkaW9ncmFwaHkv

Km1ldGhvZHM8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxv

dy1VcCBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkhlYXJ0IFZlbnRyaWNsZXMvZGlhZ25vc3Rp

YyBpbWFnaW5nLypkcnVnIGVmZmVjdHMvcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3Jk

Pkh1bWFuczwva2V5d29yZD48a2V5d29yZD5JbmNpZGVuY2U8L2tleXdvcmQ+PGtleXdvcmQ+TWFs

ZTwva2V5d29yZD48a2V5d29yZD5NYXNzYWNodXNldHRzL2VwaWRlbWlvbG9neTwva2V5d29yZD48

a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbXMvKmRydWcgdGhl

cmFweTwva2V5d29yZD48a2V5d29yZD5Qcm9nbm9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9z

cGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlJpc2sgRmFjdG9yczwva2V5d29yZD48

a2V5d29yZD5TdHJva2UgVm9sdW1lL2RydWcgZWZmZWN0czwva2V5d29yZD48a2V5d29yZD5WZW50

cmljdWxhciBGdW5jdGlvbiwgTGVmdC8qZHJ1ZyBlZmZlY3RzPC9rZXl3b3JkPjwva2V5d29yZHM+

PGRhdGVzPjx5ZWFyPjIwMTU8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5BdWcgMDE8L2RhdGU+PC9w

dWItZGF0ZXM+PC9kYXRlcz48aXNibj4xODc5LTE5MTMgKEVsZWN0cm9uaWMpJiN4RDswMDAyLTkx

NDkgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI2MDcxOTk0PC9hY2Nlc3Npb24tbnVt

Pjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwczovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1

Ym1lZC8yNjA3MTk5NDwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNv

dXJjZS1udW0+MTAuMTAxNi9qLmFtamNhcmQuMjAxNS4wNC4wNjQ8L2VsZWN0cm9uaWMtcmVzb3Vy

Y2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5XYW5nPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48UmVj

TnVtPjQzPC9SZWNOdW0+PERpc3BsYXlUZXh0PigxKTwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVj

LW51bWJlcj40MzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9

InpkOWZmeHJzMjJkcGViZTVmdHFwNXcyajB4c2YyMjByZGRzciIgdGltZXN0YW1wPSIxNTEwNzc4

MTIzIj40Mzwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGlj

bGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+V2FuZywgTC48

L2F1dGhvcj48YXV0aG9yPlRhbiwgVC4gQy48L2F1dGhvcj48YXV0aG9yPkhhbHBlcm4sIEUuIEYu

PC9hdXRob3I+PGF1dGhvcj5OZWlsYW4sIFQuIEcuPC9hdXRob3I+PGF1dGhvcj5GcmFuY2lzLCBT

LiBBLjwvYXV0aG9yPjxhdXRob3I+UGljYXJkLCBNLiBILjwvYXV0aG9yPjxhdXRob3I+RmVpLCBI

LjwvYXV0aG9yPjxhdXRob3I+SG9jaGJlcmcsIEUuIFAuPC9hdXRob3I+PGF1dGhvcj5BYnJhbXNv

biwgSi4gUy48L2F1dGhvcj48YXV0aG9yPldleW1hbiwgQS4gRS48L2F1dGhvcj48YXV0aG9yPkt1

dGVyLCBJLjwvYXV0aG9yPjxhdXRob3I+U2NoZXJyZXItQ3Jvc2JpZSwgTS48L2F1dGhvcj48L2F1

dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5DYXJkaWFjIFVsdHJhc291bmQgTGFi

b3JhdG9yeSwgRGl2aXNpb24gb2YgQ2FyZGlvbG9neSwgRGVwYXJ0bWVudCBvZiBNZWRpY2luZSwg

TWFzc2FjaHVzZXR0cyBHZW5lcmFsIEhvc3BpdGFsLCBIYXJ2YXJkIE1lZGljYWwgU2Nob29sLCBC

b3N0b24sIE1hc3NhY2h1c2V0dHMuJiN4RDtJbnN0aXR1dGUgZm9yIFRlY2hub2xvZ3kgQXNzZXNz

bWVudCwgTWFzc2FjaHVzZXR0cyBHZW5lcmFsIEhvc3BpdGFsLCBIYXJ2YXJkIE1lZGljYWwgU2No

b29sLCBCb3N0b24sIE1hc3NhY2h1c2V0dHMuJiN4RDtDYXJkaW8tT25jb2xvZ3kgUHJvZ3JhbSwg

RGl2aXNpb24gb2YgQ2FyZGlvbG9neSwgRGVwYXJ0bWVudCBvZiBNZWRpY2luZSwgTWFzc2FjaHVz

ZXR0cyBHZW5lcmFsIEhvc3BpdGFsLCBIYXJ2YXJkIE1lZGljYWwgU2Nob29sLCBCb3N0b24sIE1h

c3NhY2h1c2V0dHMuJiN4RDtDZW50ZXIgZm9yIEx5bXBob21hLCBNYXNzYWNodXNldHRzIEdlbmVy

YWwgSG9zcGl0YWwgQ2FuY2VyIENlbnRlciwgSGFydmFyZCBNZWRpY2FsIFNjaG9vbCwgQm9zdG9u

LCBNYXNzYWNodXNldHRzLiYjeEQ7Q2VudGVyIGZvciBCcmVhc3QgQ2FuY2VyLCBNYXNzYWNodXNl

dHRzIEdlbmVyYWwgSG9zcGl0YWwgQ2FuY2VyIENlbnRlciwgSGFydmFyZCBNZWRpY2FsIFNjaG9v

bCwgQm9zdG9uLCBNYXNzYWNodXNldHRzLiYjeEQ7Q2FyZGlhYyBVbHRyYXNvdW5kIExhYm9yYXRv

cnksIERpdmlzaW9uIG9mIENhcmRpb2xvZ3ksIERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIE1hc3Nh

Y2h1c2V0dHMgR2VuZXJhbCBIb3NwaXRhbCwgSGFydmFyZCBNZWRpY2FsIFNjaG9vbCwgQm9zdG9u

LCBNYXNzYWNodXNldHRzOyBDYXJkaW8tT25jb2xvZ3kgUHJvZ3JhbSwgRGl2aXNpb24gb2YgQ2Fy

ZGlvbG9neSwgRGVwYXJ0bWVudCBvZiBNZWRpY2luZSwgTWFzc2FjaHVzZXR0cyBHZW5lcmFsIEhv

c3BpdGFsLCBIYXJ2YXJkIE1lZGljYWwgU2Nob29sLCBCb3N0b24sIE1hc3NhY2h1c2V0dHMuIEVs

ZWN0cm9uaWMgYWRkcmVzczogbWFyaWVsbGVAY3Jvc2JpZS5jb20uPC9hdXRoLWFkZHJlc3M+PHRp

dGxlcz48dGl0bGU+TWFqb3IgQ2FyZGlhYyBFdmVudHMgYW5kIHRoZSBWYWx1ZSBvZiBFY2hvY2Fy

ZGlvZ3JhcGhpYyBFdmFsdWF0aW9uIGluIFBhdGllbnRzIFJlY2VpdmluZyBBbnRocmFjeWNsaW5l

LUJhc2VkIENoZW1vdGhlcmFweTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5BbSBKIENhcmRpb2w8

L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbSBKIENh

cmRpb2w8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz40NDItNjwvcGFnZXM+PHZvbHVt

ZT4xMTY8L3ZvbHVtZT48bnVtYmVyPjM8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QW50aHJh

Y3ljbGluZXMvKmFkdmVyc2UgZWZmZWN0cy90aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdv

cmQ+Q2FyZGlvdmFzY3VsYXIgRGlzZWFzZXMvY2hlbWljYWxseSBpbmR1Y2VkLypkaWFnbm9zdGlj

IGltYWdpbmcvZXBpZGVtaW9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkVjaG9jYXJkaW9ncmFwaHkv

Km1ldGhvZHM8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxv

dy1VcCBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkhlYXJ0IFZlbnRyaWNsZXMvZGlhZ25vc3Rp

YyBpbWFnaW5nLypkcnVnIGVmZmVjdHMvcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3Jk

Pkh1bWFuczwva2V5d29yZD48a2V5d29yZD5JbmNpZGVuY2U8L2tleXdvcmQ+PGtleXdvcmQ+TWFs

ZTwva2V5d29yZD48a2V5d29yZD5NYXNzYWNodXNldHRzL2VwaWRlbWlvbG9neTwva2V5d29yZD48

a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbXMvKmRydWcgdGhl

cmFweTwva2V5d29yZD48a2V5d29yZD5Qcm9nbm9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+UmV0cm9z

cGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlJpc2sgRmFjdG9yczwva2V5d29yZD48

a2V5d29yZD5TdHJva2UgVm9sdW1lL2RydWcgZWZmZWN0czwva2V5d29yZD48a2V5d29yZD5WZW50

cmljdWxhciBGdW5jdGlvbiwgTGVmdC8qZHJ1ZyBlZmZlY3RzPC9rZXl3b3JkPjwva2V5d29yZHM+

PGRhdGVzPjx5ZWFyPjIwMTU8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5BdWcgMDE8L2RhdGU+PC9w

dWItZGF0ZXM+PC9kYXRlcz48aXNibj4xODc5LTE5MTMgKEVsZWN0cm9uaWMpJiN4RDswMDAyLTkx

NDkgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI2MDcxOTk0PC9hY2Nlc3Npb24tbnVt

Pjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwczovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1

Ym1lZC8yNjA3MTk5NDwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNv

dXJjZS1udW0+MTAuMTAxNi9qLmFtamNhcmQuMjAxNS4wNC4wNjQ8L2VsZWN0cm9uaWMtcmVzb3Vy

Y2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE.DATA (1)Retrospective ?2,285, 53±16?Breast (31%), blood (49%), others (20%)/ anthracyclines?2.4% symptomatic HF and cardiac death, HR of 2.72 if pre-tx LVEF between LLN* and LLN+5 (p < 0.01), every decrement of 5% LVEF = 40% more risk, every increment of 5mm LVID = 40% more risk Romond et al., 2012PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Sb21vbmQ8L0F1dGhvcj48WWVhcj4yMDEyPC9ZZWFyPjxS

ZWNOdW0+NTY8L1JlY051bT48RGlzcGxheVRleHQ+KDIpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxy

ZWMtbnVtYmVyPjU2PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1p

ZD0iemQ5ZmZ4cnMyMmRwZWJlNWZ0cXA1dzJqMHhzZjIyMHJkZHNyIiB0aW1lc3RhbXA9IjE1MTA3

NzgyMTYiPjU2PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Sb21vbmQs

IEUuIEguPC9hdXRob3I+PGF1dGhvcj5KZW9uZywgSi4gSC48L2F1dGhvcj48YXV0aG9yPlJhc3Rv

Z2ksIFAuPC9hdXRob3I+PGF1dGhvcj5Td2FpbiwgUy4gTS48L2F1dGhvcj48YXV0aG9yPkdleWVy

LCBDLiBFLiwgSnIuPC9hdXRob3I+PGF1dGhvcj5Fd2VyLCBNLiBTLjwvYXV0aG9yPjxhdXRob3I+

UmF0aGksIFYuPC9hdXRob3I+PGF1dGhvcj5GZWhyZW5iYWNoZXIsIEwuPC9hdXRob3I+PGF1dGhv

cj5CcnVmc2t5LCBBLjwvYXV0aG9yPjxhdXRob3I+QXphciwgQy4gQS48L2F1dGhvcj48YXV0aG9y

PkZseW5uLCBQLiBKLjwvYXV0aG9yPjxhdXRob3I+WmFwYXMsIEouIEwuPC9hdXRob3I+PGF1dGhv

cj5Qb2xpa29mZiwgSi48L2F1dGhvcj48YXV0aG9yPkdyb3NzLCBILiBNLjwvYXV0aG9yPjxhdXRo

b3I+QmlnZ3MsIEQuIEQuPC9hdXRob3I+PGF1dGhvcj5BdGtpbnMsIEouIE4uPC9hdXRob3I+PGF1

dGhvcj5UYW4tQ2hpdSwgRS48L2F1dGhvcj48YXV0aG9yPlpoZW5nLCBQLjwvYXV0aG9yPjxhdXRo

b3I+WW90aGVycywgRy48L2F1dGhvcj48YXV0aG9yPk1hbW91bmFzLCBFLiBQLjwvYXV0aG9yPjxh

dXRob3I+V29sbWFyaywgTi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgt

YWRkcmVzcz5OYXRpb25hbCBTdXJnaWNhbCBBZGp1dmFudCBCcmVhc3QgYW5kIEJvd2VsIFByb2pl

Y3QsIEVhc3QgQ29tbW9ucyBQcm9mZXNzaW9uYWwgQnVpbGRpbmcsIEZvdXIgQWxsZWdoZW55IENl

bnRlciwgNXRoIEZsb29yLCBQaXR0c2J1cmdoLCBQQSAxNTIxMiwgVVNBLjwvYXV0aC1hZGRyZXNz

Pjx0aXRsZXM+PHRpdGxlPlNldmVuLXllYXIgZm9sbG93LXVwIGFzc2Vzc21lbnQgb2YgY2FyZGlh

YyBmdW5jdGlvbiBpbiBOU0FCUCBCLTMxLCBhIHJhbmRvbWl6ZWQgdHJpYWwgY29tcGFyaW5nIGRv

eG9ydWJpY2luIGFuZCBjeWNsb3Bob3NwaGFtaWRlIGZvbGxvd2VkIGJ5IHBhY2xpdGF4ZWwgKEFD

UCkgd2l0aCBBQ1AgcGx1cyB0cmFzdHV6dW1hYiBhcyBhZGp1dmFudCB0aGVyYXB5IGZvciBwYXRp

ZW50cyB3aXRoIG5vZGUtcG9zaXRpdmUsIGh1bWFuIGVwaWRlcm1hbCBncm93dGggZmFjdG9yIHJl

Y2VwdG9yIDItcG9zaXRpdmUgYnJlYXN0IGNhbmNlcjwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5K

IENsaW4gT25jb2w8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10

aXRsZT5KIENsaW4gT25jb2w8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4zNzkyLTk8

L3BhZ2VzPjx2b2x1bWU+MzA8L3ZvbHVtZT48bnVtYmVyPjMxPC9udW1iZXI+PGtleXdvcmRzPjxr

ZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWJvZGllcywgTW9ub2Nsb25hbCwgSHVt

YW5pemVkL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZS9hZHZlcnNlIGVmZmVjdHM8L2tleXdv

cmQ+PGtleXdvcmQ+QW50aW5lb3BsYXN0aWMgQ29tYmluZWQgQ2hlbW90aGVyYXB5IFByb3RvY29s

cy8qYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlLyphZHZlcnNlPC9rZXl3b3JkPjxrZXl3b3Jk

PmVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+QnJlYXN0IE5lb3BsYXNtcy8qZHJ1ZyB0aGVyYXB5

L2Vuenltb2xvZ3kvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkNoZW1vdGhlcmFweSwgQWRq

dXZhbnQ8L2tleXdvcmQ+PGtleXdvcmQ+Q3ljbG9waG9zcGhhbWlkZS9hZG1pbmlzdHJhdGlvbiAm

YW1wOyBkb3NhZ2UvYWR2ZXJzZSBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPkRveG9ydWJpY2lu

L2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZS9hZHZlcnNlIGVmZmVjdHM8L2tleXdvcmQ+PGtl

eXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxvdy1VcCBTdHVkaWVzPC9rZXl3b3Jk

PjxrZXl3b3JkPkhlYXJ0IEZhaWx1cmUvKmNoZW1pY2FsbHkgaW5kdWNlZC9kcnVnIHRoZXJhcHk8

L2tleXdvcmQ+PGtleXdvcmQ+SGVhcnQgRnVuY3Rpb24gVGVzdHM8L2tleXdvcmQ+PGtleXdvcmQ+

SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkx5bXBoYXRpYyBNZXRhc3Rhc2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPk1vZGVscywgU3RhdGlzdGljYWw8

L2tleXdvcmQ+PGtleXdvcmQ+UGFjbGl0YXhlbC9hZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2Uv

YWR2ZXJzZSBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPlJlY2VwdG9yLCBFcGlkZXJtYWwgR3Jv

d3RoIEZhY3Rvci8qYmlvc3ludGhlc2lzPC9rZXl3b3JkPjxrZXl3b3JkPlJpc2sgRmFjdG9yczwv

a2V5d29yZD48a2V5d29yZD5UcmFzdHV6dW1hYjwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48

eWVhcj4yMDEyPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+Tm92IDAxPC9kYXRlPjwvcHViLWRhdGVz

PjwvZGF0ZXM+PGlzYm4+MTUyNy03NzU1IChFbGVjdHJvbmljKSYjeEQ7MDczMi0xODNYIChMaW5r

aW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMjk4NzA4NDwvYWNjZXNzaW9uLW51bT48dXJscz48

cmVsYXRlZC11cmxzPjx1cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjI5

ODcwODQ8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGN1c3RvbTI+UE1DMzQ3ODU3NDwvY3Vz

dG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTIwMC9KQ08uMjAxMS40MC4wMDEwPC9l

bGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Sb21vbmQ8L0F1dGhvcj48WWVhcj4yMDEyPC9ZZWFyPjxS

ZWNOdW0+NTY8L1JlY051bT48RGlzcGxheVRleHQ+KDIpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxy

ZWMtbnVtYmVyPjU2PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1p

ZD0iemQ5ZmZ4cnMyMmRwZWJlNWZ0cXA1dzJqMHhzZjIyMHJkZHNyIiB0aW1lc3RhbXA9IjE1MTA3

NzgyMTYiPjU2PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Sb21vbmQs

IEUuIEguPC9hdXRob3I+PGF1dGhvcj5KZW9uZywgSi4gSC48L2F1dGhvcj48YXV0aG9yPlJhc3Rv

Z2ksIFAuPC9hdXRob3I+PGF1dGhvcj5Td2FpbiwgUy4gTS48L2F1dGhvcj48YXV0aG9yPkdleWVy

LCBDLiBFLiwgSnIuPC9hdXRob3I+PGF1dGhvcj5Fd2VyLCBNLiBTLjwvYXV0aG9yPjxhdXRob3I+

UmF0aGksIFYuPC9hdXRob3I+PGF1dGhvcj5GZWhyZW5iYWNoZXIsIEwuPC9hdXRob3I+PGF1dGhv

cj5CcnVmc2t5LCBBLjwvYXV0aG9yPjxhdXRob3I+QXphciwgQy4gQS48L2F1dGhvcj48YXV0aG9y

PkZseW5uLCBQLiBKLjwvYXV0aG9yPjxhdXRob3I+WmFwYXMsIEouIEwuPC9hdXRob3I+PGF1dGhv

cj5Qb2xpa29mZiwgSi48L2F1dGhvcj48YXV0aG9yPkdyb3NzLCBILiBNLjwvYXV0aG9yPjxhdXRo

b3I+QmlnZ3MsIEQuIEQuPC9hdXRob3I+PGF1dGhvcj5BdGtpbnMsIEouIE4uPC9hdXRob3I+PGF1

dGhvcj5UYW4tQ2hpdSwgRS48L2F1dGhvcj48YXV0aG9yPlpoZW5nLCBQLjwvYXV0aG9yPjxhdXRo

b3I+WW90aGVycywgRy48L2F1dGhvcj48YXV0aG9yPk1hbW91bmFzLCBFLiBQLjwvYXV0aG9yPjxh

dXRob3I+V29sbWFyaywgTi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgt

YWRkcmVzcz5OYXRpb25hbCBTdXJnaWNhbCBBZGp1dmFudCBCcmVhc3QgYW5kIEJvd2VsIFByb2pl

Y3QsIEVhc3QgQ29tbW9ucyBQcm9mZXNzaW9uYWwgQnVpbGRpbmcsIEZvdXIgQWxsZWdoZW55IENl

bnRlciwgNXRoIEZsb29yLCBQaXR0c2J1cmdoLCBQQSAxNTIxMiwgVVNBLjwvYXV0aC1hZGRyZXNz

Pjx0aXRsZXM+PHRpdGxlPlNldmVuLXllYXIgZm9sbG93LXVwIGFzc2Vzc21lbnQgb2YgY2FyZGlh

YyBmdW5jdGlvbiBpbiBOU0FCUCBCLTMxLCBhIHJhbmRvbWl6ZWQgdHJpYWwgY29tcGFyaW5nIGRv

eG9ydWJpY2luIGFuZCBjeWNsb3Bob3NwaGFtaWRlIGZvbGxvd2VkIGJ5IHBhY2xpdGF4ZWwgKEFD

UCkgd2l0aCBBQ1AgcGx1cyB0cmFzdHV6dW1hYiBhcyBhZGp1dmFudCB0aGVyYXB5IGZvciBwYXRp

ZW50cyB3aXRoIG5vZGUtcG9zaXRpdmUsIGh1bWFuIGVwaWRlcm1hbCBncm93dGggZmFjdG9yIHJl

Y2VwdG9yIDItcG9zaXRpdmUgYnJlYXN0IGNhbmNlcjwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5K

IENsaW4gT25jb2w8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10

aXRsZT5KIENsaW4gT25jb2w8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4zNzkyLTk8

L3BhZ2VzPjx2b2x1bWU+MzA8L3ZvbHVtZT48bnVtYmVyPjMxPC9udW1iZXI+PGtleXdvcmRzPjxr

ZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWJvZGllcywgTW9ub2Nsb25hbCwgSHVt

YW5pemVkL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZS9hZHZlcnNlIGVmZmVjdHM8L2tleXdv

cmQ+PGtleXdvcmQ+QW50aW5lb3BsYXN0aWMgQ29tYmluZWQgQ2hlbW90aGVyYXB5IFByb3RvY29s

cy8qYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlLyphZHZlcnNlPC9rZXl3b3JkPjxrZXl3b3Jk

PmVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+QnJlYXN0IE5lb3BsYXNtcy8qZHJ1ZyB0aGVyYXB5

L2Vuenltb2xvZ3kvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkNoZW1vdGhlcmFweSwgQWRq

dXZhbnQ8L2tleXdvcmQ+PGtleXdvcmQ+Q3ljbG9waG9zcGhhbWlkZS9hZG1pbmlzdHJhdGlvbiAm

YW1wOyBkb3NhZ2UvYWR2ZXJzZSBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPkRveG9ydWJpY2lu

L2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZS9hZHZlcnNlIGVmZmVjdHM8L2tleXdvcmQ+PGtl

eXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxvdy1VcCBTdHVkaWVzPC9rZXl3b3Jk

PjxrZXl3b3JkPkhlYXJ0IEZhaWx1cmUvKmNoZW1pY2FsbHkgaW5kdWNlZC9kcnVnIHRoZXJhcHk8

L2tleXdvcmQ+PGtleXdvcmQ+SGVhcnQgRnVuY3Rpb24gVGVzdHM8L2tleXdvcmQ+PGtleXdvcmQ+

SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkx5bXBoYXRpYyBNZXRhc3Rhc2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPk1vZGVscywgU3RhdGlzdGljYWw8

L2tleXdvcmQ+PGtleXdvcmQ+UGFjbGl0YXhlbC9hZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2Uv

YWR2ZXJzZSBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPlJlY2VwdG9yLCBFcGlkZXJtYWwgR3Jv

d3RoIEZhY3Rvci8qYmlvc3ludGhlc2lzPC9rZXl3b3JkPjxrZXl3b3JkPlJpc2sgRmFjdG9yczwv

a2V5d29yZD48a2V5d29yZD5UcmFzdHV6dW1hYjwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48

eWVhcj4yMDEyPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+Tm92IDAxPC9kYXRlPjwvcHViLWRhdGVz

PjwvZGF0ZXM+PGlzYm4+MTUyNy03NzU1IChFbGVjdHJvbmljKSYjeEQ7MDczMi0xODNYIChMaW5r

aW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMjk4NzA4NDwvYWNjZXNzaW9uLW51bT48dXJscz48

cmVsYXRlZC11cmxzPjx1cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjI5

ODcwODQ8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGN1c3RvbTI+UE1DMzQ3ODU3NDwvY3Vz

dG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTIwMC9KQ08uMjAxMS40MC4wMDEwPC9l

bGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (2)Prospective randomized944, 49Breast/ anthracyclines + trastuzumab4% symptomatic HF and cardiac death, HR of 6.72 if pre-tx LVEF 50% to 54% (p < 0.01) and 11.84 if post AC LVEF 55% to 64% (p < 0.001)Negishi et al., 2013 ADDIN EN.CITE <EndNote><Cite><Author>Negishi</Author><Year>2013</Year><RecNum>89</RecNum><DisplayText>(3)</DisplayText><record><rec-number>89</rec-number><foreign-keys><key app="EN" db-id="zd9ffxrs22dpebe5ftqp5w2j0xsf220rddsr" timestamp="1510785286">89</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Negishi, K.</author><author>Negishi, T.</author><author>Hare, J. L.</author><author>Haluska, B. A.</author><author>Plana, J. C.</author><author>Marwick, T. H.</author></authors></contributors><auth-address>Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.</auth-address><titles><title>Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity</title><secondary-title>J Am Soc Echocardiogr</secondary-title></titles><periodical><full-title>J Am Soc Echocardiogr</full-title></periodical><pages>493-8</pages><volume>26</volume><number>5</number><keywords><keyword>Antibodies, Monoclonal, Humanized/*adverse effects</keyword><keyword>Antineoplastic Agents/*adverse effects</keyword><keyword>Breast Neoplasms/drug therapy</keyword><keyword>*Echocardiography</keyword><keyword>Female</keyword><keyword>Heart/*drug effects</keyword><keyword>Humans</keyword><keyword>Middle Aged</keyword><keyword>Prospective Studies</keyword><keyword>Trastuzumab</keyword><keyword>Ventricular Function, Left/*drug effects</keyword></keywords><dates><year>2013</year><pub-dates><date>May</date></pub-dates></dates><isbn>1097-6795 (Electronic)&#xD;0894-7317 (Linking)</isbn><accession-num>23562088</accession-num><urls><related-urls><url>;(3)Retrospective81, 50Breast/ trastuzumab ACA change in GLS with an optimal cut point of 11% reduction (95% CI: 8.3% to 14.6%; AUC: 0.84; p < 0.001) predicted subsequent >10% decrease in LVEF at 12 months of treatment.Mousavi et al., 2015PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Nb3VzYXZpPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48

UmVjTnVtPjkyPC9SZWNOdW0+PERpc3BsYXlUZXh0Pig0KTwvRGlzcGxheVRleHQ+PHJlY29yZD48

cmVjLW51bWJlcj45MjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGIt

aWQ9InpkOWZmeHJzMjJkcGViZTVmdHFwNXcyajB4c2YyMjByZGRzciIgdGltZXN0YW1wPSIxNTEw

Nzg1NTYyIj45Mjwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFy

dGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+TW91c2F2

aSwgTi48L2F1dGhvcj48YXV0aG9yPlRhbiwgVC4gQy48L2F1dGhvcj48YXV0aG9yPkFsaSwgTS48

L2F1dGhvcj48YXV0aG9yPkhhbHBlcm4sIEUuIEYuPC9hdXRob3I+PGF1dGhvcj5XYW5nLCBMLjwv

YXV0aG9yPjxhdXRob3I+U2NoZXJyZXItQ3Jvc2JpZSwgTS48L2F1dGhvcj48L2F1dGhvcnM+PC9j

b250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5DYXJkaWFjIFVsdHJhc291bmQgTGFib3JhdG9yeSwg

TWFzc2FjaHVzZXR0cyBHZW5lcmFsIEhvc3BpdGFsIGFuZCBIYXJ2YXJkIE1lZGljYWwgU2Nob29s

LCA1NSBGcnVpdCBTdHJlZXQsIEJvc3RvbiwgTUEgMDIxMTQsIFVTQS4mI3hEO0luc3RpdHV0ZSBm

b3IgVGVjaG5vbG9neSBBc3Nlc3NtZW50LCBNYXNzYWNodXNldHRzIEdlbmVyYWwgSG9zcGl0YWwg

YW5kIEhhcnZhcmQgTWVkaWNhbCBTY2hvb2wsIEJvc3RvbiwgTUEsIFVTQS4mI3hEO0NhcmRpYWMg

VWx0cmFzb3VuZCBMYWJvcmF0b3J5LCBNYXNzYWNodXNldHRzIEdlbmVyYWwgSG9zcGl0YWwgYW5k

IEhhcnZhcmQgTWVkaWNhbCBTY2hvb2wsIDU1IEZydWl0IFN0cmVldCwgQm9zdG9uLCBNQSAwMjEx

NCwgVVNBIG1hcmllbGxlQGNyb3NiaWUuY29tLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxl

PkVjaG9jYXJkaW9ncmFwaGljIHBhcmFtZXRlcnMgb2YgbGVmdCB2ZW50cmljdWxhciBzaXplIGFu

ZCBmdW5jdGlvbiBhcyBwcmVkaWN0b3JzIG9mIHN5bXB0b21hdGljIGhlYXJ0IGZhaWx1cmUgaW4g

cGF0aWVudHMgd2l0aCBhIGxlZnQgdmVudHJpY3VsYXIgZWplY3Rpb24gZnJhY3Rpb24gb2YgNTAt

NTklIHRyZWF0ZWQgd2l0aCBhbnRocmFjeWNsaW5lczwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5F

dXIgSGVhcnQgSiBDYXJkaW92YXNjIEltYWdpbmc8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48

cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5FdXIgSGVhcnQgSiBDYXJkaW92YXNjIEltYWdpbmc8L2Z1

bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz45NzctODQ8L3BhZ2VzPjx2b2x1bWU+MTY8L3Zv

bHVtZT48bnVtYmVyPjk8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+

PGtleXdvcmQ+QWdlIEZhY3RvcnM8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5

d29yZD5BbmFseXNpcyBvZiBWYXJpYW5jZTwva2V5d29yZD48a2V5d29yZD5BbnRocmFjeWNsaW5l

cy9hZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2UvKmFkdmVyc2UgZWZmZWN0czwva2V5d29yZD48

a2V5d29yZD5Db2hvcnQgU3R1ZGllczwva2V5d29yZD48a2V5d29yZD5FY2hvY2FyZGlvZ3JhcGh5

L21ldGhvZHM8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxv

dy1VcCBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkhlYXJ0IEZhaWx1cmUvZGlhZ25vc3RpYyBp

bWFnaW5nLypldGlvbG9neS9tb3J0YWxpdHk8L2tleXdvcmQ+PGtleXdvcmQ+SGVhcnQgVmVudHJp

Y2xlcy9kaWFnbm9zdGljIGltYWdpbmcvZHJ1ZyBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPkh1

bWFuczwva2V5d29yZD48a2V5d29yZD5LYXBsYW4tTWVpZXIgRXN0aW1hdGU8L2tleXdvcmQ+PGtl

eXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29y

ZD5NdWx0aXZhcmlhdGUgQW5hbHlzaXM8L2tleXdvcmQ+PGtleXdvcmQ+T2JzZXJ2ZXIgVmFyaWF0

aW9uPC9rZXl3b3JkPjxrZXl3b3JkPlByZWRpY3RpdmUgVmFsdWUgb2YgVGVzdHM8L2tleXdvcmQ+

PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlJpc2sgQXNz

ZXNzbWVudDwva2V5d29yZD48a2V5d29yZD5TZXggRmFjdG9yczwva2V5d29yZD48a2V5d29yZD5T

dHJva2UgVm9sdW1lLypkcnVnIGVmZmVjdHMvcGh5c2lvbG9neTwva2V5d29yZD48a2V5d29yZD5T

dXJ2aXZhbCBSYXRlPC9rZXl3b3JkPjxrZXl3b3JkPlRyZWF0bWVudCBPdXRjb21lPC9rZXl3b3Jk

PjxrZXl3b3JkPlZlbnRyaWN1bGFyIER5c2Z1bmN0aW9uLCBMZWZ0LypkaWFnbm9zdGljIGltYWdp

bmcvcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPlZlbnRyaWN1bGFyIEZ1bmN0aW9u

LCBMZWZ0LypkcnVnIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+YW50aHJhY3ljbGluZTwva2V5

d29yZD48a2V5d29yZD5jaGVtb3RoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+ZWNob2NhcmRpb2dy

YXBoeTwva2V5d29yZD48a2V5d29yZD5oZWFydCBmYWlsdXJlPC9rZXl3b3JkPjxrZXl3b3JkPmxl

ZnQgdmVudHJpY3VsYXIgZnVuY3Rpb248L2tleXdvcmQ+PGtleXdvcmQ+c3RyYWluPC9rZXl3b3Jk

Pjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTU8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5TZXA8

L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4yMDQ3LTI0MTIgKEVsZWN0cm9uaWMpJiN4

RDsyMDQ3LTI0MDQgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI1OTI1MjIwPC9hY2Nl

c3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwczovL3d3dy5uY2JpLm5sbS5u

aWguZ292L3B1Ym1lZC8yNTkyNTIyMDwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ry

b25pYy1yZXNvdXJjZS1udW0+MTAuMTA5My9laGpjaS9qZXYxMTM8L2VsZWN0cm9uaWMtcmVzb3Vy

Y2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Nb3VzYXZpPC9BdXRob3I+PFllYXI+MjAxNTwvWWVhcj48

UmVjTnVtPjkyPC9SZWNOdW0+PERpc3BsYXlUZXh0Pig0KTwvRGlzcGxheVRleHQ+PHJlY29yZD48

cmVjLW51bWJlcj45MjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGIt

aWQ9InpkOWZmeHJzMjJkcGViZTVmdHFwNXcyajB4c2YyMjByZGRzciIgdGltZXN0YW1wPSIxNTEw

Nzg1NTYyIj45Mjwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFy

dGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+TW91c2F2

aSwgTi48L2F1dGhvcj48YXV0aG9yPlRhbiwgVC4gQy48L2F1dGhvcj48YXV0aG9yPkFsaSwgTS48

L2F1dGhvcj48YXV0aG9yPkhhbHBlcm4sIEUuIEYuPC9hdXRob3I+PGF1dGhvcj5XYW5nLCBMLjwv

YXV0aG9yPjxhdXRob3I+U2NoZXJyZXItQ3Jvc2JpZSwgTS48L2F1dGhvcj48L2F1dGhvcnM+PC9j

b250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5DYXJkaWFjIFVsdHJhc291bmQgTGFib3JhdG9yeSwg

TWFzc2FjaHVzZXR0cyBHZW5lcmFsIEhvc3BpdGFsIGFuZCBIYXJ2YXJkIE1lZGljYWwgU2Nob29s

LCA1NSBGcnVpdCBTdHJlZXQsIEJvc3RvbiwgTUEgMDIxMTQsIFVTQS4mI3hEO0luc3RpdHV0ZSBm

b3IgVGVjaG5vbG9neSBBc3Nlc3NtZW50LCBNYXNzYWNodXNldHRzIEdlbmVyYWwgSG9zcGl0YWwg

YW5kIEhhcnZhcmQgTWVkaWNhbCBTY2hvb2wsIEJvc3RvbiwgTUEsIFVTQS4mI3hEO0NhcmRpYWMg

VWx0cmFzb3VuZCBMYWJvcmF0b3J5LCBNYXNzYWNodXNldHRzIEdlbmVyYWwgSG9zcGl0YWwgYW5k

IEhhcnZhcmQgTWVkaWNhbCBTY2hvb2wsIDU1IEZydWl0IFN0cmVldCwgQm9zdG9uLCBNQSAwMjEx

NCwgVVNBIG1hcmllbGxlQGNyb3NiaWUuY29tLjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxl

PkVjaG9jYXJkaW9ncmFwaGljIHBhcmFtZXRlcnMgb2YgbGVmdCB2ZW50cmljdWxhciBzaXplIGFu

ZCBmdW5jdGlvbiBhcyBwcmVkaWN0b3JzIG9mIHN5bXB0b21hdGljIGhlYXJ0IGZhaWx1cmUgaW4g

cGF0aWVudHMgd2l0aCBhIGxlZnQgdmVudHJpY3VsYXIgZWplY3Rpb24gZnJhY3Rpb24gb2YgNTAt

NTklIHRyZWF0ZWQgd2l0aCBhbnRocmFjeWNsaW5lczwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5F

dXIgSGVhcnQgSiBDYXJkaW92YXNjIEltYWdpbmc8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48

cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5FdXIgSGVhcnQgSiBDYXJkaW92YXNjIEltYWdpbmc8L2Z1

bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz45NzctODQ8L3BhZ2VzPjx2b2x1bWU+MTY8L3Zv

bHVtZT48bnVtYmVyPjk8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+

PGtleXdvcmQ+QWdlIEZhY3RvcnM8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZDwva2V5d29yZD48a2V5

d29yZD5BbmFseXNpcyBvZiBWYXJpYW5jZTwva2V5d29yZD48a2V5d29yZD5BbnRocmFjeWNsaW5l

cy9hZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2UvKmFkdmVyc2UgZWZmZWN0czwva2V5d29yZD48

a2V5d29yZD5Db2hvcnQgU3R1ZGllczwva2V5d29yZD48a2V5d29yZD5FY2hvY2FyZGlvZ3JhcGh5

L21ldGhvZHM8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxv

dy1VcCBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkhlYXJ0IEZhaWx1cmUvZGlhZ25vc3RpYyBp

bWFnaW5nLypldGlvbG9neS9tb3J0YWxpdHk8L2tleXdvcmQ+PGtleXdvcmQ+SGVhcnQgVmVudHJp

Y2xlcy9kaWFnbm9zdGljIGltYWdpbmcvZHJ1ZyBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPkh1

bWFuczwva2V5d29yZD48a2V5d29yZD5LYXBsYW4tTWVpZXIgRXN0aW1hdGU8L2tleXdvcmQ+PGtl

eXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29y

ZD5NdWx0aXZhcmlhdGUgQW5hbHlzaXM8L2tleXdvcmQ+PGtleXdvcmQ+T2JzZXJ2ZXIgVmFyaWF0

aW9uPC9rZXl3b3JkPjxrZXl3b3JkPlByZWRpY3RpdmUgVmFsdWUgb2YgVGVzdHM8L2tleXdvcmQ+

PGtleXdvcmQ+UmV0cm9zcGVjdGl2ZSBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPlJpc2sgQXNz

ZXNzbWVudDwva2V5d29yZD48a2V5d29yZD5TZXggRmFjdG9yczwva2V5d29yZD48a2V5d29yZD5T

dHJva2UgVm9sdW1lLypkcnVnIGVmZmVjdHMvcGh5c2lvbG9neTwva2V5d29yZD48a2V5d29yZD5T

dXJ2aXZhbCBSYXRlPC9rZXl3b3JkPjxrZXl3b3JkPlRyZWF0bWVudCBPdXRjb21lPC9rZXl3b3Jk

PjxrZXl3b3JkPlZlbnRyaWN1bGFyIER5c2Z1bmN0aW9uLCBMZWZ0LypkaWFnbm9zdGljIGltYWdp

bmcvcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPlZlbnRyaWN1bGFyIEZ1bmN0aW9u

LCBMZWZ0LypkcnVnIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+YW50aHJhY3ljbGluZTwva2V5

d29yZD48a2V5d29yZD5jaGVtb3RoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+ZWNob2NhcmRpb2dy

YXBoeTwva2V5d29yZD48a2V5d29yZD5oZWFydCBmYWlsdXJlPC9rZXl3b3JkPjxrZXl3b3JkPmxl

ZnQgdmVudHJpY3VsYXIgZnVuY3Rpb248L2tleXdvcmQ+PGtleXdvcmQ+c3RyYWluPC9rZXl3b3Jk

Pjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTU8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5TZXA8

L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4yMDQ3LTI0MTIgKEVsZWN0cm9uaWMpJiN4

RDsyMDQ3LTI0MDQgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI1OTI1MjIwPC9hY2Nl

c3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwczovL3d3dy5uY2JpLm5sbS5u

aWguZ292L3B1Ym1lZC8yNTkyNTIyMDwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ry

b25pYy1yZXNvdXJjZS1udW0+MTAuMTA5My9laGpjaS9qZXYxMTM8L2VsZWN0cm9uaWMtcmVzb3Vy

Y2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE.DATA (4)Retrospective158, 53±15Breast (32%), blood (49%), others (20%)/ anthracyclinesAll patients had baseline LVEF of 50% to 59%. 7.6% symptomatic HF and cardiac death. LVEF not predictive. LVEDV, indexed LVEDV (LVEDVI), LVESV, indexed LVESV (LVESVI), and GLS HR of 1.03 (p < 0.02), 1.04 (p < 0.04), 1.07 (p < 0.003), 1.11 (p < 0.02), and 1.36 (p < 0.007) per unit change, respectively. GLS ≤16%, HR: 4.7 (p < 0.004). Ali et al., 2016 ADDIN EN.CITE <EndNote><Cite><Author>Ali</Author><Year>2016</Year><RecNum>61</RecNum><DisplayText>(5)</DisplayText><record><rec-number>61</rec-number><foreign-keys><key app="EN" db-id="zd9ffxrs22dpebe5ftqp5w2j0xsf220rddsr" timestamp="1510778629">61</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ali, M. T.</author><author>Yucel, E.</author><author>Bouras, S.</author><author>Wang, L.</author><author>Fei, H. W.</author><author>Halpern, E. F.</author><author>Scherrer-Crosbie, M.</author></authors></contributors><auth-address>Cardiac Ultrasound Laboratory, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.&#xD;Institute for Technology Assessment, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.&#xD;Cardiac Ultrasound Laboratory, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: marielle@.</auth-address><titles><title>Myocardial Strain Is Associated with Adverse Clinical Cardiac Events in Patients Treated with Anthracyclines</title><secondary-title>J Am Soc Echocardiogr</secondary-title></titles><periodical><full-title>J Am Soc Echocardiogr</full-title></periodical><pages>522-527 e3</pages><volume>29</volume><number>6</number><keywords><keyword>Anthracycline</keyword><keyword>Chemotherapy</keyword><keyword>Echocardiography</keyword><keyword>Heart failure</keyword><keyword>Left ventricular function</keyword><keyword>Strain</keyword></keywords><dates><year>2016</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1097-6795 (Electronic)&#xD;0894-7317 (Linking)</isbn><accession-num>27068546</accession-num><urls><related-urls><url>;(5)Retrospective450, 59 ± 18Blood/ anthracyclines6% symptomatic HF and cardiac death. LVEF (HR: 0.93; p = 0.005), and GLS (HR: 1.47; p < 0.0001). GLS < 17.5%, HR: 6.00 (p < 0.0001).*LLN; lower limits of normal= 52% in men and 54% in womenAC = anthracycline/cyclophosphamide; AUC = area under curve; GLS = global longitudinal strain; HF = heart failure; HR = hazard ratio; LVEDV = left ventricular end-diastolic volume; LVEF = left ventricular ejection fraction; LVESV = left ventricular end-systolic volume; LVID = left ventricular internal diameter in diastole; tx = treatment. Online Table 2. Selected Relevant Published Studies That Have Used Echo to Describe the Phenotype of CTRCD During Cancer TreatmentFirst Author , Year (Ref. #)MethodSample Size, Age?(years)Cancer/TreatmentEcho Timing Echo PhenotypePerez et al., 2008PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QZXJlejwvQXV0aG9yPjxZZWFyPjIwMDg8L1llYXI+PFJl

Y051bT4xMTc8L1JlY051bT48RGlzcGxheVRleHQ+KDYpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxy

ZWMtbnVtYmVyPjExNzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGIt

aWQ9InpkOWZmeHJzMjJkcGViZTVmdHFwNXcyajB4c2YyMjByZGRzciIgdGltZXN0YW1wPSIxNTE4

MjUwMzY2Ij4xMTc8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBB

cnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlBlcmV6

LCBFLiBBLjwvYXV0aG9yPjxhdXRob3I+U3VtYW4sIFYuIEouPC9hdXRob3I+PGF1dGhvcj5EYXZp

ZHNvbiwgTi4gRS48L2F1dGhvcj48YXV0aG9yPlNsZWRnZSwgRy4gVy48L2F1dGhvcj48YXV0aG9y

PkthdWZtYW4sIFAuIEEuPC9hdXRob3I+PGF1dGhvcj5IdWRpcywgQy4gQS48L2F1dGhvcj48YXV0

aG9yPk1hcnRpbm8sIFMuPC9hdXRob3I+PGF1dGhvcj5HcmFsb3csIEouIFIuPC9hdXRob3I+PGF1

dGhvcj5EYWtoaWwsIFMuIFIuPC9hdXRob3I+PGF1dGhvcj5JbmdsZSwgSi4gTi48L2F1dGhvcj48

YXV0aG9yPldpbmVyLCBFLiBQLjwvYXV0aG9yPjxhdXRob3I+R2VsbW9uLCBLLiBBLjwvYXV0aG9y

PjxhdXRob3I+R2Vyc2gsIEIuIEouPC9hdXRob3I+PGF1dGhvcj5KYWZmZSwgQS4gUy48L2F1dGhv

cj48YXV0aG9yPlJvZGVoZWZmZXIsIFIuIEouPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0

b3JzPjxhdXRoLWFkZHJlc3M+RGl2aXNpb24gb2YgSGVtYXRvbG9neS9PbmNvbG9neSwgTWF5byBD

bGluaWMsIDQ1MDAgU2FuIFBhYmxvIFJkLCBKYWNrc29udmlsbGUsIEZMIDMyMjI0LCBVU0EuIHBl

cmV6LmVkaXRoQG1heW8uZWR1PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+Q2FyZGlhYyBz

YWZldHkgYW5hbHlzaXMgb2YgZG94b3J1YmljaW4gYW5kIGN5Y2xvcGhvc3BoYW1pZGUgZm9sbG93

ZWQgYnkgcGFjbGl0YXhlbCB3aXRoIG9yIHdpdGhvdXQgdHJhc3R1enVtYWIgaW4gdGhlIE5vcnRo

IENlbnRyYWwgQ2FuY2VyIFRyZWF0bWVudCBHcm91cCBOOTgzMSBhZGp1dmFudCBicmVhc3QgY2Fu

Y2VyIHRyaWFsPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogQ2xpbiBPbmNvbDwvc2Vjb25kYXJ5

LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkogQ2xpbiBPbmNvbDwvZnVs

bC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjEyMzEtODwvcGFnZXM+PHZvbHVtZT4yNjwvdm9s

dW1lPjxudW1iZXI+ODwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZG9sZXNjZW50PC9rZXl3

b3JkPjxrZXl3b3JkPkFudGlib2RpZXMsIE1vbm9jbG9uYWwvYWRtaW5pc3RyYXRpb24gJmFtcDsg

ZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkFudGlib2RpZXMsIE1vbm9jbG9uYWwsIEh1bWFuaXpl

ZDwva2V5d29yZD48a2V5d29yZD5BbnRpbmVvcGxhc3RpYyBDb21iaW5lZCBDaGVtb3RoZXJhcHkg

UHJvdG9jb2xzLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QnJlYXN0IE5lb3Bs

YXNtcy9jb21wbGljYXRpb25zLypkcnVnIHRoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+Q3ljbG9w

aG9zcGhhbWlkZS9hZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdvcmQ+PGtleXdvcmQ+

RG9zZS1SZXNwb25zZSBSZWxhdGlvbnNoaXAsIERydWc8L2tleXdvcmQ+PGtleXdvcmQ+RG94b3J1

YmljaW4vYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFs

ZTwva2V5d29yZD48a2V5d29yZD5GbHVvcm91cmFjaWwvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9z

YWdlPC9rZXl3b3JkPjxrZXl3b3JkPkhlYXJ0LypkcnVnIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdv

cmQ+SGVhcnQgRmFpbHVyZS8qY2hlbWljYWxseSBpbmR1Y2VkL2RydWcgdGhlcmFweTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+UHJvZ25vc2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPlJlY2VwdG9yLCBFcmJCLTIvbWV0YWJvbGlzbTwva2V5d29yZD48a2V5d29yZD5SaXNr

IEZhY3RvcnM8L2tleXdvcmQ+PGtleXdvcmQ+U3Vydml2YWwgUmF0ZTwva2V5d29yZD48a2V5d29y

ZD5UYW1veGlmZW4vYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3Jk

PlRyYXN0dXp1bWFiPC9rZXl3b3JkPjxrZXl3b3JkPlZlbnRyaWN1bGFyIER5c2Z1bmN0aW9uLCBM

ZWZ0L2NoZW1pY2FsbHkgaW5kdWNlZDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4y

MDA4PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+TWFyIDEwPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0

ZXM+PGlzYm4+MTUyNy03NzU1IChFbGVjdHJvbmljKSYjeEQ7MDczMi0xODNYIChMaW5raW5nKTwv

aXNibj48YWNjZXNzaW9uLW51bT4xODI1MDM0OTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRl

ZC11cmxzPjx1cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTgyNTAzNDk8

L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGN1c3RvbTI+UE1DNDA0ODk2MDwvY3VzdG9tMj48

ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTIwMC9KQ08uMjAwNy4xMy41NDY3PC9lbGVjdHJv

bmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QZXJlejwvQXV0aG9yPjxZZWFyPjIwMDg8L1llYXI+PFJl

Y051bT4xMTc8L1JlY051bT48RGlzcGxheVRleHQ+KDYpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxy

ZWMtbnVtYmVyPjExNzwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGIt

aWQ9InpkOWZmeHJzMjJkcGViZTVmdHFwNXcyajB4c2YyMjByZGRzciIgdGltZXN0YW1wPSIxNTE4

MjUwMzY2Ij4xMTc8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBB

cnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlBlcmV6

LCBFLiBBLjwvYXV0aG9yPjxhdXRob3I+U3VtYW4sIFYuIEouPC9hdXRob3I+PGF1dGhvcj5EYXZp

ZHNvbiwgTi4gRS48L2F1dGhvcj48YXV0aG9yPlNsZWRnZSwgRy4gVy48L2F1dGhvcj48YXV0aG9y

PkthdWZtYW4sIFAuIEEuPC9hdXRob3I+PGF1dGhvcj5IdWRpcywgQy4gQS48L2F1dGhvcj48YXV0

aG9yPk1hcnRpbm8sIFMuPC9hdXRob3I+PGF1dGhvcj5HcmFsb3csIEouIFIuPC9hdXRob3I+PGF1

dGhvcj5EYWtoaWwsIFMuIFIuPC9hdXRob3I+PGF1dGhvcj5JbmdsZSwgSi4gTi48L2F1dGhvcj48

YXV0aG9yPldpbmVyLCBFLiBQLjwvYXV0aG9yPjxhdXRob3I+R2VsbW9uLCBLLiBBLjwvYXV0aG9y

PjxhdXRob3I+R2Vyc2gsIEIuIEouPC9hdXRob3I+PGF1dGhvcj5KYWZmZSwgQS4gUy48L2F1dGhv

cj48YXV0aG9yPlJvZGVoZWZmZXIsIFIuIEouPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0

b3JzPjxhdXRoLWFkZHJlc3M+RGl2aXNpb24gb2YgSGVtYXRvbG9neS9PbmNvbG9neSwgTWF5byBD

bGluaWMsIDQ1MDAgU2FuIFBhYmxvIFJkLCBKYWNrc29udmlsbGUsIEZMIDMyMjI0LCBVU0EuIHBl

cmV6LmVkaXRoQG1heW8uZWR1PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+Q2FyZGlhYyBz

YWZldHkgYW5hbHlzaXMgb2YgZG94b3J1YmljaW4gYW5kIGN5Y2xvcGhvc3BoYW1pZGUgZm9sbG93

ZWQgYnkgcGFjbGl0YXhlbCB3aXRoIG9yIHdpdGhvdXQgdHJhc3R1enVtYWIgaW4gdGhlIE5vcnRo

IENlbnRyYWwgQ2FuY2VyIFRyZWF0bWVudCBHcm91cCBOOTgzMSBhZGp1dmFudCBicmVhc3QgY2Fu

Y2VyIHRyaWFsPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogQ2xpbiBPbmNvbDwvc2Vjb25kYXJ5

LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkogQ2xpbiBPbmNvbDwvZnVs

bC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjEyMzEtODwvcGFnZXM+PHZvbHVtZT4yNjwvdm9s

dW1lPjxudW1iZXI+ODwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZG9sZXNjZW50PC9rZXl3

b3JkPjxrZXl3b3JkPkFudGlib2RpZXMsIE1vbm9jbG9uYWwvYWRtaW5pc3RyYXRpb24gJmFtcDsg

ZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkFudGlib2RpZXMsIE1vbm9jbG9uYWwsIEh1bWFuaXpl

ZDwva2V5d29yZD48a2V5d29yZD5BbnRpbmVvcGxhc3RpYyBDb21iaW5lZCBDaGVtb3RoZXJhcHkg

UHJvdG9jb2xzLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QnJlYXN0IE5lb3Bs

YXNtcy9jb21wbGljYXRpb25zLypkcnVnIHRoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+Q3ljbG9w

aG9zcGhhbWlkZS9hZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdvcmQ+PGtleXdvcmQ+

RG9zZS1SZXNwb25zZSBSZWxhdGlvbnNoaXAsIERydWc8L2tleXdvcmQ+PGtleXdvcmQ+RG94b3J1

YmljaW4vYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFs

ZTwva2V5d29yZD48a2V5d29yZD5GbHVvcm91cmFjaWwvYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9z

YWdlPC9rZXl3b3JkPjxrZXl3b3JkPkhlYXJ0LypkcnVnIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdv

cmQ+SGVhcnQgRmFpbHVyZS8qY2hlbWljYWxseSBpbmR1Y2VkL2RydWcgdGhlcmFweTwva2V5d29y

ZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+UHJvZ25vc2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPlJlY2VwdG9yLCBFcmJCLTIvbWV0YWJvbGlzbTwva2V5d29yZD48a2V5d29yZD5SaXNr

IEZhY3RvcnM8L2tleXdvcmQ+PGtleXdvcmQ+U3Vydml2YWwgUmF0ZTwva2V5d29yZD48a2V5d29y

ZD5UYW1veGlmZW4vYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3Jk

PlRyYXN0dXp1bWFiPC9rZXl3b3JkPjxrZXl3b3JkPlZlbnRyaWN1bGFyIER5c2Z1bmN0aW9uLCBM

ZWZ0L2NoZW1pY2FsbHkgaW5kdWNlZDwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4y

MDA4PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+TWFyIDEwPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0

ZXM+PGlzYm4+MTUyNy03NzU1IChFbGVjdHJvbmljKSYjeEQ7MDczMi0xODNYIChMaW5raW5nKTwv

aXNibj48YWNjZXNzaW9uLW51bT4xODI1MDM0OTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRl

ZC11cmxzPjx1cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMTgyNTAzNDk8

L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGN1c3RvbTI+UE1DNDA0ODk2MDwvY3VzdG9tMj48

ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTIwMC9KQ08uMjAwNy4xMy41NDY3PC9lbGVjdHJv

bmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (6) Prospective randomized1,944, 49Breast cancer/AC-T*; AC-T+H; AC-TH HBaseline, 3, 6, 9, 18-21 mAsymptomatic LVEF decrease >10% to <50%: AC-T:4.0% to 5.1%AC-T+H: 4.0% to 7.8%AC-THH: 5.8% to 10.4%Slamon et al., 2011PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TbGFtb248L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS

ZWNOdW0+MTE4PC9SZWNOdW0+PERpc3BsYXlUZXh0Pig3KTwvRGlzcGxheVRleHQ+PHJlY29yZD48

cmVjLW51bWJlcj4xMTg8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRi

LWlkPSJ6ZDlmZnhyczIyZHBlYmU1ZnRxcDV3MmoweHNmMjIwcmRkc3IiIHRpbWVzdGFtcD0iMTUx

ODI1MDQ4MiI+MTE4PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwg

QXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5TbGFt

b24sIEQuPC9hdXRob3I+PGF1dGhvcj5FaWVybWFubiwgVy48L2F1dGhvcj48YXV0aG9yPlJvYmVy

dCwgTi48L2F1dGhvcj48YXV0aG9yPlBpZW5rb3dza2ksIFQuPC9hdXRob3I+PGF1dGhvcj5NYXJ0

aW4sIE0uPC9hdXRob3I+PGF1dGhvcj5QcmVzcywgTS48L2F1dGhvcj48YXV0aG9yPk1hY2tleSwg

Si48L2F1dGhvcj48YXV0aG9yPkdsYXNweSwgSi48L2F1dGhvcj48YXV0aG9yPkNoYW4sIEEuPC9h

dXRob3I+PGF1dGhvcj5QYXdsaWNraSwgTS48L2F1dGhvcj48YXV0aG9yPlBpbnRlciwgVC48L2F1

dGhvcj48YXV0aG9yPlZhbGVybywgVi48L2F1dGhvcj48YXV0aG9yPkxpdSwgTS4gQy48L2F1dGhv

cj48YXV0aG9yPlNhdXRlciwgRy48L2F1dGhvcj48YXV0aG9yPnZvbiBNaW5ja3dpdHosIEcuPC9h

dXRob3I+PGF1dGhvcj5WaXNjbywgRi48L2F1dGhvcj48YXV0aG9yPkJlZSwgVi48L2F1dGhvcj48

YXV0aG9yPkJ1eXNlLCBNLjwvYXV0aG9yPjxhdXRob3I+QmVuZGFobWFuZSwgQi48L2F1dGhvcj48

YXV0aG9yPlRhYmFoLUZpc2NoLCBJLjwvYXV0aG9yPjxhdXRob3I+TGluZHNheSwgTS4gQS48L2F1

dGhvcj48YXV0aG9yPlJpdmEsIEEuPC9hdXRob3I+PGF1dGhvcj5Dcm93biwgSi48L2F1dGhvcj48

YXV0aG9yPkJyZWFzdCBDYW5jZXIgSW50ZXJuYXRpb25hbCBSZXNlYXJjaCwgR3JvdXA8L2F1dGhv

cj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5Kb25zc29uIENvbXByZWhl

bnNpdmUgQ2FuY2VyIENlbnRlciwgVW5pdmVyc2l0eSBvZiBDYWxpZm9ybmlhLUxvcyBBbmdlbGVz

LCBMb3MgQW5nZWxlcywgQ0EgOTAwOTUtMTY3OCwgVVNBLiBkc2xhbW9uQG1lZG5ldC51Y2xhLmVk

dTwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkFkanV2YW50IHRyYXN0dXp1bWFiIGluIEhF

UjItcG9zaXRpdmUgYnJlYXN0IGNhbmNlcjwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5OIEVuZ2wg

SiBNZWQ8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5O

IEVuZ2wgSiBNZWQ8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4xMjczLTgzPC9wYWdl

cz48dm9sdW1lPjM2NTwvdm9sdW1lPjxudW1iZXI+MTQ8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QW50aHJhY3ljbGluZXMvYWR2ZXJzZSBlZmZlY3RzL3RoZXJhcGV1dGljIHVzZTwva2V5d29y

ZD48a2V5d29yZD5BbnRpYm9kaWVzLCBNb25vY2xvbmFsL2FkdmVyc2UgZWZmZWN0cy8qdGhlcmFw

ZXV0aWMgdXNlPC9rZXl3b3JkPjxrZXl3b3JkPkFudGlib2RpZXMsIE1vbm9jbG9uYWwsIEh1bWFu

aXplZDwva2V5d29yZD48a2V5d29yZD5BbnRpbmVvcGxhc3RpYyBDb21iaW5lZCBDaGVtb3RoZXJh

cHkgUHJvdG9jb2xzL2FkdmVyc2UgZWZmZWN0cy8qdGhlcmFwZXV0aWMgdXNlPC9rZXl3b3JkPjxr

ZXl3b3JkPkJyZWFzdCBOZW9wbGFzbXMvKmRydWcgdGhlcmFweS9tb3J0YWxpdHk8L2tleXdvcmQ+

PGtleXdvcmQ+Q2hlbW90aGVyYXB5LCBBZGp1dmFudDwva2V5d29yZD48a2V5d29yZD5EaXNlYXNl

LUZyZWUgU3Vydml2YWw8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3Jk

PkhlYXJ0IEZhaWx1cmUvY2hlbWljYWxseSBpbmR1Y2VkPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFu

czwva2V5d29yZD48a2V5d29yZD5JbnRlbnRpb24gdG8gVHJlYXQgQW5hbHlzaXM8L2tleXdvcmQ+

PGtleXdvcmQ+TGV1a2VtaWEvY2hlbWljYWxseSBpbmR1Y2VkPC9rZXl3b3JkPjxrZXl3b3JkPk1p

ZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPipSZWNlcHRvciwgRXJiQi0yPC9rZXl3b3JkPjxr

ZXl3b3JkPlN0cm9rZSBWb2x1bWUvZHJ1ZyBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZp

dmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJhc3R1enVtYWI8L2tleXdvcmQ+PC9rZXl3b3Jk

cz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxkYXRlPk9jdCA2PC9kYXRlPjwv

cHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTUzMy00NDA2IChFbGVjdHJvbmljKSYjeEQ7MDAyOC00

NzkzIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMTk5MTk0OTwvYWNjZXNzaW9uLW51

bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9w

dWJtZWQvMjE5OTE5NDk8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGN1c3RvbTI+UE1DMzI2

ODU1MzwvY3VzdG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTA1Ni9ORUpNb2EwOTEw

MzgzPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TbGFtb248L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxS

ZWNOdW0+MTE4PC9SZWNOdW0+PERpc3BsYXlUZXh0Pig3KTwvRGlzcGxheVRleHQ+PHJlY29yZD48

cmVjLW51bWJlcj4xMTg8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRi

LWlkPSJ6ZDlmZnhyczIyZHBlYmU1ZnRxcDV3MmoweHNmMjIwcmRkc3IiIHRpbWVzdGFtcD0iMTUx

ODI1MDQ4MiI+MTE4PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwg

QXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5TbGFt

b24sIEQuPC9hdXRob3I+PGF1dGhvcj5FaWVybWFubiwgVy48L2F1dGhvcj48YXV0aG9yPlJvYmVy

dCwgTi48L2F1dGhvcj48YXV0aG9yPlBpZW5rb3dza2ksIFQuPC9hdXRob3I+PGF1dGhvcj5NYXJ0

aW4sIE0uPC9hdXRob3I+PGF1dGhvcj5QcmVzcywgTS48L2F1dGhvcj48YXV0aG9yPk1hY2tleSwg

Si48L2F1dGhvcj48YXV0aG9yPkdsYXNweSwgSi48L2F1dGhvcj48YXV0aG9yPkNoYW4sIEEuPC9h

dXRob3I+PGF1dGhvcj5QYXdsaWNraSwgTS48L2F1dGhvcj48YXV0aG9yPlBpbnRlciwgVC48L2F1

dGhvcj48YXV0aG9yPlZhbGVybywgVi48L2F1dGhvcj48YXV0aG9yPkxpdSwgTS4gQy48L2F1dGhv

cj48YXV0aG9yPlNhdXRlciwgRy48L2F1dGhvcj48YXV0aG9yPnZvbiBNaW5ja3dpdHosIEcuPC9h

dXRob3I+PGF1dGhvcj5WaXNjbywgRi48L2F1dGhvcj48YXV0aG9yPkJlZSwgVi48L2F1dGhvcj48

YXV0aG9yPkJ1eXNlLCBNLjwvYXV0aG9yPjxhdXRob3I+QmVuZGFobWFuZSwgQi48L2F1dGhvcj48

YXV0aG9yPlRhYmFoLUZpc2NoLCBJLjwvYXV0aG9yPjxhdXRob3I+TGluZHNheSwgTS4gQS48L2F1

dGhvcj48YXV0aG9yPlJpdmEsIEEuPC9hdXRob3I+PGF1dGhvcj5Dcm93biwgSi48L2F1dGhvcj48

YXV0aG9yPkJyZWFzdCBDYW5jZXIgSW50ZXJuYXRpb25hbCBSZXNlYXJjaCwgR3JvdXA8L2F1dGhv

cj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5Kb25zc29uIENvbXByZWhl

bnNpdmUgQ2FuY2VyIENlbnRlciwgVW5pdmVyc2l0eSBvZiBDYWxpZm9ybmlhLUxvcyBBbmdlbGVz

LCBMb3MgQW5nZWxlcywgQ0EgOTAwOTUtMTY3OCwgVVNBLiBkc2xhbW9uQG1lZG5ldC51Y2xhLmVk

dTwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkFkanV2YW50IHRyYXN0dXp1bWFiIGluIEhF

UjItcG9zaXRpdmUgYnJlYXN0IGNhbmNlcjwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5OIEVuZ2wg

SiBNZWQ8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5O

IEVuZ2wgSiBNZWQ8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4xMjczLTgzPC9wYWdl

cz48dm9sdW1lPjM2NTwvdm9sdW1lPjxudW1iZXI+MTQ8L251bWJlcj48a2V5d29yZHM+PGtleXdv

cmQ+QW50aHJhY3ljbGluZXMvYWR2ZXJzZSBlZmZlY3RzL3RoZXJhcGV1dGljIHVzZTwva2V5d29y

ZD48a2V5d29yZD5BbnRpYm9kaWVzLCBNb25vY2xvbmFsL2FkdmVyc2UgZWZmZWN0cy8qdGhlcmFw

ZXV0aWMgdXNlPC9rZXl3b3JkPjxrZXl3b3JkPkFudGlib2RpZXMsIE1vbm9jbG9uYWwsIEh1bWFu

aXplZDwva2V5d29yZD48a2V5d29yZD5BbnRpbmVvcGxhc3RpYyBDb21iaW5lZCBDaGVtb3RoZXJh

cHkgUHJvdG9jb2xzL2FkdmVyc2UgZWZmZWN0cy8qdGhlcmFwZXV0aWMgdXNlPC9rZXl3b3JkPjxr

ZXl3b3JkPkJyZWFzdCBOZW9wbGFzbXMvKmRydWcgdGhlcmFweS9tb3J0YWxpdHk8L2tleXdvcmQ+

PGtleXdvcmQ+Q2hlbW90aGVyYXB5LCBBZGp1dmFudDwva2V5d29yZD48a2V5d29yZD5EaXNlYXNl

LUZyZWUgU3Vydml2YWw8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3Jk

PkhlYXJ0IEZhaWx1cmUvY2hlbWljYWxseSBpbmR1Y2VkPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFu

czwva2V5d29yZD48a2V5d29yZD5JbnRlbnRpb24gdG8gVHJlYXQgQW5hbHlzaXM8L2tleXdvcmQ+

PGtleXdvcmQ+TGV1a2VtaWEvY2hlbWljYWxseSBpbmR1Y2VkPC9rZXl3b3JkPjxrZXl3b3JkPk1p

ZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPipSZWNlcHRvciwgRXJiQi0yPC9rZXl3b3JkPjxr

ZXl3b3JkPlN0cm9rZSBWb2x1bWUvZHJ1ZyBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPlN1cnZp

dmFsIFJhdGU8L2tleXdvcmQ+PGtleXdvcmQ+VHJhc3R1enVtYWI8L2tleXdvcmQ+PC9rZXl3b3Jk

cz48ZGF0ZXM+PHllYXI+MjAxMTwveWVhcj48cHViLWRhdGVzPjxkYXRlPk9jdCA2PC9kYXRlPjwv

cHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTUzMy00NDA2IChFbGVjdHJvbmljKSYjeEQ7MDAyOC00

NzkzIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMTk5MTk0OTwvYWNjZXNzaW9uLW51

bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9w

dWJtZWQvMjE5OTE5NDk8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGN1c3RvbTI+UE1DMzI2

ODU1MzwvY3VzdG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTA1Ni9ORUpNb2EwOTEw

MzgzPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA (7) Prospective randomized 3,222;<50 in >50% of patientsBreast cancer/AC-T; AC-T+H; TCHBaseline, 7 times over study duration Asymptomatic LVEF decrease >10 %to <50%:9.4 to 18.6%Cardinale et al., 2015PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DYXJkaW5hbGU8L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFy

PjxSZWNOdW0+Nzc8L1JlY051bT48RGlzcGxheVRleHQ+KDgpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjc3PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iemQ5ZmZ4cnMyMmRwZWJlNWZ0cXA1dzJqMHhzZjIyMHJkZHNyIiB0aW1lc3RhbXA9IjE1

MTA3ODQxMzkiPjc3PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwg

QXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5DYXJk

aW5hbGUsIEQuPC9hdXRob3I+PGF1dGhvcj5Db2xvbWJvLCBBLjwvYXV0aG9yPjxhdXRob3I+QmFj

Y2hpYW5pLCBHLjwvYXV0aG9yPjxhdXRob3I+VGVkZXNjaGksIEkuPC9hdXRob3I+PGF1dGhvcj5N

ZXJvbmksIEMuIEEuPC9hdXRob3I+PGF1dGhvcj5WZWdsaWEsIEYuPC9hdXRob3I+PGF1dGhvcj5D

aXZlbGxpLCBNLjwvYXV0aG9yPjxhdXRob3I+TGFtYW50aWEsIEcuPC9hdXRob3I+PGF1dGhvcj5D

b2xvbWJvLCBOLjwvYXV0aG9yPjxhdXRob3I+Q3VyaWdsaWFubywgRy48L2F1dGhvcj48YXV0aG9y

PkZpb3JlbnRpbmksIEMuPC9hdXRob3I+PGF1dGhvcj5DaXBvbGxhLCBDLiBNLjwvYXV0aG9yPjwv

YXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkZyb20gRXVyb3BlYW4gSW5zdGl0

dXRlIG9mIE9uY29sb2d5LCBNaWxhbiwgSXRhbHkgKEQuQy4sIEEuQy4sIEcuQi4sIEkuVC4sIEMu

QS5NLiwgTS5DLiwgRy5MLiwgTi5DLiwgRy5DLiwgQy5NLkMuKTsgYW5kIENlbnRybyBDYXJkaW9s

b2dpY28gTW9uemlubyAoSS5SLkMuQy5TLiksIE1pbGFuLCBJdGFseSAoRi5WLiwgQy5GLikuIGRh

bmllbGEuY2FyZGluYWxlQGllby5pdC4mI3hEO0Zyb20gRXVyb3BlYW4gSW5zdGl0dXRlIG9mIE9u

Y29sb2d5LCBNaWxhbiwgSXRhbHkgKEQuQy4sIEEuQy4sIEcuQi4sIEkuVC4sIEMuQS5NLiwgTS5D

LiwgRy5MLiwgTi5DLiwgRy5DLiwgQy5NLkMuKTsgYW5kIENlbnRybyBDYXJkaW9sb2dpY28gTW9u

emlubyAoSS5SLkMuQy5TLiksIE1pbGFuLCBJdGFseSAoRi5WLiwgQy5GLikuPC9hdXRoLWFkZHJl

c3M+PHRpdGxlcz48dGl0bGU+RWFybHkgZGV0ZWN0aW9uIG9mIGFudGhyYWN5Y2xpbmUgY2FyZGlv

dG94aWNpdHkgYW5kIGltcHJvdmVtZW50IHdpdGggaGVhcnQgZmFpbHVyZSB0aGVyYXB5PC90aXRs

ZT48c2Vjb25kYXJ5LXRpdGxlPkNpcmN1bGF0aW9uPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+

PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Q2lyY3VsYXRpb248L2Z1bGwtdGl0bGU+PC9wZXJpb2Rp

Y2FsPjxwYWdlcz4xOTgxLTg8L3BhZ2VzPjx2b2x1bWU+MTMxPC92b2x1bWU+PG51bWJlcj4yMjwv

bnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BbnRocmFj

eWNsaW5lcy9hZHZlcnNlIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWJpb3RpY3MsIEFu

dGluZW9wbGFzdGljLyphZHZlcnNlIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyZGlvdG94

aWNpdHkvZGlhZ25vc2lzL3RoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+Q29ob3J0IFN0dWRpZXM8

L2tleXdvcmQ+PGtleXdvcmQ+RG94b3J1YmljaW4vKmFkdmVyc2UgZWZmZWN0czwva2V5d29yZD48

a2V5d29yZD5FYXJseSBEaWFnbm9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3Jk

PjxrZXl3b3JkPkZvbGxvdy1VcCBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkhlYXJ0IEZhaWx1

cmUvKmNoZW1pY2FsbHkgaW5kdWNlZC8qZGlhZ25vc2lzL3RoZXJhcHk8L2tleXdvcmQ+PGtleXdv

cmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxl

IEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+UHJvc3BlY3RpdmUgU3R1ZGllczwva2V5d29yZD48a2V5

d29yZD5TdHJva2UgVm9sdW1lL2RydWcgZWZmZWN0cy9waHlzaW9sb2d5PC9rZXl3b3JkPjxrZXl3

b3JkPmFudGhyYWN5Y2xpbmVzPC9rZXl3b3JkPjxrZXl3b3JkPmNhcmRpb215b3BhdGhpZXM8L2tl

eXdvcmQ+PGtleXdvcmQ+Y2FyZGlvdG94aWNpdHk8L2tleXdvcmQ+PGtleXdvcmQ+ZHJ1ZyB0aGVy

YXB5PC9rZXl3b3JkPjxrZXl3b3JkPmhlYXJ0IGZhaWx1cmU8L2tleXdvcmQ+PGtleXdvcmQ+cmVj

b3Zlcnkgb2YgZnVuY3Rpb248L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxNTwv

eWVhcj48cHViLWRhdGVzPjxkYXRlPkp1biAwMjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxp

c2JuPjE1MjQtNDUzOSAoRWxlY3Ryb25pYykmI3hEOzAwMDktNzMyMiAoTGlua2luZyk8L2lzYm4+

PGFjY2Vzc2lvbi1udW0+MjU5NDg1Mzg8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJs

cz48dXJsPmh0dHBzOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzI1OTQ4NTM4PC91cmw+

PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMTYxL0NJ

UkNVTEFUSU9OQUhBLjExNC4wMTM3Nzc8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3Jk

PjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DYXJkaW5hbGU8L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFy

PjxSZWNOdW0+Nzc8L1JlY051bT48RGlzcGxheVRleHQ+KDgpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjc3PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iemQ5ZmZ4cnMyMmRwZWJlNWZ0cXA1dzJqMHhzZjIyMHJkZHNyIiB0aW1lc3RhbXA9IjE1

MTA3ODQxMzkiPjc3PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwg

QXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5DYXJk

aW5hbGUsIEQuPC9hdXRob3I+PGF1dGhvcj5Db2xvbWJvLCBBLjwvYXV0aG9yPjxhdXRob3I+QmFj

Y2hpYW5pLCBHLjwvYXV0aG9yPjxhdXRob3I+VGVkZXNjaGksIEkuPC9hdXRob3I+PGF1dGhvcj5N

ZXJvbmksIEMuIEEuPC9hdXRob3I+PGF1dGhvcj5WZWdsaWEsIEYuPC9hdXRob3I+PGF1dGhvcj5D

aXZlbGxpLCBNLjwvYXV0aG9yPjxhdXRob3I+TGFtYW50aWEsIEcuPC9hdXRob3I+PGF1dGhvcj5D

b2xvbWJvLCBOLjwvYXV0aG9yPjxhdXRob3I+Q3VyaWdsaWFubywgRy48L2F1dGhvcj48YXV0aG9y

PkZpb3JlbnRpbmksIEMuPC9hdXRob3I+PGF1dGhvcj5DaXBvbGxhLCBDLiBNLjwvYXV0aG9yPjwv

YXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkZyb20gRXVyb3BlYW4gSW5zdGl0

dXRlIG9mIE9uY29sb2d5LCBNaWxhbiwgSXRhbHkgKEQuQy4sIEEuQy4sIEcuQi4sIEkuVC4sIEMu

QS5NLiwgTS5DLiwgRy5MLiwgTi5DLiwgRy5DLiwgQy5NLkMuKTsgYW5kIENlbnRybyBDYXJkaW9s

b2dpY28gTW9uemlubyAoSS5SLkMuQy5TLiksIE1pbGFuLCBJdGFseSAoRi5WLiwgQy5GLikuIGRh

bmllbGEuY2FyZGluYWxlQGllby5pdC4mI3hEO0Zyb20gRXVyb3BlYW4gSW5zdGl0dXRlIG9mIE9u

Y29sb2d5LCBNaWxhbiwgSXRhbHkgKEQuQy4sIEEuQy4sIEcuQi4sIEkuVC4sIEMuQS5NLiwgTS5D

LiwgRy5MLiwgTi5DLiwgRy5DLiwgQy5NLkMuKTsgYW5kIENlbnRybyBDYXJkaW9sb2dpY28gTW9u

emlubyAoSS5SLkMuQy5TLiksIE1pbGFuLCBJdGFseSAoRi5WLiwgQy5GLikuPC9hdXRoLWFkZHJl

c3M+PHRpdGxlcz48dGl0bGU+RWFybHkgZGV0ZWN0aW9uIG9mIGFudGhyYWN5Y2xpbmUgY2FyZGlv

dG94aWNpdHkgYW5kIGltcHJvdmVtZW50IHdpdGggaGVhcnQgZmFpbHVyZSB0aGVyYXB5PC90aXRs

ZT48c2Vjb25kYXJ5LXRpdGxlPkNpcmN1bGF0aW9uPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+

PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Q2lyY3VsYXRpb248L2Z1bGwtdGl0bGU+PC9wZXJpb2Rp

Y2FsPjxwYWdlcz4xOTgxLTg8L3BhZ2VzPjx2b2x1bWU+MTMxPC92b2x1bWU+PG51bWJlcj4yMjwv

bnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BbnRocmFj

eWNsaW5lcy9hZHZlcnNlIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWJpb3RpY3MsIEFu

dGluZW9wbGFzdGljLyphZHZlcnNlIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyZGlvdG94

aWNpdHkvZGlhZ25vc2lzL3RoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+Q29ob3J0IFN0dWRpZXM8

L2tleXdvcmQ+PGtleXdvcmQ+RG94b3J1YmljaW4vKmFkdmVyc2UgZWZmZWN0czwva2V5d29yZD48

a2V5d29yZD5FYXJseSBEaWFnbm9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3Jk

PjxrZXl3b3JkPkZvbGxvdy1VcCBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkhlYXJ0IEZhaWx1

cmUvKmNoZW1pY2FsbHkgaW5kdWNlZC8qZGlhZ25vc2lzL3RoZXJhcHk8L2tleXdvcmQ+PGtleXdv

cmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxl

IEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+UHJvc3BlY3RpdmUgU3R1ZGllczwva2V5d29yZD48a2V5

d29yZD5TdHJva2UgVm9sdW1lL2RydWcgZWZmZWN0cy9waHlzaW9sb2d5PC9rZXl3b3JkPjxrZXl3

b3JkPmFudGhyYWN5Y2xpbmVzPC9rZXl3b3JkPjxrZXl3b3JkPmNhcmRpb215b3BhdGhpZXM8L2tl

eXdvcmQ+PGtleXdvcmQ+Y2FyZGlvdG94aWNpdHk8L2tleXdvcmQ+PGtleXdvcmQ+ZHJ1ZyB0aGVy

YXB5PC9rZXl3b3JkPjxrZXl3b3JkPmhlYXJ0IGZhaWx1cmU8L2tleXdvcmQ+PGtleXdvcmQ+cmVj

b3Zlcnkgb2YgZnVuY3Rpb248L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxNTwv

eWVhcj48cHViLWRhdGVzPjxkYXRlPkp1biAwMjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxp

c2JuPjE1MjQtNDUzOSAoRWxlY3Ryb25pYykmI3hEOzAwMDktNzMyMiAoTGlua2luZyk8L2lzYm4+

PGFjY2Vzc2lvbi1udW0+MjU5NDg1Mzg8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJs

cz48dXJsPmh0dHBzOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzI1OTQ4NTM4PC91cmw+

PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMTYxL0NJ

UkNVTEFUSU9OQUhBLjExNC4wMTM3Nzc8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3Jk

PjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE.DATA (8)Prospective2,625, 51±13Breast cancer, HL, NHL, myeloma, other types of solid tumors/AC;EC;CEF;ACOD;VAD;ChIVPP;ABVVPBaseline, every 3 m during chemotherapy, at the end of treatment, every 3 m during the first year after chemotherapy, every 6 m afterwards for 4 yearsIncidence of cardiotoxicity 9% (LVEF decrease >10 absolute points to <50%); 98% of cases occurred within the first year and was associated with anthracycline dose and LVEF at the end of treatment.Procter et al., 2010PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Qcm9jdGVyPC9BdXRob3I+PFllYXI+MjAxMDwvWWVhcj48

UmVjTnVtPjExOTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oOSk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+

PHJlYy1udW1iZXI+MTE5PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iemQ5ZmZ4cnMyMmRwZWJlNWZ0cXA1dzJqMHhzZjIyMHJkZHNyIiB0aW1lc3RhbXA9IjE1

MTgyNTA3OTUiPjExOTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFs

IEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+UHJv

Y3RlciwgTS48L2F1dGhvcj48YXV0aG9yPlN1dGVyLCBULiBNLjwvYXV0aG9yPjxhdXRob3I+ZGUg

QXphbWJ1amEsIEUuPC9hdXRob3I+PGF1dGhvcj5EYWZuaSwgVS48L2F1dGhvcj48YXV0aG9yPnZh

biBEb29yZW4sIFYuPC9hdXRob3I+PGF1dGhvcj5NdWVobGJhdWVyLCBTLjwvYXV0aG9yPjxhdXRo

b3I+Q2xpbWVudCwgTS4gQS48L2F1dGhvcj48YXV0aG9yPlJlY2hiZXJnZXIsIEUuPC9hdXRob3I+

PGF1dGhvcj5MaXUsIFcuIFQuPC9hdXRob3I+PGF1dGhvcj5Ub2ksIE0uPC9hdXRob3I+PGF1dGhv

cj5Db29tYmVzLCBSLiBDLjwvYXV0aG9yPjxhdXRob3I+RG9kd2VsbCwgRC48L2F1dGhvcj48YXV0

aG9yPlBhZ2FuaSwgTy48L2F1dGhvcj48YXV0aG9yPk1hZHJpZCwgSi48L2F1dGhvcj48YXV0aG9y

PkhhbGwsIE0uPC9hdXRob3I+PGF1dGhvcj5DaGVuLCBTLiBDLjwvYXV0aG9yPjxhdXRob3I+Rm9j

YW4sIEMuPC9hdXRob3I+PGF1dGhvcj5NdXNjaG9sLCBNLjwvYXV0aG9yPjxhdXRob3I+dmFuIFZl

bGRodWlzZW4sIEQuIEouPC9hdXRob3I+PGF1dGhvcj5QaWNjYXJ0LUdlYmhhcnQsIE0uIEouPC9h

dXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RnJvbnRpZXIgU2Np

ZW5jZSBTY290bGFuZCwgS2luY3JhaWcsIEtpbmd1c3NpZSwgSW1wZXJpYWwgQ29sbGVnZSBMb25k

b24sIExvbmRvbiwgVUsuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+TG9uZ2VyLXRlcm0g

YXNzZXNzbWVudCBvZiB0cmFzdHV6dW1hYi1yZWxhdGVkIGNhcmRpYWMgYWR2ZXJzZSBldmVudHMg

aW4gdGhlIEhlcmNlcHRpbiBBZGp1dmFudCAoSEVSQSkgdHJpYWw8L3RpdGxlPjxzZWNvbmRhcnkt

dGl0bGU+SiBDbGluIE9uY29sPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+

PGZ1bGwtdGl0bGU+SiBDbGluIE9uY29sPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+

MzQyMi04PC9wYWdlcz48dm9sdW1lPjI4PC92b2x1bWU+PG51bWJlcj4yMTwvbnVtYmVyPjxrZXl3

b3Jkcz48a2V5d29yZD5BbnRpYm9kaWVzLCBNb25vY2xvbmFsLyphZHZlcnNlIGVmZmVjdHM8L2tl

eXdvcmQ+PGtleXdvcmQ+QW50aWJvZGllcywgTW9ub2Nsb25hbCwgSHVtYW5pemVkPC9rZXl3b3Jk

PjxrZXl3b3JkPkFudGluZW9wbGFzdGljIEFnZW50cy8qYWR2ZXJzZSBlZmZlY3RzPC9rZXl3b3Jk

PjxrZXl3b3JkPkJyZWFzdCBOZW9wbGFzbXMvKmRydWcgdGhlcmFweTwva2V5d29yZD48a2V5d29y

ZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SGVhcnQgRmFpbHVyZS8qY2hlbWljYWxseSBpbmR1

Y2VkPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5SZWNlcHRvciwg

RXJiQi0yL2FuYWx5c2lzPC9rZXl3b3JkPjxrZXl3b3JkPlRyYXN0dXp1bWFiPC9rZXl3b3JkPjxr

ZXl3b3JkPlZlbnRyaWN1bGFyIEZ1bmN0aW9uLCBMZWZ0L2RydWcgZWZmZWN0czwva2V5d29yZD48

L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDEwPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+SnVsIDIw

PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTUyNy03NzU1IChFbGVjdHJvbmljKSYj

eEQ7MDczMi0xODNYIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMDUzMDI4MDwvYWNj

ZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0u

bmloLmdvdi9wdWJtZWQvMjA1MzAyODA8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0

cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyMDAvSkNPLjIwMDkuMjYuMDQ2MzwvZWxlY3Ryb25pYy1y

ZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Qcm9jdGVyPC9BdXRob3I+PFllYXI+MjAxMDwvWWVhcj48

UmVjTnVtPjExOTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oOSk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+

PHJlYy1udW1iZXI+MTE5PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iemQ5ZmZ4cnMyMmRwZWJlNWZ0cXA1dzJqMHhzZjIyMHJkZHNyIiB0aW1lc3RhbXA9IjE1

MTgyNTA3OTUiPjExOTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFs

IEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+UHJv

Y3RlciwgTS48L2F1dGhvcj48YXV0aG9yPlN1dGVyLCBULiBNLjwvYXV0aG9yPjxhdXRob3I+ZGUg

QXphbWJ1amEsIEUuPC9hdXRob3I+PGF1dGhvcj5EYWZuaSwgVS48L2F1dGhvcj48YXV0aG9yPnZh

biBEb29yZW4sIFYuPC9hdXRob3I+PGF1dGhvcj5NdWVobGJhdWVyLCBTLjwvYXV0aG9yPjxhdXRo

b3I+Q2xpbWVudCwgTS4gQS48L2F1dGhvcj48YXV0aG9yPlJlY2hiZXJnZXIsIEUuPC9hdXRob3I+

PGF1dGhvcj5MaXUsIFcuIFQuPC9hdXRob3I+PGF1dGhvcj5Ub2ksIE0uPC9hdXRob3I+PGF1dGhv

cj5Db29tYmVzLCBSLiBDLjwvYXV0aG9yPjxhdXRob3I+RG9kd2VsbCwgRC48L2F1dGhvcj48YXV0

aG9yPlBhZ2FuaSwgTy48L2F1dGhvcj48YXV0aG9yPk1hZHJpZCwgSi48L2F1dGhvcj48YXV0aG9y

PkhhbGwsIE0uPC9hdXRob3I+PGF1dGhvcj5DaGVuLCBTLiBDLjwvYXV0aG9yPjxhdXRob3I+Rm9j

YW4sIEMuPC9hdXRob3I+PGF1dGhvcj5NdXNjaG9sLCBNLjwvYXV0aG9yPjxhdXRob3I+dmFuIFZl

bGRodWlzZW4sIEQuIEouPC9hdXRob3I+PGF1dGhvcj5QaWNjYXJ0LUdlYmhhcnQsIE0uIEouPC9h

dXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+RnJvbnRpZXIgU2Np

ZW5jZSBTY290bGFuZCwgS2luY3JhaWcsIEtpbmd1c3NpZSwgSW1wZXJpYWwgQ29sbGVnZSBMb25k

b24sIExvbmRvbiwgVUsuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+TG9uZ2VyLXRlcm0g

YXNzZXNzbWVudCBvZiB0cmFzdHV6dW1hYi1yZWxhdGVkIGNhcmRpYWMgYWR2ZXJzZSBldmVudHMg

aW4gdGhlIEhlcmNlcHRpbiBBZGp1dmFudCAoSEVSQSkgdHJpYWw8L3RpdGxlPjxzZWNvbmRhcnkt

dGl0bGU+SiBDbGluIE9uY29sPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+

PGZ1bGwtdGl0bGU+SiBDbGluIE9uY29sPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+

MzQyMi04PC9wYWdlcz48dm9sdW1lPjI4PC92b2x1bWU+PG51bWJlcj4yMTwvbnVtYmVyPjxrZXl3

b3Jkcz48a2V5d29yZD5BbnRpYm9kaWVzLCBNb25vY2xvbmFsLyphZHZlcnNlIGVmZmVjdHM8L2tl

eXdvcmQ+PGtleXdvcmQ+QW50aWJvZGllcywgTW9ub2Nsb25hbCwgSHVtYW5pemVkPC9rZXl3b3Jk

PjxrZXl3b3JkPkFudGluZW9wbGFzdGljIEFnZW50cy8qYWR2ZXJzZSBlZmZlY3RzPC9rZXl3b3Jk

PjxrZXl3b3JkPkJyZWFzdCBOZW9wbGFzbXMvKmRydWcgdGhlcmFweTwva2V5d29yZD48a2V5d29y

ZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SGVhcnQgRmFpbHVyZS8qY2hlbWljYWxseSBpbmR1

Y2VkPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5SZWNlcHRvciwg

RXJiQi0yL2FuYWx5c2lzPC9rZXl3b3JkPjxrZXl3b3JkPlRyYXN0dXp1bWFiPC9rZXl3b3JkPjxr

ZXl3b3JkPlZlbnRyaWN1bGFyIEZ1bmN0aW9uLCBMZWZ0L2RydWcgZWZmZWN0czwva2V5d29yZD48

L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDEwPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+SnVsIDIw

PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTUyNy03NzU1IChFbGVjdHJvbmljKSYj

eEQ7MDczMi0xODNYIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMDUzMDI4MDwvYWNj

ZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0u

bmloLmdvdi9wdWJtZWQvMjA1MzAyODA8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0

cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEyMDAvSkNPLjIwMDkuMjYuMDQ2MzwvZWxlY3Ryb25pYy1y

ZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE.DATA (9)Prospective randomized 1,698,49Breast cancer/Chemotherapy H x 1 yrChemotherapy H x 2 yr3, 6, 12, 18, 24, 30, and 36 m, and annually thereafter up to 10 years Asymptomatic LVEF decrease >10 %to <50%:4.1% to 7.2%*AC-T denotes doxorubicin and cyclophosphamide followed by docetaxelAC-T+H = doxorubicin and cyclophosphamide followed by paclitaxel then Herceptin; AC-TH H = doxorubicin and cyclophosphamide followed by paclitaxel plus herceptin then herceptin alone, LVEF = left ventricular ejection fraction; TCH = docetaxel, carboplatin, and Herceptin; HL = Hodgkin lymphoma; NHL = non-Hodgkin lymphoma; CEF = cyclophosphamide, epirubicin, 5-fluorouracil; ACOD = doxorubicin, cyclophosphamide, vincristine, dexamethasone; VAD = vincristine, doxorubicin, dexamethasone; ChlVPP/ABVVP = chlorambucil, vinblastine, procarbazine, doxorubicin, bleomycin, vincristine, etoposide; A = doxorubicin; H = herceptin; A+H = doxorubicin and herceptin. Online Table 3. Selected Relevant Published Studies That Have Used Echo to Assess the Role of Heart Failure Pharmacotherapy in the Prevention or Treatment of CTRCDFirst Author, Year (Ref. #)MethodSample Size, Age (years)Drugs Used for Protection Cancer/TreatmentEcho TimingEndpointsCardinale et al., 2006PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DYXJkaW5hbGU8L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFy

PjxSZWNOdW0+Nzc8L1JlY051bT48RGlzcGxheVRleHQ+KDgpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjc3PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iemQ5ZmZ4cnMyMmRwZWJlNWZ0cXA1dzJqMHhzZjIyMHJkZHNyIiB0aW1lc3RhbXA9IjE1

MTA3ODQxMzkiPjc3PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwg

QXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5DYXJk

aW5hbGUsIEQuPC9hdXRob3I+PGF1dGhvcj5Db2xvbWJvLCBBLjwvYXV0aG9yPjxhdXRob3I+QmFj

Y2hpYW5pLCBHLjwvYXV0aG9yPjxhdXRob3I+VGVkZXNjaGksIEkuPC9hdXRob3I+PGF1dGhvcj5N

ZXJvbmksIEMuIEEuPC9hdXRob3I+PGF1dGhvcj5WZWdsaWEsIEYuPC9hdXRob3I+PGF1dGhvcj5D

aXZlbGxpLCBNLjwvYXV0aG9yPjxhdXRob3I+TGFtYW50aWEsIEcuPC9hdXRob3I+PGF1dGhvcj5D

b2xvbWJvLCBOLjwvYXV0aG9yPjxhdXRob3I+Q3VyaWdsaWFubywgRy48L2F1dGhvcj48YXV0aG9y

PkZpb3JlbnRpbmksIEMuPC9hdXRob3I+PGF1dGhvcj5DaXBvbGxhLCBDLiBNLjwvYXV0aG9yPjwv

YXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkZyb20gRXVyb3BlYW4gSW5zdGl0

dXRlIG9mIE9uY29sb2d5LCBNaWxhbiwgSXRhbHkgKEQuQy4sIEEuQy4sIEcuQi4sIEkuVC4sIEMu

QS5NLiwgTS5DLiwgRy5MLiwgTi5DLiwgRy5DLiwgQy5NLkMuKTsgYW5kIENlbnRybyBDYXJkaW9s

b2dpY28gTW9uemlubyAoSS5SLkMuQy5TLiksIE1pbGFuLCBJdGFseSAoRi5WLiwgQy5GLikuIGRh

bmllbGEuY2FyZGluYWxlQGllby5pdC4mI3hEO0Zyb20gRXVyb3BlYW4gSW5zdGl0dXRlIG9mIE9u

Y29sb2d5LCBNaWxhbiwgSXRhbHkgKEQuQy4sIEEuQy4sIEcuQi4sIEkuVC4sIEMuQS5NLiwgTS5D

LiwgRy5MLiwgTi5DLiwgRy5DLiwgQy5NLkMuKTsgYW5kIENlbnRybyBDYXJkaW9sb2dpY28gTW9u

emlubyAoSS5SLkMuQy5TLiksIE1pbGFuLCBJdGFseSAoRi5WLiwgQy5GLikuPC9hdXRoLWFkZHJl

c3M+PHRpdGxlcz48dGl0bGU+RWFybHkgZGV0ZWN0aW9uIG9mIGFudGhyYWN5Y2xpbmUgY2FyZGlv

dG94aWNpdHkgYW5kIGltcHJvdmVtZW50IHdpdGggaGVhcnQgZmFpbHVyZSB0aGVyYXB5PC90aXRs

ZT48c2Vjb25kYXJ5LXRpdGxlPkNpcmN1bGF0aW9uPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+

PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Q2lyY3VsYXRpb248L2Z1bGwtdGl0bGU+PC9wZXJpb2Rp

Y2FsPjxwYWdlcz4xOTgxLTg8L3BhZ2VzPjx2b2x1bWU+MTMxPC92b2x1bWU+PG51bWJlcj4yMjwv

bnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BbnRocmFj

eWNsaW5lcy9hZHZlcnNlIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWJpb3RpY3MsIEFu

dGluZW9wbGFzdGljLyphZHZlcnNlIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyZGlvdG94

aWNpdHkvZGlhZ25vc2lzL3RoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+Q29ob3J0IFN0dWRpZXM8

L2tleXdvcmQ+PGtleXdvcmQ+RG94b3J1YmljaW4vKmFkdmVyc2UgZWZmZWN0czwva2V5d29yZD48

a2V5d29yZD5FYXJseSBEaWFnbm9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3Jk

PjxrZXl3b3JkPkZvbGxvdy1VcCBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkhlYXJ0IEZhaWx1

cmUvKmNoZW1pY2FsbHkgaW5kdWNlZC8qZGlhZ25vc2lzL3RoZXJhcHk8L2tleXdvcmQ+PGtleXdv

cmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxl

IEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+UHJvc3BlY3RpdmUgU3R1ZGllczwva2V5d29yZD48a2V5

d29yZD5TdHJva2UgVm9sdW1lL2RydWcgZWZmZWN0cy9waHlzaW9sb2d5PC9rZXl3b3JkPjxrZXl3

b3JkPmFudGhyYWN5Y2xpbmVzPC9rZXl3b3JkPjxrZXl3b3JkPmNhcmRpb215b3BhdGhpZXM8L2tl

eXdvcmQ+PGtleXdvcmQ+Y2FyZGlvdG94aWNpdHk8L2tleXdvcmQ+PGtleXdvcmQ+ZHJ1ZyB0aGVy

YXB5PC9rZXl3b3JkPjxrZXl3b3JkPmhlYXJ0IGZhaWx1cmU8L2tleXdvcmQ+PGtleXdvcmQ+cmVj

b3Zlcnkgb2YgZnVuY3Rpb248L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxNTwv

eWVhcj48cHViLWRhdGVzPjxkYXRlPkp1biAwMjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxp

c2JuPjE1MjQtNDUzOSAoRWxlY3Ryb25pYykmI3hEOzAwMDktNzMyMiAoTGlua2luZyk8L2lzYm4+

PGFjY2Vzc2lvbi1udW0+MjU5NDg1Mzg8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJs

cz48dXJsPmh0dHBzOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzI1OTQ4NTM4PC91cmw+

PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMTYxL0NJ

UkNVTEFUSU9OQUhBLjExNC4wMTM3Nzc8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3Jk

PjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DYXJkaW5hbGU8L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFy

PjxSZWNOdW0+Nzc8L1JlY051bT48RGlzcGxheVRleHQ+KDgpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjc3PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iemQ5ZmZ4cnMyMmRwZWJlNWZ0cXA1dzJqMHhzZjIyMHJkZHNyIiB0aW1lc3RhbXA9IjE1

MTA3ODQxMzkiPjc3PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwg

QXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5DYXJk

aW5hbGUsIEQuPC9hdXRob3I+PGF1dGhvcj5Db2xvbWJvLCBBLjwvYXV0aG9yPjxhdXRob3I+QmFj

Y2hpYW5pLCBHLjwvYXV0aG9yPjxhdXRob3I+VGVkZXNjaGksIEkuPC9hdXRob3I+PGF1dGhvcj5N

ZXJvbmksIEMuIEEuPC9hdXRob3I+PGF1dGhvcj5WZWdsaWEsIEYuPC9hdXRob3I+PGF1dGhvcj5D

aXZlbGxpLCBNLjwvYXV0aG9yPjxhdXRob3I+TGFtYW50aWEsIEcuPC9hdXRob3I+PGF1dGhvcj5D

b2xvbWJvLCBOLjwvYXV0aG9yPjxhdXRob3I+Q3VyaWdsaWFubywgRy48L2F1dGhvcj48YXV0aG9y

PkZpb3JlbnRpbmksIEMuPC9hdXRob3I+PGF1dGhvcj5DaXBvbGxhLCBDLiBNLjwvYXV0aG9yPjwv

YXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkZyb20gRXVyb3BlYW4gSW5zdGl0

dXRlIG9mIE9uY29sb2d5LCBNaWxhbiwgSXRhbHkgKEQuQy4sIEEuQy4sIEcuQi4sIEkuVC4sIEMu

QS5NLiwgTS5DLiwgRy5MLiwgTi5DLiwgRy5DLiwgQy5NLkMuKTsgYW5kIENlbnRybyBDYXJkaW9s

b2dpY28gTW9uemlubyAoSS5SLkMuQy5TLiksIE1pbGFuLCBJdGFseSAoRi5WLiwgQy5GLikuIGRh

bmllbGEuY2FyZGluYWxlQGllby5pdC4mI3hEO0Zyb20gRXVyb3BlYW4gSW5zdGl0dXRlIG9mIE9u

Y29sb2d5LCBNaWxhbiwgSXRhbHkgKEQuQy4sIEEuQy4sIEcuQi4sIEkuVC4sIEMuQS5NLiwgTS5D

LiwgRy5MLiwgTi5DLiwgRy5DLiwgQy5NLkMuKTsgYW5kIENlbnRybyBDYXJkaW9sb2dpY28gTW9u

emlubyAoSS5SLkMuQy5TLiksIE1pbGFuLCBJdGFseSAoRi5WLiwgQy5GLikuPC9hdXRoLWFkZHJl

c3M+PHRpdGxlcz48dGl0bGU+RWFybHkgZGV0ZWN0aW9uIG9mIGFudGhyYWN5Y2xpbmUgY2FyZGlv

dG94aWNpdHkgYW5kIGltcHJvdmVtZW50IHdpdGggaGVhcnQgZmFpbHVyZSB0aGVyYXB5PC90aXRs

ZT48c2Vjb25kYXJ5LXRpdGxlPkNpcmN1bGF0aW9uPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+

PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Q2lyY3VsYXRpb248L2Z1bGwtdGl0bGU+PC9wZXJpb2Rp

Y2FsPjxwYWdlcz4xOTgxLTg8L3BhZ2VzPjx2b2x1bWU+MTMxPC92b2x1bWU+PG51bWJlcj4yMjwv

bnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BbnRocmFj

eWNsaW5lcy9hZHZlcnNlIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWJpb3RpY3MsIEFu

dGluZW9wbGFzdGljLyphZHZlcnNlIGVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyZGlvdG94

aWNpdHkvZGlhZ25vc2lzL3RoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+Q29ob3J0IFN0dWRpZXM8

L2tleXdvcmQ+PGtleXdvcmQ+RG94b3J1YmljaW4vKmFkdmVyc2UgZWZmZWN0czwva2V5d29yZD48

a2V5d29yZD5FYXJseSBEaWFnbm9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3Jk

PjxrZXl3b3JkPkZvbGxvdy1VcCBTdHVkaWVzPC9rZXl3b3JkPjxrZXl3b3JkPkhlYXJ0IEZhaWx1

cmUvKmNoZW1pY2FsbHkgaW5kdWNlZC8qZGlhZ25vc2lzL3RoZXJhcHk8L2tleXdvcmQ+PGtleXdv

cmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxl

IEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+UHJvc3BlY3RpdmUgU3R1ZGllczwva2V5d29yZD48a2V5

d29yZD5TdHJva2UgVm9sdW1lL2RydWcgZWZmZWN0cy9waHlzaW9sb2d5PC9rZXl3b3JkPjxrZXl3

b3JkPmFudGhyYWN5Y2xpbmVzPC9rZXl3b3JkPjxrZXl3b3JkPmNhcmRpb215b3BhdGhpZXM8L2tl

eXdvcmQ+PGtleXdvcmQ+Y2FyZGlvdG94aWNpdHk8L2tleXdvcmQ+PGtleXdvcmQ+ZHJ1ZyB0aGVy

YXB5PC9rZXl3b3JkPjxrZXl3b3JkPmhlYXJ0IGZhaWx1cmU8L2tleXdvcmQ+PGtleXdvcmQ+cmVj

b3Zlcnkgb2YgZnVuY3Rpb248L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxNTwv

eWVhcj48cHViLWRhdGVzPjxkYXRlPkp1biAwMjwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxp

c2JuPjE1MjQtNDUzOSAoRWxlY3Ryb25pYykmI3hEOzAwMDktNzMyMiAoTGlua2luZyk8L2lzYm4+

PGFjY2Vzc2lvbi1udW0+MjU5NDg1Mzg8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJs

cz48dXJsPmh0dHBzOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzI1OTQ4NTM4PC91cmw+

PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMTYxL0NJ

UkNVTEFUSU9OQUhBLjExNC4wMTM3Nzc8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3Jk

PjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE.DATA (8)Prospective randomized 114, Tx (n = 56) 47±11,Control (n = 58) 44±13Enalapril AML, BC, E, HL, M, NHL/HDCBaseline; at 1, 3, 6, and 12 mos after the end of HDCLVEF decrease >10% to <50%:Enalapril vs. control: 43% vs. 0%( p < 0.001) Bosch et al., 201PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Cb3NjaDwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+PFJl

Y051bT4xMjA8L1JlY051bT48RGlzcGxheVRleHQ+KDEwKTwvRGlzcGxheVRleHQ+PHJlY29yZD48

cmVjLW51bWJlcj4xMjA8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRi

LWlkPSJ6ZDlmZnhyczIyZHBlYmU1ZnRxcDV3MmoweHNmMjIwcmRkc3IiIHRpbWVzdGFtcD0iMTUx

ODI1MDk3MyI+MTIwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwg

QXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Cb3Nj

aCwgWC48L2F1dGhvcj48YXV0aG9yPlJvdmlyYSwgTS48L2F1dGhvcj48YXV0aG9yPlNpdGdlcywg

TS48L2F1dGhvcj48YXV0aG9yPkRvbWVuZWNoLCBBLjwvYXV0aG9yPjxhdXRob3I+T3J0aXotUGVy

ZXosIEouIFQuPC9hdXRob3I+PGF1dGhvcj5kZSBDYXJhbHQsIFQuIE0uPC9hdXRob3I+PGF1dGhv

cj5Nb3JhbGVzLVJ1aXosIE0uPC9hdXRob3I+PGF1dGhvcj5QZXJlYSwgUi4gSi48L2F1dGhvcj48

YXV0aG9yPk1vbnpvLCBNLjwvYXV0aG9yPjxhdXRob3I+RXN0ZXZlLCBKLjwvYXV0aG9yPjwvYXV0

aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkNhcmRpb2xvZ3kgRGVwYXJ0bWVudCwg

VGhvcmF4IEluc3RpdHV0ZSwgSG9zcGl0YWwgQ2xpbmljLCBCYXJjZWxvbmEsIFNwYWluLiB4Ym9z

Y2hAY2xpbmljLnViLmVzPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+RW5hbGFwcmlsIGFu

ZCBjYXJ2ZWRpbG9sIGZvciBwcmV2ZW50aW5nIGNoZW1vdGhlcmFweS1pbmR1Y2VkIGxlZnQgdmVu

dHJpY3VsYXIgc3lzdG9saWMgZHlzZnVuY3Rpb24gaW4gcGF0aWVudHMgd2l0aCBtYWxpZ25hbnQg

aGVtb3BhdGhpZXM6IHRoZSBPVkVSQ09NRSB0cmlhbCAocHJldmVudGlPbiBvZiBsZWZ0IFZlbnRy

aWN1bGFyIGR5c2Z1bmN0aW9uIHdpdGggRW5hbGFwcmlsIGFuZCBjYVJ2ZWRpbG9sIGluIHBhdGll

bnRzIHN1Ym1pdHRlZCB0byBpbnRlbnNpdmUgQ2hlbU90aGVyYXB5IGZvciB0aGUgdHJlYXRtZW50

IG9mIE1hbGlnbmFudCBoRW1vcGF0aGllcyk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SiBBbSBD

b2xsIENhcmRpb2w8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10

aXRsZT5KIEFtIENvbGwgQ2FyZGlvbDwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjIz

NTUtNjI8L3BhZ2VzPjx2b2x1bWU+NjE8L3ZvbHVtZT48bnVtYmVyPjIzPC9udW1iZXI+PGtleXdv

cmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFudGluZW9wbGFzdGljIEFnZW50

cy8qYWR2ZXJzZSBlZmZlY3RzL3RoZXJhcGV1dGljIHVzZTwva2V5d29yZD48a2V5d29yZD5DYXJi

YXpvbGVzLyphZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdvcmQ+PGtleXdvcmQ+RG9z

ZS1SZXNwb25zZSBSZWxhdGlvbnNoaXAsIERydWc8L2tleXdvcmQ+PGtleXdvcmQ+RHJ1ZyBBZG1p

bmlzdHJhdGlvbiBTY2hlZHVsZTwva2V5d29yZD48a2V5d29yZD5EcnVnIFRoZXJhcHksIENvbWJp

bmF0aW9uPC9rZXl3b3JkPjxrZXl3b3JkPkVjaG9jYXJkaW9ncmFwaHksIERvcHBsZXI8L2tleXdv

cmQ+PGtleXdvcmQ+RW5hbGFwcmlsLyphZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdv

cmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxvdy1VcCBTdHVkaWVzPC9r

ZXl3b3JkPjxrZXl3b3JkPkhlbWF0b2xvZ2ljIE5lb3BsYXNtcy8qZHJ1ZyB0aGVyYXB5L3BhdGhv

bG9neTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5

d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5Qcm9wYW5vbGFtaW5l

cy8qYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPlJlZmVyZW5j

ZSBWYWx1ZXM8L2tleXdvcmQ+PGtleXdvcmQ+UmlzayBBc3Nlc3NtZW50PC9rZXl3b3JkPjxrZXl3

b3JkPlNldmVyaXR5IG9mIElsbG5lc3MgSW5kZXg8L2tleXdvcmQ+PGtleXdvcmQ+U3Vydml2YWwg

UmF0ZTwva2V5d29yZD48a2V5d29yZD5UcmVhdG1lbnQgT3V0Y29tZTwva2V5d29yZD48a2V5d29y

ZD5WZW50cmljdWxhciBEeXNmdW5jdGlvbiwgTGVmdC9jaGVtaWNhbGx5IGluZHVjZWQvKmRydWcg

dGhlcmFweS8qcHJldmVudGlvbiAmYW1wOzwva2V5d29yZD48a2V5d29yZD5jb250cm9sPC9rZXl3

b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTM8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5K

dW4gMTE8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNTU4LTM1OTcgKEVsZWN0cm9u

aWMpJiN4RDswNzM1LTEwOTcgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIzNTgzNzYz

PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwczovL3d3dy5uY2Jp

Lm5sbS5uaWguZ292L3B1Ym1lZC8yMzU4Mzc2MzwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48

ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTAxNi9qLmphY2MuMjAxMy4wMi4wNzI8L2VsZWN0

cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Cb3NjaDwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+PFJl

Y051bT4xMjA8L1JlY051bT48RGlzcGxheVRleHQ+KDEwKTwvRGlzcGxheVRleHQ+PHJlY29yZD48

cmVjLW51bWJlcj4xMjA8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRi

LWlkPSJ6ZDlmZnhyczIyZHBlYmU1ZnRxcDV3MmoweHNmMjIwcmRkc3IiIHRpbWVzdGFtcD0iMTUx

ODI1MDk3MyI+MTIwPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwg

QXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Cb3Nj

aCwgWC48L2F1dGhvcj48YXV0aG9yPlJvdmlyYSwgTS48L2F1dGhvcj48YXV0aG9yPlNpdGdlcywg

TS48L2F1dGhvcj48YXV0aG9yPkRvbWVuZWNoLCBBLjwvYXV0aG9yPjxhdXRob3I+T3J0aXotUGVy

ZXosIEouIFQuPC9hdXRob3I+PGF1dGhvcj5kZSBDYXJhbHQsIFQuIE0uPC9hdXRob3I+PGF1dGhv

cj5Nb3JhbGVzLVJ1aXosIE0uPC9hdXRob3I+PGF1dGhvcj5QZXJlYSwgUi4gSi48L2F1dGhvcj48

YXV0aG9yPk1vbnpvLCBNLjwvYXV0aG9yPjxhdXRob3I+RXN0ZXZlLCBKLjwvYXV0aG9yPjwvYXV0

aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkNhcmRpb2xvZ3kgRGVwYXJ0bWVudCwg

VGhvcmF4IEluc3RpdHV0ZSwgSG9zcGl0YWwgQ2xpbmljLCBCYXJjZWxvbmEsIFNwYWluLiB4Ym9z

Y2hAY2xpbmljLnViLmVzPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+RW5hbGFwcmlsIGFu

ZCBjYXJ2ZWRpbG9sIGZvciBwcmV2ZW50aW5nIGNoZW1vdGhlcmFweS1pbmR1Y2VkIGxlZnQgdmVu

dHJpY3VsYXIgc3lzdG9saWMgZHlzZnVuY3Rpb24gaW4gcGF0aWVudHMgd2l0aCBtYWxpZ25hbnQg

aGVtb3BhdGhpZXM6IHRoZSBPVkVSQ09NRSB0cmlhbCAocHJldmVudGlPbiBvZiBsZWZ0IFZlbnRy

aWN1bGFyIGR5c2Z1bmN0aW9uIHdpdGggRW5hbGFwcmlsIGFuZCBjYVJ2ZWRpbG9sIGluIHBhdGll

bnRzIHN1Ym1pdHRlZCB0byBpbnRlbnNpdmUgQ2hlbU90aGVyYXB5IGZvciB0aGUgdHJlYXRtZW50

IG9mIE1hbGlnbmFudCBoRW1vcGF0aGllcyk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SiBBbSBD

b2xsIENhcmRpb2w8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10

aXRsZT5KIEFtIENvbGwgQ2FyZGlvbDwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjIz

NTUtNjI8L3BhZ2VzPjx2b2x1bWU+NjE8L3ZvbHVtZT48bnVtYmVyPjIzPC9udW1iZXI+PGtleXdv

cmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkFudGluZW9wbGFzdGljIEFnZW50

cy8qYWR2ZXJzZSBlZmZlY3RzL3RoZXJhcGV1dGljIHVzZTwva2V5d29yZD48a2V5d29yZD5DYXJi

YXpvbGVzLyphZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdvcmQ+PGtleXdvcmQ+RG9z

ZS1SZXNwb25zZSBSZWxhdGlvbnNoaXAsIERydWc8L2tleXdvcmQ+PGtleXdvcmQ+RHJ1ZyBBZG1p

bmlzdHJhdGlvbiBTY2hlZHVsZTwva2V5d29yZD48a2V5d29yZD5EcnVnIFRoZXJhcHksIENvbWJp

bmF0aW9uPC9rZXl3b3JkPjxrZXl3b3JkPkVjaG9jYXJkaW9ncmFwaHksIERvcHBsZXI8L2tleXdv

cmQ+PGtleXdvcmQ+RW5hbGFwcmlsLyphZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2U8L2tleXdv

cmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxvdy1VcCBTdHVkaWVzPC9r

ZXl3b3JkPjxrZXl3b3JkPkhlbWF0b2xvZ2ljIE5lb3BsYXNtcy8qZHJ1ZyB0aGVyYXB5L3BhdGhv

bG9neTwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5

d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5Qcm9wYW5vbGFtaW5l

cy8qYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlPC9rZXl3b3JkPjxrZXl3b3JkPlJlZmVyZW5j

ZSBWYWx1ZXM8L2tleXdvcmQ+PGtleXdvcmQ+UmlzayBBc3Nlc3NtZW50PC9rZXl3b3JkPjxrZXl3

b3JkPlNldmVyaXR5IG9mIElsbG5lc3MgSW5kZXg8L2tleXdvcmQ+PGtleXdvcmQ+U3Vydml2YWwg

UmF0ZTwva2V5d29yZD48a2V5d29yZD5UcmVhdG1lbnQgT3V0Y29tZTwva2V5d29yZD48a2V5d29y

ZD5WZW50cmljdWxhciBEeXNmdW5jdGlvbiwgTGVmdC9jaGVtaWNhbGx5IGluZHVjZWQvKmRydWcg

dGhlcmFweS8qcHJldmVudGlvbiAmYW1wOzwva2V5d29yZD48a2V5d29yZD5jb250cm9sPC9rZXl3

b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTM8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5K

dW4gMTE8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNTU4LTM1OTcgKEVsZWN0cm9u

aWMpJiN4RDswNzM1LTEwOTcgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIzNTgzNzYz

PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwczovL3d3dy5uY2Jp

Lm5sbS5uaWguZ292L3B1Ym1lZC8yMzU4Mzc2MzwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48

ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTAxNi9qLmphY2MuMjAxMy4wMi4wNzI8L2VsZWN0

cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE.DATA (10)Prospective randomized 80,Tx (n = 45) 49.7 ± 14, Control (n = 45) 51 ± 13Enalapril and carvedilol vs. control AL, HL, non-HL, MM/HSCT Baseline and 6 mos after randomization Absolute change from baseline in LVEF:No change in the treatment group but significant decrease in controls, resulting in a 3.1% absolute difference (p = 0.035)Seicean et al., 2013PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TZWljZWFuPC9BdXRob3I+PFllYXI+MjAxMzwvWWVhcj48

UmVjTnVtPjEyMTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMTEpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjEyMTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9InpkOWZmeHJzMjJkcGViZTVmdHFwNXcyajB4c2YyMjByZGRzciIgdGltZXN0YW1wPSIx

NTE4MjUxMDMzIj4xMjE8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5h

bCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlNl

aWNlYW4sIFMuPC9hdXRob3I+PGF1dGhvcj5TZWljZWFuLCBBLjwvYXV0aG9yPjxhdXRob3I+QWxh

biwgTi48L2F1dGhvcj48YXV0aG9yPlBsYW5hLCBKLiBDLjwvYXV0aG9yPjxhdXRob3I+QnVkZCwg

Ry4gVC48L2F1dGhvcj48YXV0aG9yPk1hcndpY2ssIFQuIEguPC9hdXRob3I+PC9hdXRob3JzPjwv

Y29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+SGVhcnQgYW5kIFZhc2N1bGFyIEluc3RpdHV0ZSwg

Q2xldmVsYW5kIENsaW5pYywgQ2xldmVsYW5kLCBPSCwgVVNBLjwvYXV0aC1hZGRyZXNzPjx0aXRs

ZXM+PHRpdGxlPkNhcmRpb3Byb3RlY3RpdmUgZWZmZWN0IG9mIGJldGEtYWRyZW5vY2VwdG9yIGJs

b2NrYWRlIGluIHBhdGllbnRzIHdpdGggYnJlYXN0IGNhbmNlciB1bmRlcmdvaW5nIGNoZW1vdGhl

cmFweTogZm9sbG93LXVwIHN0dWR5IG9mIGhlYXJ0IGZhaWx1cmU8L3RpdGxlPjxzZWNvbmRhcnkt

dGl0bGU+Q2lyYyBIZWFydCBGYWlsPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGlj

YWw+PGZ1bGwtdGl0bGU+Q2lyYyBIZWFydCBGYWlsPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48

cGFnZXM+NDIwLTY8L3BhZ2VzPjx2b2x1bWU+Njwvdm9sdW1lPjxudW1iZXI+MzwvbnVtYmVyPjxr

ZXl3b3Jkcz48a2V5d29yZD5BZHJlbmVyZ2ljIGJldGEtQW50YWdvbmlzdHMvKnRoZXJhcGV1dGlj

IHVzZTwva2V5d29yZD48a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkFudGhyYWN5Y2xp

bmVzLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWJvZGllcywgTW9ub2Ns

b25hbCwgSHVtYW5pemVkLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QW50aW5l

b3BsYXN0aWMgQWdlbnRzLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QnJlYXN0

IE5lb3BsYXNtcy8qZHJ1ZyB0aGVyYXB5L2VwaWRlbWlvbG9neS9tb3J0YWxpdHk8L2tleXdvcmQ+

PGtleXdvcmQ+Q2FyZGlvdG9uaWMgQWdlbnRzLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtl

eXdvcmQ+Q29tb3JiaWRpdHk8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3

b3JkPkdlbmVzLCBlcmJCLTIvcGh5c2lvbG9neTwva2V5d29yZD48a2V5d29yZD5IZWFydCBGYWls

dXJlL2VwaWRlbWlvbG9neS9nZW5ldGljcy9waHlzaW9wYXRob2xvZ3kvKnByZXZlbnRpb24gJmFt

cDsgY29udHJvbDwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWlk

ZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+UHJvcGVuc2l0eSBTY29yZTwva2V5d29yZD48a2V5

d29yZD5UcmFzdHV6dW1hYjwva2V5d29yZD48a2V5d29yZD5hbnRocmFjeWNsaW5lczwva2V5d29y

ZD48a2V5d29yZD5icmVhc3QgY2FuY2VyPC9rZXl3b3JkPjxrZXl3b3JkPmhlYXJ0IGZhaWx1cmU8

L2tleXdvcmQ+PGtleXdvcmQ+dG94aWNpdHk8L2tleXdvcmQ+PGtleXdvcmQ+YmV0YS1ibG9ja2Vy

PC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTM8L3llYXI+PHB1Yi1kYXRlcz48

ZGF0ZT5NYXk8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xOTQxLTMyOTcgKEVsZWN0

cm9uaWMpJiN4RDsxOTQxLTMyODkgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIzNDI1

OTc4PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwczovL3d3dy5u

Y2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yMzQyNTk3ODwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJs

cz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTE2MS9DSVJDSEVBUlRGQUlMVVJFLjExMi4w

MDAwNTU8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

AG==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TZWljZWFuPC9BdXRob3I+PFllYXI+MjAxMzwvWWVhcj48

UmVjTnVtPjEyMTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMTEpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjEyMTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIg

ZGItaWQ9InpkOWZmeHJzMjJkcGViZTVmdHFwNXcyajB4c2YyMjByZGRzciIgdGltZXN0YW1wPSIx

NTE4MjUxMDMzIj4xMjE8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5h

bCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlNl

aWNlYW4sIFMuPC9hdXRob3I+PGF1dGhvcj5TZWljZWFuLCBBLjwvYXV0aG9yPjxhdXRob3I+QWxh

biwgTi48L2F1dGhvcj48YXV0aG9yPlBsYW5hLCBKLiBDLjwvYXV0aG9yPjxhdXRob3I+QnVkZCwg

Ry4gVC48L2F1dGhvcj48YXV0aG9yPk1hcndpY2ssIFQuIEguPC9hdXRob3I+PC9hdXRob3JzPjwv

Y29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+SGVhcnQgYW5kIFZhc2N1bGFyIEluc3RpdHV0ZSwg

Q2xldmVsYW5kIENsaW5pYywgQ2xldmVsYW5kLCBPSCwgVVNBLjwvYXV0aC1hZGRyZXNzPjx0aXRs

ZXM+PHRpdGxlPkNhcmRpb3Byb3RlY3RpdmUgZWZmZWN0IG9mIGJldGEtYWRyZW5vY2VwdG9yIGJs

b2NrYWRlIGluIHBhdGllbnRzIHdpdGggYnJlYXN0IGNhbmNlciB1bmRlcmdvaW5nIGNoZW1vdGhl

cmFweTogZm9sbG93LXVwIHN0dWR5IG9mIGhlYXJ0IGZhaWx1cmU8L3RpdGxlPjxzZWNvbmRhcnkt

dGl0bGU+Q2lyYyBIZWFydCBGYWlsPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGlj

YWw+PGZ1bGwtdGl0bGU+Q2lyYyBIZWFydCBGYWlsPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48

cGFnZXM+NDIwLTY8L3BhZ2VzPjx2b2x1bWU+Njwvdm9sdW1lPjxudW1iZXI+MzwvbnVtYmVyPjxr

ZXl3b3Jkcz48a2V5d29yZD5BZHJlbmVyZ2ljIGJldGEtQW50YWdvbmlzdHMvKnRoZXJhcGV1dGlj

IHVzZTwva2V5d29yZD48a2V5d29yZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkFudGhyYWN5Y2xp

bmVzLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWJvZGllcywgTW9ub2Ns

b25hbCwgSHVtYW5pemVkLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QW50aW5l

b3BsYXN0aWMgQWdlbnRzLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QnJlYXN0

IE5lb3BsYXNtcy8qZHJ1ZyB0aGVyYXB5L2VwaWRlbWlvbG9neS9tb3J0YWxpdHk8L2tleXdvcmQ+

PGtleXdvcmQ+Q2FyZGlvdG9uaWMgQWdlbnRzLyp0aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtl

eXdvcmQ+Q29tb3JiaWRpdHk8L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3

b3JkPkdlbmVzLCBlcmJCLTIvcGh5c2lvbG9neTwva2V5d29yZD48a2V5d29yZD5IZWFydCBGYWls

dXJlL2VwaWRlbWlvbG9neS9nZW5ldGljcy9waHlzaW9wYXRob2xvZ3kvKnByZXZlbnRpb24gJmFt

cDsgY29udHJvbDwva2V5d29yZD48a2V5d29yZD5IdW1hbnM8L2tleXdvcmQ+PGtleXdvcmQ+TWlk

ZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+UHJvcGVuc2l0eSBTY29yZTwva2V5d29yZD48a2V5

d29yZD5UcmFzdHV6dW1hYjwva2V5d29yZD48a2V5d29yZD5hbnRocmFjeWNsaW5lczwva2V5d29y

ZD48a2V5d29yZD5icmVhc3QgY2FuY2VyPC9rZXl3b3JkPjxrZXl3b3JkPmhlYXJ0IGZhaWx1cmU8

L2tleXdvcmQ+PGtleXdvcmQ+dG94aWNpdHk8L2tleXdvcmQ+PGtleXdvcmQ+YmV0YS1ibG9ja2Vy

PC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTM8L3llYXI+PHB1Yi1kYXRlcz48

ZGF0ZT5NYXk8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xOTQxLTMyOTcgKEVsZWN0

cm9uaWMpJiN4RDsxOTQxLTMyODkgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjIzNDI1

OTc4PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwczovL3d3dy5u

Y2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yMzQyNTk3ODwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJs

cz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTE2MS9DSVJDSEVBUlRGQUlMVVJFLjExMi4w

MDAwNTU8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

AG==

ADDIN EN.CITE.DATA (11)Retrospective106,5710Any BB given uninterrupted during A and/or TBC/AC trastuzumabNAHF admissions during 3.2 yrs of follow-up:BB vs. controls: 5 vs. 27 (p < 0.008)Tx = treatment; BB = beta blocker; LVEF = left ventricular ejection fraction; HF = heart failure; BC = breast cancer; AML = acute myeloid leukemia; AL = acute leukemia; HL = Hodgkin Lymphoma; MM = multiple myeloma; E= Ewing’s sarcoma; HDC = high dose chemotherapy including ARAC indicates cytarabine; BEAM = carmustine-etoposide-cytarabine-melphalan; DAUNO = daunorubicin; ESAP = etoposide-carboplatin-cytarabine-dexamethasone; ICE = ifosfamide-carboplatin-etoposide; IDA = idarubicin; MEL = melphalan; MITOX = mitoxantrone; SEQ = sequential; TEC = taxotere-epirubicin-cyclophosphamide; TICE = taxotere-ifosfamide-carboplatin-etoposide; AC = anthracyclines; ; HSCT = hematopoietic stem-cell transplantation; A= anthracycline; T= trastuzumab.Online Table 4. Selected Relevant Published Studies That Have Used Echo to Assess Cardiac Function After Cancer TreatmentFirst Author, Year (Ref. #)MethodSample Size, Age (years)Cancer/TreatmentEcho Timing?Since DiagnosisKey FindingsLipshultz et al., 2005PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5MaXBzaHVsdHo8L0F1dGhvcj48WWVhcj4yMDA1PC9ZZWFy

PjxSZWNOdW0+MTIyPC9SZWNOdW0+PERpc3BsYXlUZXh0PigxMik8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+MTIyPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iemQ5ZmZ4cnMyMmRwZWJlNWZ0cXA1dzJqMHhzZjIyMHJkZHNyIiB0aW1lc3RhbXA9

IjE1MTgyNTExODIiPjEyMjwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3Vy

bmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+

TGlwc2h1bHR6LCBTLiBFLjwvYXV0aG9yPjxhdXRob3I+TGlwc2l0eiwgUy4gUi48L2F1dGhvcj48

YXV0aG9yPlNhbGxhbiwgUy4gRS48L2F1dGhvcj48YXV0aG9yPkRhbHRvbiwgVi4gTS48L2F1dGhv

cj48YXV0aG9yPk1vbmUsIFMuIE0uPC9hdXRob3I+PGF1dGhvcj5HZWxiZXIsIFIuIEQuPC9hdXRo

b3I+PGF1dGhvcj5Db2xhbiwgUy4gRC48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+

PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIFBlZGlhdHJpY3MgKEQ4MjApLCBNaWxsZXIgU2No

b29sIG9mIE1lZGljaW5lIGF0IHRoZSBVbml2ZXJzaXR5IG9mIE1pYW1pLCBNaWFtaSwgRkwgMzMx

MDEsIFVTQS4gc2xpcHNodWx0ekBtZWQubWlhbWkuZWR1PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+Q2hyb25pYyBwcm9ncmVzc2l2ZSBjYXJkaWFjIGR5c2Z1bmN0aW9uIHllYXJzIGFmdGVy

IGRveG9ydWJpY2luIHRoZXJhcHkgZm9yIGNoaWxkaG9vZCBhY3V0ZSBseW1waG9ibGFzdGljIGxl

dWtlbWlhPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogQ2xpbiBPbmNvbDwvc2Vjb25kYXJ5LXRp

dGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkogQ2xpbiBPbmNvbDwvZnVsbC10

aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjI2MjktMzY8L3BhZ2VzPjx2b2x1bWU+MjM8L3ZvbHVt

ZT48bnVtYmVyPjEyPC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkb2xlc2NlbnQ8L2tleXdv

cmQ+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWJpb3RpY3MsIEFudGluZW9w

bGFzdGljL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZS8qYWR2ZXJzZSBlZmZlY3RzLyp0aGVy

YXBldXRpYzwva2V5d29yZD48a2V5d29yZD51c2U8L2tleXdvcmQ+PGtleXdvcmQ+Qmxvb2QgUHJl

c3N1cmU8L2tleXdvcmQ+PGtleXdvcmQ+Q2hpbGQ8L2tleXdvcmQ+PGtleXdvcmQ+Q2hpbGQsIFBy

ZXNjaG9vbDwva2V5d29yZD48a2V5d29yZD5Eb3hvcnViaWNpbi9hZG1pbmlzdHJhdGlvbiAmYW1w

OyBkb3NhZ2UvKmFkdmVyc2UgZWZmZWN0cy8qdGhlcmFwZXV0aWMgdXNlPC9rZXl3b3JkPjxrZXl3

b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5IZWFydCBEaXNlYXNlcy8qY2hlbWljYWxseSBp

bmR1Y2VkPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5JbmZhbnQ8

L2tleXdvcmQ+PGtleXdvcmQ+TG9uZ2l0dWRpbmFsIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+

TWFsZTwva2V5d29yZD48a2V5d29yZD5Nb3JiaWRpdHk8L2tleXdvcmQ+PGtleXdvcmQ+UHJlY3Vy

c29yIENlbGwgTHltcGhvYmxhc3RpYyBMZXVrZW1pYS1MeW1waG9tYS8qZHJ1ZyB0aGVyYXB5PC9r

ZXl3b3JkPjxrZXl3b3JkPlRpbWUgRmFjdG9yczwva2V5d29yZD48a2V5d29yZD5WZW50cmljdWxh

ciBEeXNmdW5jdGlvbiwgTGVmdC8qY2hlbWljYWxseSBpbmR1Y2VkPC9rZXl3b3JkPjwva2V5d29y

ZHM+PGRhdGVzPjx5ZWFyPjIwMDU8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5BcHIgMjA8L2RhdGU+

PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4wNzMyLTE4M1ggKFByaW50KSYjeEQ7MDczMi0xODNY

IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4xNTgzNzk3ODwvYWNjZXNzaW9uLW51bT48

dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJt

ZWQvMTU4Mzc5Nzg8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3Vy

Y2UtbnVtPjEwLjEyMDAvSkNPLjIwMDUuMTIuMTIxPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48

L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5MaXBzaHVsdHo8L0F1dGhvcj48WWVhcj4yMDA1PC9ZZWFy

PjxSZWNOdW0+MTIyPC9SZWNOdW0+PERpc3BsYXlUZXh0PigxMik8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+MTIyPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iemQ5ZmZ4cnMyMmRwZWJlNWZ0cXA1dzJqMHhzZjIyMHJkZHNyIiB0aW1lc3RhbXA9

IjE1MTgyNTExODIiPjEyMjwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3Vy

bmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+

TGlwc2h1bHR6LCBTLiBFLjwvYXV0aG9yPjxhdXRob3I+TGlwc2l0eiwgUy4gUi48L2F1dGhvcj48

YXV0aG9yPlNhbGxhbiwgUy4gRS48L2F1dGhvcj48YXV0aG9yPkRhbHRvbiwgVi4gTS48L2F1dGhv

cj48YXV0aG9yPk1vbmUsIFMuIE0uPC9hdXRob3I+PGF1dGhvcj5HZWxiZXIsIFIuIEQuPC9hdXRo

b3I+PGF1dGhvcj5Db2xhbiwgUy4gRC48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+

PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50IG9mIFBlZGlhdHJpY3MgKEQ4MjApLCBNaWxsZXIgU2No

b29sIG9mIE1lZGljaW5lIGF0IHRoZSBVbml2ZXJzaXR5IG9mIE1pYW1pLCBNaWFtaSwgRkwgMzMx

MDEsIFVTQS4gc2xpcHNodWx0ekBtZWQubWlhbWkuZWR1PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48

dGl0bGU+Q2hyb25pYyBwcm9ncmVzc2l2ZSBjYXJkaWFjIGR5c2Z1bmN0aW9uIHllYXJzIGFmdGVy

IGRveG9ydWJpY2luIHRoZXJhcHkgZm9yIGNoaWxkaG9vZCBhY3V0ZSBseW1waG9ibGFzdGljIGxl

dWtlbWlhPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkogQ2xpbiBPbmNvbDwvc2Vjb25kYXJ5LXRp

dGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkogQ2xpbiBPbmNvbDwvZnVsbC10

aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjI2MjktMzY8L3BhZ2VzPjx2b2x1bWU+MjM8L3ZvbHVt

ZT48bnVtYmVyPjEyPC9udW1iZXI+PGtleXdvcmRzPjxrZXl3b3JkPkFkb2xlc2NlbnQ8L2tleXdv

cmQ+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWJpb3RpY3MsIEFudGluZW9w

bGFzdGljL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZS8qYWR2ZXJzZSBlZmZlY3RzLyp0aGVy

YXBldXRpYzwva2V5d29yZD48a2V5d29yZD51c2U8L2tleXdvcmQ+PGtleXdvcmQ+Qmxvb2QgUHJl

c3N1cmU8L2tleXdvcmQ+PGtleXdvcmQ+Q2hpbGQ8L2tleXdvcmQ+PGtleXdvcmQ+Q2hpbGQsIFBy

ZXNjaG9vbDwva2V5d29yZD48a2V5d29yZD5Eb3hvcnViaWNpbi9hZG1pbmlzdHJhdGlvbiAmYW1w

OyBkb3NhZ2UvKmFkdmVyc2UgZWZmZWN0cy8qdGhlcmFwZXV0aWMgdXNlPC9rZXl3b3JkPjxrZXl3

b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5IZWFydCBEaXNlYXNlcy8qY2hlbWljYWxseSBp

bmR1Y2VkPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5JbmZhbnQ8

L2tleXdvcmQ+PGtleXdvcmQ+TG9uZ2l0dWRpbmFsIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+

TWFsZTwva2V5d29yZD48a2V5d29yZD5Nb3JiaWRpdHk8L2tleXdvcmQ+PGtleXdvcmQ+UHJlY3Vy

c29yIENlbGwgTHltcGhvYmxhc3RpYyBMZXVrZW1pYS1MeW1waG9tYS8qZHJ1ZyB0aGVyYXB5PC9r

ZXl3b3JkPjxrZXl3b3JkPlRpbWUgRmFjdG9yczwva2V5d29yZD48a2V5d29yZD5WZW50cmljdWxh

ciBEeXNmdW5jdGlvbiwgTGVmdC8qY2hlbWljYWxseSBpbmR1Y2VkPC9rZXl3b3JkPjwva2V5d29y

ZHM+PGRhdGVzPjx5ZWFyPjIwMDU8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5BcHIgMjA8L2RhdGU+

PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4wNzMyLTE4M1ggKFByaW50KSYjeEQ7MDczMi0xODNY

IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4xNTgzNzk3ODwvYWNjZXNzaW9uLW51bT48

dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJt

ZWQvMTU4Mzc5Nzg8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3Vy

Y2UtbnVtPjEwLjEyMDAvSkNPLjIwMDUuMTIuMTIxPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48

L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA (12)Prospective 499, age at cancer diagnosis = 4.4 Acute lymphoblastic, leukemia/doxorubicin11.8 yrsProgressive and persistent cardiac abnormalities years after doxorubicin treatment. Significantly reduced LV mass, fractional shortening, dimension. Results expressed as z scores calculated based on cardiac values of normal children. Romond et al., 2012PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Sb21vbmQ8L0F1dGhvcj48WWVhcj4yMDEyPC9ZZWFyPjxS

ZWNOdW0+NTY8L1JlY051bT48RGlzcGxheVRleHQ+KDIpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxy

ZWMtbnVtYmVyPjU2PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1p

ZD0iemQ5ZmZ4cnMyMmRwZWJlNWZ0cXA1dzJqMHhzZjIyMHJkZHNyIiB0aW1lc3RhbXA9IjE1MTA3

NzgyMTYiPjU2PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Sb21vbmQs

IEUuIEguPC9hdXRob3I+PGF1dGhvcj5KZW9uZywgSi4gSC48L2F1dGhvcj48YXV0aG9yPlJhc3Rv

Z2ksIFAuPC9hdXRob3I+PGF1dGhvcj5Td2FpbiwgUy4gTS48L2F1dGhvcj48YXV0aG9yPkdleWVy

LCBDLiBFLiwgSnIuPC9hdXRob3I+PGF1dGhvcj5Fd2VyLCBNLiBTLjwvYXV0aG9yPjxhdXRob3I+

UmF0aGksIFYuPC9hdXRob3I+PGF1dGhvcj5GZWhyZW5iYWNoZXIsIEwuPC9hdXRob3I+PGF1dGhv

cj5CcnVmc2t5LCBBLjwvYXV0aG9yPjxhdXRob3I+QXphciwgQy4gQS48L2F1dGhvcj48YXV0aG9y

PkZseW5uLCBQLiBKLjwvYXV0aG9yPjxhdXRob3I+WmFwYXMsIEouIEwuPC9hdXRob3I+PGF1dGhv

cj5Qb2xpa29mZiwgSi48L2F1dGhvcj48YXV0aG9yPkdyb3NzLCBILiBNLjwvYXV0aG9yPjxhdXRo

b3I+QmlnZ3MsIEQuIEQuPC9hdXRob3I+PGF1dGhvcj5BdGtpbnMsIEouIE4uPC9hdXRob3I+PGF1

dGhvcj5UYW4tQ2hpdSwgRS48L2F1dGhvcj48YXV0aG9yPlpoZW5nLCBQLjwvYXV0aG9yPjxhdXRo

b3I+WW90aGVycywgRy48L2F1dGhvcj48YXV0aG9yPk1hbW91bmFzLCBFLiBQLjwvYXV0aG9yPjxh

dXRob3I+V29sbWFyaywgTi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgt

YWRkcmVzcz5OYXRpb25hbCBTdXJnaWNhbCBBZGp1dmFudCBCcmVhc3QgYW5kIEJvd2VsIFByb2pl

Y3QsIEVhc3QgQ29tbW9ucyBQcm9mZXNzaW9uYWwgQnVpbGRpbmcsIEZvdXIgQWxsZWdoZW55IENl

bnRlciwgNXRoIEZsb29yLCBQaXR0c2J1cmdoLCBQQSAxNTIxMiwgVVNBLjwvYXV0aC1hZGRyZXNz

Pjx0aXRsZXM+PHRpdGxlPlNldmVuLXllYXIgZm9sbG93LXVwIGFzc2Vzc21lbnQgb2YgY2FyZGlh

YyBmdW5jdGlvbiBpbiBOU0FCUCBCLTMxLCBhIHJhbmRvbWl6ZWQgdHJpYWwgY29tcGFyaW5nIGRv

eG9ydWJpY2luIGFuZCBjeWNsb3Bob3NwaGFtaWRlIGZvbGxvd2VkIGJ5IHBhY2xpdGF4ZWwgKEFD

UCkgd2l0aCBBQ1AgcGx1cyB0cmFzdHV6dW1hYiBhcyBhZGp1dmFudCB0aGVyYXB5IGZvciBwYXRp

ZW50cyB3aXRoIG5vZGUtcG9zaXRpdmUsIGh1bWFuIGVwaWRlcm1hbCBncm93dGggZmFjdG9yIHJl

Y2VwdG9yIDItcG9zaXRpdmUgYnJlYXN0IGNhbmNlcjwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5K

IENsaW4gT25jb2w8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10

aXRsZT5KIENsaW4gT25jb2w8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4zNzkyLTk8

L3BhZ2VzPjx2b2x1bWU+MzA8L3ZvbHVtZT48bnVtYmVyPjMxPC9udW1iZXI+PGtleXdvcmRzPjxr

ZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWJvZGllcywgTW9ub2Nsb25hbCwgSHVt

YW5pemVkL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZS9hZHZlcnNlIGVmZmVjdHM8L2tleXdv

cmQ+PGtleXdvcmQ+QW50aW5lb3BsYXN0aWMgQ29tYmluZWQgQ2hlbW90aGVyYXB5IFByb3RvY29s

cy8qYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlLyphZHZlcnNlPC9rZXl3b3JkPjxrZXl3b3Jk

PmVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+QnJlYXN0IE5lb3BsYXNtcy8qZHJ1ZyB0aGVyYXB5

L2Vuenltb2xvZ3kvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkNoZW1vdGhlcmFweSwgQWRq

dXZhbnQ8L2tleXdvcmQ+PGtleXdvcmQ+Q3ljbG9waG9zcGhhbWlkZS9hZG1pbmlzdHJhdGlvbiAm

YW1wOyBkb3NhZ2UvYWR2ZXJzZSBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPkRveG9ydWJpY2lu

L2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZS9hZHZlcnNlIGVmZmVjdHM8L2tleXdvcmQ+PGtl

eXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxvdy1VcCBTdHVkaWVzPC9rZXl3b3Jk

PjxrZXl3b3JkPkhlYXJ0IEZhaWx1cmUvKmNoZW1pY2FsbHkgaW5kdWNlZC9kcnVnIHRoZXJhcHk8

L2tleXdvcmQ+PGtleXdvcmQ+SGVhcnQgRnVuY3Rpb24gVGVzdHM8L2tleXdvcmQ+PGtleXdvcmQ+

SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkx5bXBoYXRpYyBNZXRhc3Rhc2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPk1vZGVscywgU3RhdGlzdGljYWw8

L2tleXdvcmQ+PGtleXdvcmQ+UGFjbGl0YXhlbC9hZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2Uv

YWR2ZXJzZSBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPlJlY2VwdG9yLCBFcGlkZXJtYWwgR3Jv

d3RoIEZhY3Rvci8qYmlvc3ludGhlc2lzPC9rZXl3b3JkPjxrZXl3b3JkPlJpc2sgRmFjdG9yczwv

a2V5d29yZD48a2V5d29yZD5UcmFzdHV6dW1hYjwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48

eWVhcj4yMDEyPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+Tm92IDAxPC9kYXRlPjwvcHViLWRhdGVz

PjwvZGF0ZXM+PGlzYm4+MTUyNy03NzU1IChFbGVjdHJvbmljKSYjeEQ7MDczMi0xODNYIChMaW5r

aW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMjk4NzA4NDwvYWNjZXNzaW9uLW51bT48dXJscz48

cmVsYXRlZC11cmxzPjx1cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjI5

ODcwODQ8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGN1c3RvbTI+UE1DMzQ3ODU3NDwvY3Vz

dG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTIwMC9KQ08uMjAxMS40MC4wMDEwPC9l

bGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Sb21vbmQ8L0F1dGhvcj48WWVhcj4yMDEyPC9ZZWFyPjxS

ZWNOdW0+NTY8L1JlY051bT48RGlzcGxheVRleHQ+KDIpPC9EaXNwbGF5VGV4dD48cmVjb3JkPjxy

ZWMtbnVtYmVyPjU2PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1p

ZD0iemQ5ZmZ4cnMyMmRwZWJlNWZ0cXA1dzJqMHhzZjIyMHJkZHNyIiB0aW1lc3RhbXA9IjE1MTA3

NzgyMTYiPjU2PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0

aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Sb21vbmQs

IEUuIEguPC9hdXRob3I+PGF1dGhvcj5KZW9uZywgSi4gSC48L2F1dGhvcj48YXV0aG9yPlJhc3Rv

Z2ksIFAuPC9hdXRob3I+PGF1dGhvcj5Td2FpbiwgUy4gTS48L2F1dGhvcj48YXV0aG9yPkdleWVy

LCBDLiBFLiwgSnIuPC9hdXRob3I+PGF1dGhvcj5Fd2VyLCBNLiBTLjwvYXV0aG9yPjxhdXRob3I+

UmF0aGksIFYuPC9hdXRob3I+PGF1dGhvcj5GZWhyZW5iYWNoZXIsIEwuPC9hdXRob3I+PGF1dGhv

cj5CcnVmc2t5LCBBLjwvYXV0aG9yPjxhdXRob3I+QXphciwgQy4gQS48L2F1dGhvcj48YXV0aG9y

PkZseW5uLCBQLiBKLjwvYXV0aG9yPjxhdXRob3I+WmFwYXMsIEouIEwuPC9hdXRob3I+PGF1dGhv

cj5Qb2xpa29mZiwgSi48L2F1dGhvcj48YXV0aG9yPkdyb3NzLCBILiBNLjwvYXV0aG9yPjxhdXRo

b3I+QmlnZ3MsIEQuIEQuPC9hdXRob3I+PGF1dGhvcj5BdGtpbnMsIEouIE4uPC9hdXRob3I+PGF1

dGhvcj5UYW4tQ2hpdSwgRS48L2F1dGhvcj48YXV0aG9yPlpoZW5nLCBQLjwvYXV0aG9yPjxhdXRo

b3I+WW90aGVycywgRy48L2F1dGhvcj48YXV0aG9yPk1hbW91bmFzLCBFLiBQLjwvYXV0aG9yPjxh

dXRob3I+V29sbWFyaywgTi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgt

YWRkcmVzcz5OYXRpb25hbCBTdXJnaWNhbCBBZGp1dmFudCBCcmVhc3QgYW5kIEJvd2VsIFByb2pl

Y3QsIEVhc3QgQ29tbW9ucyBQcm9mZXNzaW9uYWwgQnVpbGRpbmcsIEZvdXIgQWxsZWdoZW55IENl

bnRlciwgNXRoIEZsb29yLCBQaXR0c2J1cmdoLCBQQSAxNTIxMiwgVVNBLjwvYXV0aC1hZGRyZXNz

Pjx0aXRsZXM+PHRpdGxlPlNldmVuLXllYXIgZm9sbG93LXVwIGFzc2Vzc21lbnQgb2YgY2FyZGlh

YyBmdW5jdGlvbiBpbiBOU0FCUCBCLTMxLCBhIHJhbmRvbWl6ZWQgdHJpYWwgY29tcGFyaW5nIGRv

eG9ydWJpY2luIGFuZCBjeWNsb3Bob3NwaGFtaWRlIGZvbGxvd2VkIGJ5IHBhY2xpdGF4ZWwgKEFD

UCkgd2l0aCBBQ1AgcGx1cyB0cmFzdHV6dW1hYiBhcyBhZGp1dmFudCB0aGVyYXB5IGZvciBwYXRp

ZW50cyB3aXRoIG5vZGUtcG9zaXRpdmUsIGh1bWFuIGVwaWRlcm1hbCBncm93dGggZmFjdG9yIHJl

Y2VwdG9yIDItcG9zaXRpdmUgYnJlYXN0IGNhbmNlcjwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5K

IENsaW4gT25jb2w8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10

aXRsZT5KIENsaW4gT25jb2w8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4zNzkyLTk8

L3BhZ2VzPjx2b2x1bWU+MzA8L3ZvbHVtZT48bnVtYmVyPjMxPC9udW1iZXI+PGtleXdvcmRzPjxr

ZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QW50aWJvZGllcywgTW9ub2Nsb25hbCwgSHVt

YW5pemVkL2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZS9hZHZlcnNlIGVmZmVjdHM8L2tleXdv

cmQ+PGtleXdvcmQ+QW50aW5lb3BsYXN0aWMgQ29tYmluZWQgQ2hlbW90aGVyYXB5IFByb3RvY29s

cy8qYWRtaW5pc3RyYXRpb24gJmFtcDsgZG9zYWdlLyphZHZlcnNlPC9rZXl3b3JkPjxrZXl3b3Jk

PmVmZmVjdHM8L2tleXdvcmQ+PGtleXdvcmQ+QnJlYXN0IE5lb3BsYXNtcy8qZHJ1ZyB0aGVyYXB5

L2Vuenltb2xvZ3kvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkNoZW1vdGhlcmFweSwgQWRq

dXZhbnQ8L2tleXdvcmQ+PGtleXdvcmQ+Q3ljbG9waG9zcGhhbWlkZS9hZG1pbmlzdHJhdGlvbiAm

YW1wOyBkb3NhZ2UvYWR2ZXJzZSBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPkRveG9ydWJpY2lu

L2FkbWluaXN0cmF0aW9uICZhbXA7IGRvc2FnZS9hZHZlcnNlIGVmZmVjdHM8L2tleXdvcmQ+PGtl

eXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxvdy1VcCBTdHVkaWVzPC9rZXl3b3Jk

PjxrZXl3b3JkPkhlYXJ0IEZhaWx1cmUvKmNoZW1pY2FsbHkgaW5kdWNlZC9kcnVnIHRoZXJhcHk8

L2tleXdvcmQ+PGtleXdvcmQ+SGVhcnQgRnVuY3Rpb24gVGVzdHM8L2tleXdvcmQ+PGtleXdvcmQ+

SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkx5bXBoYXRpYyBNZXRhc3Rhc2lzPC9rZXl3b3JkPjxr

ZXl3b3JkPk1pZGRsZSBBZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPk1vZGVscywgU3RhdGlzdGljYWw8

L2tleXdvcmQ+PGtleXdvcmQ+UGFjbGl0YXhlbC9hZG1pbmlzdHJhdGlvbiAmYW1wOyBkb3NhZ2Uv

YWR2ZXJzZSBlZmZlY3RzPC9rZXl3b3JkPjxrZXl3b3JkPlJlY2VwdG9yLCBFcGlkZXJtYWwgR3Jv

d3RoIEZhY3Rvci8qYmlvc3ludGhlc2lzPC9rZXl3b3JkPjxrZXl3b3JkPlJpc2sgRmFjdG9yczwv

a2V5d29yZD48a2V5d29yZD5UcmFzdHV6dW1hYjwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48

eWVhcj4yMDEyPC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+Tm92IDAxPC9kYXRlPjwvcHViLWRhdGVz

PjwvZGF0ZXM+PGlzYm4+MTUyNy03NzU1IChFbGVjdHJvbmljKSYjeEQ7MDczMi0xODNYIChMaW5r

aW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMjk4NzA4NDwvYWNjZXNzaW9uLW51bT48dXJscz48

cmVsYXRlZC11cmxzPjx1cmw+aHR0cHM6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9wdWJtZWQvMjI5

ODcwODQ8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGN1c3RvbTI+UE1DMzQ3ODU3NDwvY3Vz

dG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTIwMC9KQ08uMjAxMS40MC4wMDEwPC9l

bGVjdHJvbmljLXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA (2)Prospectiverandomized2,119, 49Breast cancer/ anthracycline and trastuzumab7 yrsThe cumulative incidence of heart failure/ cardiac death among trastuzumab treated evaluable patients was 4.0% (95% CI: 2.8% to 5.2%). Relative risk 3.3 (95% CI: 1.63 to 6.66 p < 0.001). Most relevant risk factors for end point were age, treatment with anthracyclines and baseline and post-anthracycline LVEF.Armstrong et al., 2015PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Bcm1zdHJvbmc8L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFy

PjxSZWNOdW0+MTIzPC9SZWNOdW0+PERpc3BsYXlUZXh0PigxMyk8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+MTIzPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iemQ5ZmZ4cnMyMmRwZWJlNWZ0cXA1dzJqMHhzZjIyMHJkZHNyIiB0aW1lc3RhbXA9

IjE1MTgyNTEyOTgiPjEyMzwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3Vy

bmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+

QXJtc3Ryb25nLCBHLiBULjwvYXV0aG9yPjxhdXRob3I+Sm9zaGksIFYuIE0uPC9hdXRob3I+PGF1

dGhvcj5OZXNzLCBLLiBLLjwvYXV0aG9yPjxhdXRob3I+TWFyd2ljaywgVC4gSC48L2F1dGhvcj48

YXV0aG9yPlpoYW5nLCBOLjwvYXV0aG9yPjxhdXRob3I+U3JpdmFzdGF2YSwgRC48L2F1dGhvcj48

YXV0aG9yPkdyaWZmaW4sIEIuIFAuPC9hdXRob3I+PGF1dGhvcj5HcmltbSwgUi4gQS48L2F1dGhv

cj48YXV0aG9yPlRob21hcywgSi48L2F1dGhvcj48YXV0aG9yPlBoZWxhbiwgRC48L2F1dGhvcj48

YXV0aG9yPkNvbGxpZXIsIFAuPC9hdXRob3I+PGF1dGhvcj5LcnVsbCwgSy4gUi48L2F1dGhvcj48

YXV0aG9yPk11bHJvb25leSwgRC4gQS48L2F1dGhvcj48YXV0aG9yPkdyZWVuLCBELiBNLjwvYXV0

aG9yPjxhdXRob3I+SHVkc29uLCBNLiBNLjwvYXV0aG9yPjxhdXRob3I+Um9iaXNvbiwgTC4gTC48

L2F1dGhvcj48YXV0aG9yPlBsYW5hLCBKLiBDLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1

dG9ycz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgRXBpZGVtaW9sb2d5IGFuZCBDYW5jZXIg

Q29udHJvbCwgU3QuIEp1ZGUgQ2hpbGRyZW4mYXBvcztzIFJlc2VhcmNoIEhvc3BpdGFsLCBNZW1w

aGlzLCBUZW5uZXNzZWUuIEVsZWN0cm9uaWMgYWRkcmVzczogZ3JlZy5hcm1zdHJvbmdAc3RqdWRl

Lm9yZy4mI3hEO0RlcGFydG1lbnQgb2YgUGVkaWF0cmljcywgVW5pdmVyc2l0eSBvZiBUZW5uZXNz

ZWUgSGVhbHRoIFNjaWVuY2UgQ2VudGVyLCBNZW1waGlzLCBUZW5uZXNzZWUuJiN4RDtEZXBhcnRt

ZW50IG9mIEVwaWRlbWlvbG9neSBhbmQgQ2FuY2VyIENvbnRyb2wsIFN0LiBKdWRlIENoaWxkcmVu

JmFwb3M7cyBSZXNlYXJjaCBIb3NwaXRhbCwgTWVtcGhpcywgVGVubmVzc2VlLiYjeEQ7TWVuemll

cyBSZXNlYXJjaCBJbnN0aXR1dGUsIFVuaXZlcnNpdHkgb2YgVGFzbWFuaWEsIEhvYmFydCwgQXVz

dHJhbGlhLiYjeEQ7RGVwYXJ0bWVudCBvZiBCaW9zdGF0aXN0aWNzLCBTdC4gSnVkZSBDaGlsZHJl

biZhcG9zO3MgUmVzZWFyY2ggSG9zcGl0YWwsIE1lbXBoaXMsIFRlbm5lc3NlZS4mI3hEO0RlcGFy

dG1lbnQgb2YgQ2FyZGlvdmFzY3VsYXIgTWVkaWNpbmUsIFRoZSBDbGV2ZWxhbmQgQ2xpbmljLCBD

bGV2ZWxhbmQsIE9oaW8uJiN4RDtCbHVobSBDYXJkaW92YXNjdWxhciBJbnN0aXR1dGUsIE5vcnRo

d2VzdGVybiBNZW1vcmlhbCBIb3NwaXRhbCwgQ2hpY2FnbywgSWxsaW5vaXMuJiN4RDtEZXBhcnRt

ZW50IG9mIE9uY29sb2d5LCBTdC4gSnVkZSBDaGlsZHJlbiZhcG9zO3MgUmVzZWFyY2ggSG9zcGl0

YWwsIE1lbXBoaXMsIFRlbm5lc3NlZS4mI3hEO0JheWxvciBDb2xsZWdlIG9mIE1lZGljaW5lLCBI

b3VzdG9uLCBUZXhhcy48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Db21wcmVoZW5zaXZl

IEVjaG9jYXJkaW9ncmFwaGljIERldGVjdGlvbiBvZiBUcmVhdG1lbnQtUmVsYXRlZCBDYXJkaWFj

IER5c2Z1bmN0aW9uIGluIEFkdWx0IFN1cnZpdm9ycyBvZiBDaGlsZGhvb2QgQ2FuY2VyOiBSZXN1

bHRzIEZyb20gdGhlIFN0LiBKdWRlIExpZmV0aW1lIENvaG9ydCBTdHVkeTwvdGl0bGU+PHNlY29u

ZGFyeS10aXRsZT5KIEFtIENvbGwgQ2FyZGlvbDwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxw

ZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkogQW0gQ29sbCBDYXJkaW9sPC9mdWxsLXRpdGxlPjwvcGVy

aW9kaWNhbD48cGFnZXM+MjUxMS0yMjwvcGFnZXM+PHZvbHVtZT42NTwvdm9sdW1lPjxudW1iZXI+

MjM8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWRvbGVzY2VudDwva2V5d29yZD48a2V5d29y

ZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BbnRpYmlvdGljcywgQW50aW5lb3BsYXN0aWMvKmFk

dmVyc2UgZWZmZWN0czwva2V5d29yZD48a2V5d29yZD5DYXJkaW92YXNjdWxhciBEaXNlYXNlcy8q

Y2hlbWljYWxseSBpbmR1Y2VkLypkaWFnbm9zdGljIGltYWdpbmcvZXBpZGVtaW9sb2d5PC9rZXl3

b3JkPjxrZXl3b3JkPkNoaWxkPC9rZXl3b3JkPjxrZXl3b3JkPkNoaWxkLCBQcmVzY2hvb2w8L2tl

eXdvcmQ+PGtleXdvcmQ+Q29ob3J0IFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+KkVjaG9jYXJk

aW9ncmFwaHksIFRocmVlLURpbWVuc2lvbmFsL3RyZW5kczwva2V5d29yZD48a2V5d29yZD5GZW1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+Rm9sbG93LVVwIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+

SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkluZmFudDwva2V5d29yZD48a2V5d29yZD5JbmZhbnQs

IE5ld2Jvcm48L2tleXdvcmQ+PGtleXdvcmQ+TG9uZ2l0dWRpbmFsIFN0dWRpZXM8L2tleXdvcmQ+

PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbXMvKmRydWcgdGhlcmFweS9l

cGlkZW1pb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+U3Ryb2tlIFZvbHVtZS9kcnVnIGVmZmVjdHMv

cGh5c2lvbG9neTwva2V5d29yZD48a2V5d29yZD4qU3Vydml2b3JzPC9rZXl3b3JkPjxrZXl3b3Jk

PlRpbWUgRmFjdG9yczwva2V5d29yZD48a2V5d29yZD5UcmVhdG1lbnQgT3V0Y29tZTwva2V5d29y

ZD48a2V5d29yZD5Zb3VuZyBBZHVsdDwva2V5d29yZD48a2V5d29yZD5jYXJkaW9teW9wYXRoeTwv

a2V5d29yZD48a2V5d29yZD5jYXJkaW90b3hpY2l0eTwva2V5d29yZD48a2V5d29yZD5oZWFydCBm

YWlsdXJlPC9rZXl3b3JkPjxrZXl3b3JkPmxhdGUgZWZmZWN0czwva2V5d29yZD48a2V5d29yZD5z

Y3JlZW5pbmc8L2tleXdvcmQ+PGtleXdvcmQ+c3RyYWluPC9rZXl3b3JkPjwva2V5d29yZHM+PGRh

dGVzPjx5ZWFyPjIwMTU8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KdW4gMTY8L2RhdGU+PC9wdWIt

ZGF0ZXM+PC9kYXRlcz48aXNibj4xNTU4LTM1OTcgKEVsZWN0cm9uaWMpJiN4RDswNzM1LTEwOTcg

KExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI2MDY1OTkwPC9hY2Nlc3Npb24tbnVtPjx1

cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwczovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1l

ZC8yNjA2NTk5MDwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48Y3VzdG9tMj5QTUM0NTM5MTIz

PC9jdXN0b20yPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDE2L2ouamFjYy4yMDE1LjA0

LjAxMzwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Bcm1zdHJvbmc8L0F1dGhvcj48WWVhcj4yMDE1PC9ZZWFy

PjxSZWNOdW0+MTIzPC9SZWNOdW0+PERpc3BsYXlUZXh0PigxMyk8L0Rpc3BsYXlUZXh0PjxyZWNv

cmQ+PHJlYy1udW1iZXI+MTIzPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVO

IiBkYi1pZD0iemQ5ZmZ4cnMyMmRwZWJlNWZ0cXA1dzJqMHhzZjIyMHJkZHNyIiB0aW1lc3RhbXA9

IjE1MTgyNTEyOTgiPjEyMzwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3Vy

bmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+

QXJtc3Ryb25nLCBHLiBULjwvYXV0aG9yPjxhdXRob3I+Sm9zaGksIFYuIE0uPC9hdXRob3I+PGF1

dGhvcj5OZXNzLCBLLiBLLjwvYXV0aG9yPjxhdXRob3I+TWFyd2ljaywgVC4gSC48L2F1dGhvcj48

YXV0aG9yPlpoYW5nLCBOLjwvYXV0aG9yPjxhdXRob3I+U3JpdmFzdGF2YSwgRC48L2F1dGhvcj48

YXV0aG9yPkdyaWZmaW4sIEIuIFAuPC9hdXRob3I+PGF1dGhvcj5HcmltbSwgUi4gQS48L2F1dGhv

cj48YXV0aG9yPlRob21hcywgSi48L2F1dGhvcj48YXV0aG9yPlBoZWxhbiwgRC48L2F1dGhvcj48

YXV0aG9yPkNvbGxpZXIsIFAuPC9hdXRob3I+PGF1dGhvcj5LcnVsbCwgSy4gUi48L2F1dGhvcj48

YXV0aG9yPk11bHJvb25leSwgRC4gQS48L2F1dGhvcj48YXV0aG9yPkdyZWVuLCBELiBNLjwvYXV0

aG9yPjxhdXRob3I+SHVkc29uLCBNLiBNLjwvYXV0aG9yPjxhdXRob3I+Um9iaXNvbiwgTC4gTC48

L2F1dGhvcj48YXV0aG9yPlBsYW5hLCBKLiBDLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1

dG9ycz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgRXBpZGVtaW9sb2d5IGFuZCBDYW5jZXIg

Q29udHJvbCwgU3QuIEp1ZGUgQ2hpbGRyZW4mYXBvcztzIFJlc2VhcmNoIEhvc3BpdGFsLCBNZW1w

aGlzLCBUZW5uZXNzZWUuIEVsZWN0cm9uaWMgYWRkcmVzczogZ3JlZy5hcm1zdHJvbmdAc3RqdWRl

Lm9yZy4mI3hEO0RlcGFydG1lbnQgb2YgUGVkaWF0cmljcywgVW5pdmVyc2l0eSBvZiBUZW5uZXNz

ZWUgSGVhbHRoIFNjaWVuY2UgQ2VudGVyLCBNZW1waGlzLCBUZW5uZXNzZWUuJiN4RDtEZXBhcnRt

ZW50IG9mIEVwaWRlbWlvbG9neSBhbmQgQ2FuY2VyIENvbnRyb2wsIFN0LiBKdWRlIENoaWxkcmVu

JmFwb3M7cyBSZXNlYXJjaCBIb3NwaXRhbCwgTWVtcGhpcywgVGVubmVzc2VlLiYjeEQ7TWVuemll

cyBSZXNlYXJjaCBJbnN0aXR1dGUsIFVuaXZlcnNpdHkgb2YgVGFzbWFuaWEsIEhvYmFydCwgQXVz

dHJhbGlhLiYjeEQ7RGVwYXJ0bWVudCBvZiBCaW9zdGF0aXN0aWNzLCBTdC4gSnVkZSBDaGlsZHJl

biZhcG9zO3MgUmVzZWFyY2ggSG9zcGl0YWwsIE1lbXBoaXMsIFRlbm5lc3NlZS4mI3hEO0RlcGFy

dG1lbnQgb2YgQ2FyZGlvdmFzY3VsYXIgTWVkaWNpbmUsIFRoZSBDbGV2ZWxhbmQgQ2xpbmljLCBD

bGV2ZWxhbmQsIE9oaW8uJiN4RDtCbHVobSBDYXJkaW92YXNjdWxhciBJbnN0aXR1dGUsIE5vcnRo

d2VzdGVybiBNZW1vcmlhbCBIb3NwaXRhbCwgQ2hpY2FnbywgSWxsaW5vaXMuJiN4RDtEZXBhcnRt

ZW50IG9mIE9uY29sb2d5LCBTdC4gSnVkZSBDaGlsZHJlbiZhcG9zO3MgUmVzZWFyY2ggSG9zcGl0

YWwsIE1lbXBoaXMsIFRlbm5lc3NlZS4mI3hEO0JheWxvciBDb2xsZWdlIG9mIE1lZGljaW5lLCBI

b3VzdG9uLCBUZXhhcy48L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Db21wcmVoZW5zaXZl

IEVjaG9jYXJkaW9ncmFwaGljIERldGVjdGlvbiBvZiBUcmVhdG1lbnQtUmVsYXRlZCBDYXJkaWFj

IER5c2Z1bmN0aW9uIGluIEFkdWx0IFN1cnZpdm9ycyBvZiBDaGlsZGhvb2QgQ2FuY2VyOiBSZXN1

bHRzIEZyb20gdGhlIFN0LiBKdWRlIExpZmV0aW1lIENvaG9ydCBTdHVkeTwvdGl0bGU+PHNlY29u

ZGFyeS10aXRsZT5KIEFtIENvbGwgQ2FyZGlvbDwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxw

ZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkogQW0gQ29sbCBDYXJkaW9sPC9mdWxsLXRpdGxlPjwvcGVy

aW9kaWNhbD48cGFnZXM+MjUxMS0yMjwvcGFnZXM+PHZvbHVtZT42NTwvdm9sdW1lPjxudW1iZXI+

MjM8L251bWJlcj48a2V5d29yZHM+PGtleXdvcmQ+QWRvbGVzY2VudDwva2V5d29yZD48a2V5d29y

ZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5BbnRpYmlvdGljcywgQW50aW5lb3BsYXN0aWMvKmFk

dmVyc2UgZWZmZWN0czwva2V5d29yZD48a2V5d29yZD5DYXJkaW92YXNjdWxhciBEaXNlYXNlcy8q

Y2hlbWljYWxseSBpbmR1Y2VkLypkaWFnbm9zdGljIGltYWdpbmcvZXBpZGVtaW9sb2d5PC9rZXl3

b3JkPjxrZXl3b3JkPkNoaWxkPC9rZXl3b3JkPjxrZXl3b3JkPkNoaWxkLCBQcmVzY2hvb2w8L2tl

eXdvcmQ+PGtleXdvcmQ+Q29ob3J0IFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+KkVjaG9jYXJk

aW9ncmFwaHksIFRocmVlLURpbWVuc2lvbmFsL3RyZW5kczwva2V5d29yZD48a2V5d29yZD5GZW1h

bGU8L2tleXdvcmQ+PGtleXdvcmQ+Rm9sbG93LVVwIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+

SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkluZmFudDwva2V5d29yZD48a2V5d29yZD5JbmZhbnQs

IE5ld2Jvcm48L2tleXdvcmQ+PGtleXdvcmQ+TG9uZ2l0dWRpbmFsIFN0dWRpZXM8L2tleXdvcmQ+

PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbXMvKmRydWcgdGhlcmFweS9l

cGlkZW1pb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+U3Ryb2tlIFZvbHVtZS9kcnVnIGVmZmVjdHMv

cGh5c2lvbG9neTwva2V5d29yZD48a2V5d29yZD4qU3Vydml2b3JzPC9rZXl3b3JkPjxrZXl3b3Jk

PlRpbWUgRmFjdG9yczwva2V5d29yZD48a2V5d29yZD5UcmVhdG1lbnQgT3V0Y29tZTwva2V5d29y

ZD48a2V5d29yZD5Zb3VuZyBBZHVsdDwva2V5d29yZD48a2V5d29yZD5jYXJkaW9teW9wYXRoeTwv

a2V5d29yZD48a2V5d29yZD5jYXJkaW90b3hpY2l0eTwva2V5d29yZD48a2V5d29yZD5oZWFydCBm

YWlsdXJlPC9rZXl3b3JkPjxrZXl3b3JkPmxhdGUgZWZmZWN0czwva2V5d29yZD48a2V5d29yZD5z

Y3JlZW5pbmc8L2tleXdvcmQ+PGtleXdvcmQ+c3RyYWluPC9rZXl3b3JkPjwva2V5d29yZHM+PGRh

dGVzPjx5ZWFyPjIwMTU8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KdW4gMTY8L2RhdGU+PC9wdWIt

ZGF0ZXM+PC9kYXRlcz48aXNibj4xNTU4LTM1OTcgKEVsZWN0cm9uaWMpJiN4RDswNzM1LTEwOTcg

KExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI2MDY1OTkwPC9hY2Nlc3Npb24tbnVtPjx1

cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwczovL3d3dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1l

ZC8yNjA2NTk5MDwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48Y3VzdG9tMj5QTUM0NTM5MTIz

PC9jdXN0b20yPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDE2L2ouamFjYy4yMDE1LjA0

LjAxMzwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE.DATA (13)Retrospective1,820,31 (18-65)Blood malignancies, sarcomas, melanoma, Retinoblastoma, Wil’s tumor, carcinoma, CNS, bone tumor/ anthracyclines, radiation>10 yrs5.8% of the population had 3D LVEFs <50%.Cardiac dysfunction detected by GLS (31.8%), GCS (23.1%) and diastolic dysfunction (11%) was more prevalent than abnormal LVEF.Narayan et al., 2017PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OYXJheWFuPC9BdXRob3I+PFllYXI+MjAxNzwvWWVhcj48

UmVjTnVtPjgxPC9SZWNOdW0+PERpc3BsYXlUZXh0PigxNCk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+

PHJlYy1udW1iZXI+ODE8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRi

LWlkPSJ6ZDlmZnhyczIyZHBlYmU1ZnRxcDV3MmoweHNmMjIwcmRkc3IiIHRpbWVzdGFtcD0iMTUx

MDc4NDU4NSI+ODE8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBB

cnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk5hcmF5

YW4sIEguIEsuPC9hdXRob3I+PGF1dGhvcj5GaW5rZWxtYW4sIEIuPC9hdXRob3I+PGF1dGhvcj5G

cmVuY2gsIEIuPC9hdXRob3I+PGF1dGhvcj5QbGFwcGVydCwgVC48L2F1dGhvcj48YXV0aG9yPkh5

bWFuLCBELjwvYXV0aG9yPjxhdXRob3I+U21pdGgsIEEuIE0uPC9hdXRob3I+PGF1dGhvcj5NYXJn

dWxpZXMsIEsuIEIuPC9hdXRob3I+PGF1dGhvcj5LeSwgQi48L2F1dGhvcj48L2F1dGhvcnM+PC9j

b250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5Gcm9tIERlcGFydG1lbnQgb2YgUGVkaWF0cmljcywg

RGl2aXNpb24gb2YgQ2FyZGlvbG9neSwgVGhlIENoaWxkcmVuJmFwb3M7cyBIb3NwaXRhbCBvZiBQ

aGlsYWRlbHBoaWEsIFBBIChILksuTi4pOyBEZXBhcnRtZW50IG9mIEJpb3N0YXRpc3RpY3MgYW5k

IEVwaWRlbWlvbG9neSwgUGVyZWxtYW4gU2Nob29sIG9mIE1lZGljaW5lIGF0IHRoZSBVbml2ZXJz

aXR5IG9mIFBlbm5zeWx2YW5pYSwgUGhpbGFkZWxwaGlhIChCLiBGaW5rZWxtYW4sIEIuIEZyZW5j

aCwgQi5LLik7IGFuZCBEZXBhcnRtZW50IG9mIE1lZGljaW5lLCBEaXZpc2lvbiBvZiBDYXJkaW9s

b2d5LCBQZXJlbG1hbiBTY2hvb2wgb2YgTWVkaWNpbmUgYXQgdGhlIFVuaXZlcnNpdHkgb2YgUGVu

bnN5bHZhbmlhLCBQaGlsYWRlbHBoaWEgKEIuIEZpbmtlbG1hbiwgVC5QLiwgRC5ILiwgQS5NLlMu

LCBLLkIuTS4sIEIuSy4pLiYjeEQ7RnJvbSBEZXBhcnRtZW50IG9mIFBlZGlhdHJpY3MsIERpdmlz

aW9uIG9mIENhcmRpb2xvZ3ksIFRoZSBDaGlsZHJlbiZhcG9zO3MgSG9zcGl0YWwgb2YgUGhpbGFk

ZWxwaGlhLCBQQSAoSC5LLk4uKTsgRGVwYXJ0bWVudCBvZiBCaW9zdGF0aXN0aWNzIGFuZCBFcGlk

ZW1pb2xvZ3ksIFBlcmVsbWFuIFNjaG9vbCBvZiBNZWRpY2luZSBhdCB0aGUgVW5pdmVyc2l0eSBv

ZiBQZW5uc3lsdmFuaWEsIFBoaWxhZGVscGhpYSAoQi4gRmlua2VsbWFuLCBCLiBGcmVuY2gsIEIu

Sy4pOyBhbmQgRGVwYXJ0bWVudCBvZiBNZWRpY2luZSwgRGl2aXNpb24gb2YgQ2FyZGlvbG9neSwg

UGVyZWxtYW4gU2Nob29sIG9mIE1lZGljaW5lIGF0IHRoZSBVbml2ZXJzaXR5IG9mIFBlbm5zeWx2

YW5pYSwgUGhpbGFkZWxwaGlhIChCLiBGaW5rZWxtYW4sIFQuUC4sIEQuSC4sIEEuTS5TLiwgSy5C

Lk0uLCBCLksuKS4gYm9ubmllLmt5QHVwaHMudXBlbm4uZWR1LjwvYXV0aC1hZGRyZXNzPjx0aXRs

ZXM+PHRpdGxlPkRldGFpbGVkIEVjaG9jYXJkaW9ncmFwaGljIFBoZW5vdHlwaW5nIGluIEJyZWFz

dCBDYW5jZXIgUGF0aWVudHM6IEFzc29jaWF0aW9ucyBXaXRoIEVqZWN0aW9uIEZyYWN0aW9uIERl

Y2xpbmUsIFJlY292ZXJ5LCBhbmQgSGVhcnQgRmFpbHVyZSBTeW1wdG9tcyBPdmVyIDMgWWVhcnMg

b2YgRm9sbG93LVVwPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkNpcmN1bGF0aW9uPC9zZWNvbmRh

cnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Q2lyY3VsYXRpb248L2Z1

bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4xMzk3LTE0MTI8L3BhZ2VzPjx2b2x1bWU+MTM1

PC92b2x1bWU+PG51bWJlcj4xNTwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5

d29yZD48a2V5d29yZD5BbnRpbmVvcGxhc3RpYyBDb21iaW5lZCBDaGVtb3RoZXJhcHkgUHJvdG9j

b2xzL2FkdmVyc2UgZWZmZWN0cy90aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QnJl

YXN0IE5lb3BsYXNtcy8qY29tcGxpY2F0aW9ucy9kaWFnbm9zaXMvZHJ1ZyB0aGVyYXB5PC9rZXl3

b3JkPjxrZXl3b3JkPkNvbWJpbmVkIE1vZGFsaXR5IFRoZXJhcHkvYWR2ZXJzZSBlZmZlY3RzL21l

dGhvZHM8L2tleXdvcmQ+PGtleXdvcmQ+KkVjaG9jYXJkaW9ncmFwaHkvbWV0aG9kczwva2V5d29y

ZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+Rm9sbG93LVVwIFN0dWRpZXM8L2tl

eXdvcmQ+PGtleXdvcmQ+SGVhcnQgRmFpbHVyZS8qZGlhZ25vc2lzL2RydWcgdGhlcmFweS8qZXRp

b2xvZ3kvcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkhlYXJ0IEZ1bmN0aW9uIFRl

c3RzPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdl

ZDwva2V5d29yZD48a2V5d29yZD4qUGhlbm90eXBlPC9rZXl3b3JkPjxrZXl3b3JkPlJlcHJvZHVj

aWJpbGl0eSBvZiBSZXN1bHRzPC9rZXl3b3JkPjxrZXl3b3JkPipTdHJva2UgVm9sdW1lL2RydWcg

ZWZmZWN0czwva2V5d29yZD48a2V5d29yZD5UcmVhdG1lbnQgT3V0Y29tZTwva2V5d29yZD48a2V5

d29yZD5WZW50cmljdWxhciBSZW1vZGVsaW5nL2RydWcgZWZmZWN0czwva2V5d29yZD48a2V5d29y

ZD5jYXJkaW90b3hpY2l0eTwva2V5d29yZD48a2V5d29yZD5kb3hvcnViaWNpbjwva2V5d29yZD48

a2V5d29yZD5lY2hvY2FyZGlvZ3JhcGh5PC9rZXl3b3JkPjxrZXl3b3JkPm1lZGljYWwgb25jb2xv

Z3k8L2tleXdvcmQ+PGtleXdvcmQ+dHJhc3R1enVtYWI8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0

ZXM+PHllYXI+MjAxNzwveWVhcj48cHViLWRhdGVzPjxkYXRlPkFwciAxMTwvZGF0ZT48L3B1Yi1k

YXRlcz48L2RhdGVzPjxpc2JuPjE1MjQtNDUzOSAoRWxlY3Ryb25pYykmI3hEOzAwMDktNzMyMiAo

TGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjgxMDQ3MTU8L2FjY2Vzc2lvbi1udW0+PHVy

bHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHBzOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVk

LzI4MTA0NzE1PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxjdXN0b20yPlBNQzUzODg1NjA8

L2N1c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjExNjEvQ0lSQ1VMQVRJT05BSEEu

MTE2LjAyMzQ2MzwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwvRW5k

Tm90ZT5=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OYXJheWFuPC9BdXRob3I+PFllYXI+MjAxNzwvWWVhcj48

UmVjTnVtPjgxPC9SZWNOdW0+PERpc3BsYXlUZXh0PigxNCk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+

PHJlYy1udW1iZXI+ODE8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRi

LWlkPSJ6ZDlmZnhyczIyZHBlYmU1ZnRxcDV3MmoweHNmMjIwcmRkc3IiIHRpbWVzdGFtcD0iMTUx

MDc4NDU4NSI+ODE8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBB

cnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk5hcmF5

YW4sIEguIEsuPC9hdXRob3I+PGF1dGhvcj5GaW5rZWxtYW4sIEIuPC9hdXRob3I+PGF1dGhvcj5G

cmVuY2gsIEIuPC9hdXRob3I+PGF1dGhvcj5QbGFwcGVydCwgVC48L2F1dGhvcj48YXV0aG9yPkh5

bWFuLCBELjwvYXV0aG9yPjxhdXRob3I+U21pdGgsIEEuIE0uPC9hdXRob3I+PGF1dGhvcj5NYXJn

dWxpZXMsIEsuIEIuPC9hdXRob3I+PGF1dGhvcj5LeSwgQi48L2F1dGhvcj48L2F1dGhvcnM+PC9j

b250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5Gcm9tIERlcGFydG1lbnQgb2YgUGVkaWF0cmljcywg

RGl2aXNpb24gb2YgQ2FyZGlvbG9neSwgVGhlIENoaWxkcmVuJmFwb3M7cyBIb3NwaXRhbCBvZiBQ

aGlsYWRlbHBoaWEsIFBBIChILksuTi4pOyBEZXBhcnRtZW50IG9mIEJpb3N0YXRpc3RpY3MgYW5k

IEVwaWRlbWlvbG9neSwgUGVyZWxtYW4gU2Nob29sIG9mIE1lZGljaW5lIGF0IHRoZSBVbml2ZXJz

aXR5IG9mIFBlbm5zeWx2YW5pYSwgUGhpbGFkZWxwaGlhIChCLiBGaW5rZWxtYW4sIEIuIEZyZW5j

aCwgQi5LLik7IGFuZCBEZXBhcnRtZW50IG9mIE1lZGljaW5lLCBEaXZpc2lvbiBvZiBDYXJkaW9s

b2d5LCBQZXJlbG1hbiBTY2hvb2wgb2YgTWVkaWNpbmUgYXQgdGhlIFVuaXZlcnNpdHkgb2YgUGVu

bnN5bHZhbmlhLCBQaGlsYWRlbHBoaWEgKEIuIEZpbmtlbG1hbiwgVC5QLiwgRC5ILiwgQS5NLlMu

LCBLLkIuTS4sIEIuSy4pLiYjeEQ7RnJvbSBEZXBhcnRtZW50IG9mIFBlZGlhdHJpY3MsIERpdmlz

aW9uIG9mIENhcmRpb2xvZ3ksIFRoZSBDaGlsZHJlbiZhcG9zO3MgSG9zcGl0YWwgb2YgUGhpbGFk

ZWxwaGlhLCBQQSAoSC5LLk4uKTsgRGVwYXJ0bWVudCBvZiBCaW9zdGF0aXN0aWNzIGFuZCBFcGlk

ZW1pb2xvZ3ksIFBlcmVsbWFuIFNjaG9vbCBvZiBNZWRpY2luZSBhdCB0aGUgVW5pdmVyc2l0eSBv

ZiBQZW5uc3lsdmFuaWEsIFBoaWxhZGVscGhpYSAoQi4gRmlua2VsbWFuLCBCLiBGcmVuY2gsIEIu

Sy4pOyBhbmQgRGVwYXJ0bWVudCBvZiBNZWRpY2luZSwgRGl2aXNpb24gb2YgQ2FyZGlvbG9neSwg

UGVyZWxtYW4gU2Nob29sIG9mIE1lZGljaW5lIGF0IHRoZSBVbml2ZXJzaXR5IG9mIFBlbm5zeWx2

YW5pYSwgUGhpbGFkZWxwaGlhIChCLiBGaW5rZWxtYW4sIFQuUC4sIEQuSC4sIEEuTS5TLiwgSy5C

Lk0uLCBCLksuKS4gYm9ubmllLmt5QHVwaHMudXBlbm4uZWR1LjwvYXV0aC1hZGRyZXNzPjx0aXRs

ZXM+PHRpdGxlPkRldGFpbGVkIEVjaG9jYXJkaW9ncmFwaGljIFBoZW5vdHlwaW5nIGluIEJyZWFz

dCBDYW5jZXIgUGF0aWVudHM6IEFzc29jaWF0aW9ucyBXaXRoIEVqZWN0aW9uIEZyYWN0aW9uIERl

Y2xpbmUsIFJlY292ZXJ5LCBhbmQgSGVhcnQgRmFpbHVyZSBTeW1wdG9tcyBPdmVyIDMgWWVhcnMg

b2YgRm9sbG93LVVwPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkNpcmN1bGF0aW9uPC9zZWNvbmRh

cnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+Q2lyY3VsYXRpb248L2Z1

bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz4xMzk3LTE0MTI8L3BhZ2VzPjx2b2x1bWU+MTM1

PC92b2x1bWU+PG51bWJlcj4xNTwvbnVtYmVyPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5

d29yZD48a2V5d29yZD5BbnRpbmVvcGxhc3RpYyBDb21iaW5lZCBDaGVtb3RoZXJhcHkgUHJvdG9j

b2xzL2FkdmVyc2UgZWZmZWN0cy90aGVyYXBldXRpYyB1c2U8L2tleXdvcmQ+PGtleXdvcmQ+QnJl

YXN0IE5lb3BsYXNtcy8qY29tcGxpY2F0aW9ucy9kaWFnbm9zaXMvZHJ1ZyB0aGVyYXB5PC9rZXl3

b3JkPjxrZXl3b3JkPkNvbWJpbmVkIE1vZGFsaXR5IFRoZXJhcHkvYWR2ZXJzZSBlZmZlY3RzL21l

dGhvZHM8L2tleXdvcmQ+PGtleXdvcmQ+KkVjaG9jYXJkaW9ncmFwaHkvbWV0aG9kczwva2V5d29y

ZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+Rm9sbG93LVVwIFN0dWRpZXM8L2tl

eXdvcmQ+PGtleXdvcmQ+SGVhcnQgRmFpbHVyZS8qZGlhZ25vc2lzL2RydWcgdGhlcmFweS8qZXRp

b2xvZ3kvcGh5c2lvcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkhlYXJ0IEZ1bmN0aW9uIFRl

c3RzPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdl

ZDwva2V5d29yZD48a2V5d29yZD4qUGhlbm90eXBlPC9rZXl3b3JkPjxrZXl3b3JkPlJlcHJvZHVj

aWJpbGl0eSBvZiBSZXN1bHRzPC9rZXl3b3JkPjxrZXl3b3JkPipTdHJva2UgVm9sdW1lL2RydWcg

ZWZmZWN0czwva2V5d29yZD48a2V5d29yZD5UcmVhdG1lbnQgT3V0Y29tZTwva2V5d29yZD48a2V5

d29yZD5WZW50cmljdWxhciBSZW1vZGVsaW5nL2RydWcgZWZmZWN0czwva2V5d29yZD48a2V5d29y

ZD5jYXJkaW90b3hpY2l0eTwva2V5d29yZD48a2V5d29yZD5kb3hvcnViaWNpbjwva2V5d29yZD48

a2V5d29yZD5lY2hvY2FyZGlvZ3JhcGh5PC9rZXl3b3JkPjxrZXl3b3JkPm1lZGljYWwgb25jb2xv

Z3k8L2tleXdvcmQ+PGtleXdvcmQ+dHJhc3R1enVtYWI8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0

ZXM+PHllYXI+MjAxNzwveWVhcj48cHViLWRhdGVzPjxkYXRlPkFwciAxMTwvZGF0ZT48L3B1Yi1k

YXRlcz48L2RhdGVzPjxpc2JuPjE1MjQtNDUzOSAoRWxlY3Ryb25pYykmI3hEOzAwMDktNzMyMiAo

TGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjgxMDQ3MTU8L2FjY2Vzc2lvbi1udW0+PHVy

bHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHBzOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVk

LzI4MTA0NzE1PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxjdXN0b20yPlBNQzUzODg1NjA8

L2N1c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjExNjEvQ0lSQ1VMQVRJT05BSEEu

MTE2LjAyMzQ2MzwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwvRW5k

Tm90ZT5=

ADDIN EN.CITE.DATA (14)Prospective277, 48 (41-57)Breast cancer/doxorubicin, trastuzumab3 yrsWith Doxorubicin, there was a 3-year change in LVEF of -3.8% (95% CI: -5.1% to -2.5%). With trastuzumab, a -2.8%(95% CI:-5.3% to -0.4%). Changes in volumes, strain and ventriculo-arterial coupling were consistently associated with concurrent and subsequent LVEF declines and recovery across therapies. GLS = global longitudinal strain; GCS = global circumferential strain.Online Table 5 Guidelines on Cardiac Surveillance Before, During and After Cancer TherapyGuidelinesSpecific Cancer AgentPre-Tx LVEF evaluationCardiotoxicityDefinitionMonitoringFrequencyIntervention: Stopping/restarting recommendationsMonitoring post TxFDA ADDIN EN.CITE <EndNote><Cite><RecNum>5</RecNum><DisplayText>(15, 16)</DisplayText><record><rec-number>5</rec-number><foreign-keys><key app="EN" db-id="zd9ffxrs22dpebe5ftqp5w2j0xsf220rddsr" timestamp="1510775373">5</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors></contributors><titles><title><style face="normal" font="default" size="100%">Food and Drug Administration. Adriamycin (DOXOrubicin HCl) for Injection. Version 2.0, 2012. Available online </style><style face="underline" font="default" size="100%"> face="normal" font="default" size="100%">. Accessed November 15, 2017</style></title></titles><dates></dates><urls></urls></record></Cite><Cite><RecNum>6</RecNum><record><rec-number>6</rec-number><foreign-keys><key app="EN" db-id="zd9ffxrs22dpebe5ftqp5w2j0xsf220rddsr" timestamp="1510775628">6</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors></contributors><titles><title><style face="normal" font="default" size="100%">Food and Drug Administration. HERCEPTIN (trastuzumab) Label. 2010. Available Online </style><style face="underline" font="default" size="100%">;(15, 16)Doxorubicin YesDrop of 10% to below the LLN, or an absolute LVEF of 45%, or a 20% decline in LVEF at any levelRepeat LVEF measurement for higher cumulative anthracycline doses; frequency not specifiedCarefully weigh risk/benefit of continued therapy Not specifiedTrastuzumab Yes≥ 16% absolute decrease in LVEF from pre-treatment values; LVEF below institutional LLN and ≥ 10% absolute decrease in LVEF from pretreatment values. LVEF measurements every 3 months during and upon completion of trastuzumabWithhold for at least 4 weeks, repeat LVEF measurement at 4 week intervals if trastuzumab is withheld for LV dysfunction, may be resumed if, within 4?8 weeks, the LVEF returns to normal limits and the absolute decrease from baseline is ≤ 15%.LVEF measurementevery 6 months for at least 2 years following completion of trastuzumab as a component of adjuvant therapy.NCCN ADDIN EN.CITE <EndNote><Cite><RecNum>29</RecNum><DisplayText>(17)</DisplayText><record><rec-number>29</rec-number><foreign-keys><key app="EN" db-id="zd9ffxrs22dpebe5ftqp5w2j0xsf220rddsr" timestamp="1510776972">29</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors></contributors><titles><title><style face="normal" font="default" size="100%">National Comprehensive Cancer Network. NCCN Guidelines Version 2.2017. Anthracycline-Induced Cardiac Toxicity. Available online: </style><style face="underline" font="default" size="100%">;(17)TrastuzumabYesNot specifiedDuring therapy*Same as FDANot specifiedASEPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QbGFuYTwvQXV0aG9yPjxZZWFyPjIwMTQ8L1llYXI+PFJl

Y051bT44PC9SZWNOdW0+PERpc3BsYXlUZXh0PigxOCk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJl

Yy1udW1iZXI+ODwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9

InpkOWZmeHJzMjJkcGViZTVmdHFwNXcyajB4c2YyMjByZGRzciIgdGltZXN0YW1wPSIxNTEwNzc2

MTQ1Ij44PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNs

ZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5QbGFuYSwgSi4g

Qy48L2F1dGhvcj48YXV0aG9yPkdhbGRlcmlzaSwgTS48L2F1dGhvcj48YXV0aG9yPkJhcmFjLCBB

LjwvYXV0aG9yPjxhdXRob3I+RXdlciwgTS4gUy48L2F1dGhvcj48YXV0aG9yPkt5LCBCLjwvYXV0

aG9yPjxhdXRob3I+U2NoZXJyZXItQ3Jvc2JpZSwgTS48L2F1dGhvcj48YXV0aG9yPkdhbmFtZSwg

Si48L2F1dGhvcj48YXV0aG9yPlNlYmFnLCBJLiBBLjwvYXV0aG9yPjxhdXRob3I+QWdsZXIsIEQu

IEEuPC9hdXRob3I+PGF1dGhvcj5CYWRhbm8sIEwuIFAuPC9hdXRob3I+PGF1dGhvcj5CYW5jaHMs

IEouPC9hdXRob3I+PGF1dGhvcj5DYXJkaW5hbGUsIEQuPC9hdXRob3I+PGF1dGhvcj5DYXJ2ZXIs

IEouPC9hdXRob3I+PGF1dGhvcj5DZXJxdWVpcmEsIE0uPC9hdXRob3I+PGF1dGhvcj5EZUNhcmEs

IEouIE0uPC9hdXRob3I+PGF1dGhvcj5FZHZhcmRzZW4sIFQuPC9hdXRob3I+PGF1dGhvcj5GbGFt

bSwgUy4gRC48L2F1dGhvcj48YXV0aG9yPkZvcmNlLCBULjwvYXV0aG9yPjxhdXRob3I+R3JpZmZp

biwgQi4gUC48L2F1dGhvcj48YXV0aG9yPkplcnVzYWxlbSwgRy48L2F1dGhvcj48YXV0aG9yPkxp

dSwgSi4gRS48L2F1dGhvcj48YXV0aG9yPk1hZ2FsaGFlcywgQS48L2F1dGhvcj48YXV0aG9yPk1h

cndpY2ssIFQuPC9hdXRob3I+PGF1dGhvcj5TYW5jaGV6LCBMLiBZLjwvYXV0aG9yPjxhdXRob3I+

U2ljYXJpLCBSLjwvYXV0aG9yPjxhdXRob3I+VmlsbGFycmFnYSwgSC4gUi48L2F1dGhvcj48YXV0

aG9yPkxhbmNlbGxvdHRpLCBQLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0

aC1hZGRyZXNzPkNsZXZlbGFuZCBDbGluaWMsIENsZXZlbGFuZCwgT2hpby4mI3hEO0ZlZGVyaWNv

IElJIFVuaXZlcnNpdHkgSG9zcGl0YWwsIE5hcGxlcywgSXRhbHkuJiN4RDtNZWRzdGFyIFdhc2hp

bmd0b24gSG9zcGl0YWwgQ2VudGVyLCBXYXNoaW5ndG9uLCBEaXN0cmljdCBvZiBDb2x1bWJpYS4m

I3hEO01EIEFuZGVyc29uIENhbmNlciBDZW50ZXIsIFVuaXZlcnNpdHkgb2YgVGV4YXMsIEhvdXN0

b24sIFRleGFzLiYjeEQ7VW5pdmVyc2l0eSBvZiBQZW5uc3lsdmFuaWEsIFBoaWxhZGVscGhpYSwg

UGVubnN5bHZhbmlhLiYjeEQ7TWFzc2FjaHVzZXR0cyBHZW5lcmFsIEhvc3BpdGFsLCBCb3N0b24s

IE1hc3NhY2h1c2V0dHMuJiN4RDtNY01hc3RlciBVbml2ZXJzaXR5LCBIYW1pbHRvbiwgT250YXJp

bywgQ2FuYWRhLiYjeEQ7SmV3aXNoIEdlbmVyYWwgSG9zcGl0YWwgYW5kIE1jR2lsbCBVbml2ZXJz

aXR5LCBNb250cmVhbCwgUXVlYmVjLCBDYW5hZGEuJiN4RDtVbml2ZXJzaXR5IG9mIFBhZHVhLCBQ

YWR1YSwgSXRhbHkuJiN4RDtFdXJvcGVhbiBJbnN0aXR1dGUgb2YgT25jb2xvZ3ksIE1pbGFuLCBJ

dGFseS4mI3hEO0FicmFtc29uIENhbmNlciBDZW50ZXIgYXQgdGhlIFVuaXZlcnNpdHkgb2YgUGVu

bnN5bHZhbmlhLCBQaGlsYWRlbHBoaWEsIFBlbm5zeWx2YW5pYS4mI3hEO1VuaXZlcnNpdHkgb2Yg

Q2hpY2FnbyBNZWRpY2luZSwgQ2hpY2FnbywgSWxsaW5vaXMuJiN4RDtPc2xvIFVuaXZlcnNpdHkg

SG9zcGl0YWwgYW5kIFVuaXZlcnNpdHkgb2YgT3NsbywgT3NsbywgTm9yd2F5LiYjeEQ7VGVtcGxl

IFVuaXZlcnNpdHksIFBoaWxhZGVscGhpYSwgUGVubnN5bHZhbmlhLiYjeEQ7VW5pdmVyc2l0eSBv

ZiBMaWVnZSwgTGllZ2UsIEJlbGdpdW0uJiN4RDtNZW1vcmlhbCBTbG9hbi1LZXR0ZXJpbmcgQ2Fu

Y2VyIENlbnRlciwgTmV3IFlvcmssIE5ldyBZb3JrLiYjeEQ7U2FudGEgTWFyaWUgVW5pdmVyc2l0

eSBIb3NwaXRhbCwgTGlzYm9uLCBQb3J0dWdhbC4mI3hEO01lbnppZXMgUmVzZWFyY2ggSW5zdGl0

dXRlIFRhc21hbmlhLCBIb2JhcnQsIEF1c3RyYWxpYS4mI3hEO0NOUiBJbnN0aXR1dGUgb2YgQ2xp

bmljYWwgUGh5c2lvbG9neSwgUGlzYSwgSXRhbHkuJiN4RDtNYXlvIENsaW5pYywgUm9jaGVzdGVy

LCBNaW5uZXNvdGEuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+RXhwZXJ0IGNvbnNlbnN1

cyBmb3IgbXVsdGltb2RhbGl0eSBpbWFnaW5nIGV2YWx1YXRpb24gb2YgYWR1bHQgcGF0aWVudHMg

ZHVyaW5nIGFuZCBhZnRlciBjYW5jZXIgdGhlcmFweTogYSByZXBvcnQgZnJvbSB0aGUgQW1lcmlj

YW4gU29jaWV0eSBvZiBFY2hvY2FyZGlvZ3JhcGh5IGFuZCB0aGUgRXVyb3BlYW4gQXNzb2NpYXRp

b24gb2YgQ2FyZGlvdmFzY3VsYXIgSW1hZ2luZzwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KIEFt

IFNvYyBFY2hvY2FyZGlvZ3I8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5KIEFtIFNvYyBFY2hvY2FyZGlvZ3I8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2Fs

PjxwYWdlcz45MTEtMzk8L3BhZ2VzPjx2b2x1bWU+Mjc8L3ZvbHVtZT48bnVtYmVyPjk8L251bWJl

cj48a2V5d29yZHM+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyZGlvbG9neS9z

dGFuZGFyZHM8L2tleXdvcmQ+PGtleXdvcmQ+Q2hlbW9yYWRpb3RoZXJhcHkvKmFkdmVyc2UgZWZm

ZWN0cy8qc3RhbmRhcmRzPC9rZXl3b3JkPjxrZXl3b3JkPkV1cm9wZTwva2V5d29yZD48a2V5d29y

ZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8

L2tleXdvcmQ+PGtleXdvcmQ+TWVkaWNhbCBPbmNvbG9neS9zdGFuZGFyZHM8L2tleXdvcmQ+PGtl

eXdvcmQ+TXVsdGltb2RhbCBJbWFnaW5nLypzdGFuZGFyZHM8L2tleXdvcmQ+PGtleXdvcmQ+TmVv

cGxhc21zLypkaWFnbm9zaXMvKnRoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+UHJhY3RpY2UgR3Vp

ZGVsaW5lcyBhcyBUb3BpYzwva2V5d29yZD48a2V5d29yZD5SYWRpb2xvZ3kvc3RhbmRhcmRzPC9r

ZXl3b3JkPjxrZXl3b3JkPlVuaXRlZCBTdGF0ZXM8L2tleXdvcmQ+PGtleXdvcmQ+VmVudHJpY3Vs

YXIgRHlzZnVuY3Rpb24sIExlZnQvKmRpYWdub3Npcy8qZXRpb2xvZ3kvcHJldmVudGlvbiAmYW1w

OyBjb250cm9sPC9rZXl3b3JkPjxrZXl3b3JkPkJpb21hcmtlcnM8L2tleXdvcmQ+PGtleXdvcmQ+

Q2hlbW90aGVyYXB5PC9rZXl3b3JkPjxrZXl3b3JkPkRveG9ydWJpY2luPC9rZXl3b3JkPjxrZXl3

b3JkPkVhcmx5IGRldGVjdGlvbjwva2V5d29yZD48a2V5d29yZD5MZWZ0IHZlbnRyaWN1bGFyIGR5

c2Z1bmN0aW9uPC9rZXl3b3JkPjxrZXl3b3JkPlN0cmFpbjwva2V5d29yZD48a2V5d29yZD5UaHJl

ZS1kaW1lbnNpb25hbCBlY2hvY2FyZGlvZ3JhcGh5PC9rZXl3b3JkPjxrZXl3b3JkPlRyYXN0dXp1

bWFiPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTQ8L3llYXI+PHB1Yi1kYXRl

cz48ZGF0ZT5TZXA8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xMDk3LTY3OTUgKEVs

ZWN0cm9uaWMpJiN4RDswODk0LTczMTcgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI1

MTcyMzk5PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwczovL3d3

dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yNTE3MjM5OTwvdXJsPjwvcmVsYXRlZC11cmxzPjwv

dXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTAxNi9qLmVjaG8uMjAxNC4wNy4wMTI8

L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QbGFuYTwvQXV0aG9yPjxZZWFyPjIwMTQ8L1llYXI+PFJl

Y051bT44PC9SZWNOdW0+PERpc3BsYXlUZXh0PigxOCk8L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJl

Yy1udW1iZXI+ODwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9

InpkOWZmeHJzMjJkcGViZTVmdHFwNXcyajB4c2YyMjByZGRzciIgdGltZXN0YW1wPSIxNTEwNzc2

MTQ1Ij44PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNs

ZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5QbGFuYSwgSi4g

Qy48L2F1dGhvcj48YXV0aG9yPkdhbGRlcmlzaSwgTS48L2F1dGhvcj48YXV0aG9yPkJhcmFjLCBB

LjwvYXV0aG9yPjxhdXRob3I+RXdlciwgTS4gUy48L2F1dGhvcj48YXV0aG9yPkt5LCBCLjwvYXV0

aG9yPjxhdXRob3I+U2NoZXJyZXItQ3Jvc2JpZSwgTS48L2F1dGhvcj48YXV0aG9yPkdhbmFtZSwg

Si48L2F1dGhvcj48YXV0aG9yPlNlYmFnLCBJLiBBLjwvYXV0aG9yPjxhdXRob3I+QWdsZXIsIEQu

IEEuPC9hdXRob3I+PGF1dGhvcj5CYWRhbm8sIEwuIFAuPC9hdXRob3I+PGF1dGhvcj5CYW5jaHMs

IEouPC9hdXRob3I+PGF1dGhvcj5DYXJkaW5hbGUsIEQuPC9hdXRob3I+PGF1dGhvcj5DYXJ2ZXIs

IEouPC9hdXRob3I+PGF1dGhvcj5DZXJxdWVpcmEsIE0uPC9hdXRob3I+PGF1dGhvcj5EZUNhcmEs

IEouIE0uPC9hdXRob3I+PGF1dGhvcj5FZHZhcmRzZW4sIFQuPC9hdXRob3I+PGF1dGhvcj5GbGFt

bSwgUy4gRC48L2F1dGhvcj48YXV0aG9yPkZvcmNlLCBULjwvYXV0aG9yPjxhdXRob3I+R3JpZmZp

biwgQi4gUC48L2F1dGhvcj48YXV0aG9yPkplcnVzYWxlbSwgRy48L2F1dGhvcj48YXV0aG9yPkxp

dSwgSi4gRS48L2F1dGhvcj48YXV0aG9yPk1hZ2FsaGFlcywgQS48L2F1dGhvcj48YXV0aG9yPk1h

cndpY2ssIFQuPC9hdXRob3I+PGF1dGhvcj5TYW5jaGV6LCBMLiBZLjwvYXV0aG9yPjxhdXRob3I+

U2ljYXJpLCBSLjwvYXV0aG9yPjxhdXRob3I+VmlsbGFycmFnYSwgSC4gUi48L2F1dGhvcj48YXV0

aG9yPkxhbmNlbGxvdHRpLCBQLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0

aC1hZGRyZXNzPkNsZXZlbGFuZCBDbGluaWMsIENsZXZlbGFuZCwgT2hpby4mI3hEO0ZlZGVyaWNv

IElJIFVuaXZlcnNpdHkgSG9zcGl0YWwsIE5hcGxlcywgSXRhbHkuJiN4RDtNZWRzdGFyIFdhc2hp

bmd0b24gSG9zcGl0YWwgQ2VudGVyLCBXYXNoaW5ndG9uLCBEaXN0cmljdCBvZiBDb2x1bWJpYS4m

I3hEO01EIEFuZGVyc29uIENhbmNlciBDZW50ZXIsIFVuaXZlcnNpdHkgb2YgVGV4YXMsIEhvdXN0

b24sIFRleGFzLiYjeEQ7VW5pdmVyc2l0eSBvZiBQZW5uc3lsdmFuaWEsIFBoaWxhZGVscGhpYSwg

UGVubnN5bHZhbmlhLiYjeEQ7TWFzc2FjaHVzZXR0cyBHZW5lcmFsIEhvc3BpdGFsLCBCb3N0b24s

IE1hc3NhY2h1c2V0dHMuJiN4RDtNY01hc3RlciBVbml2ZXJzaXR5LCBIYW1pbHRvbiwgT250YXJp

bywgQ2FuYWRhLiYjeEQ7SmV3aXNoIEdlbmVyYWwgSG9zcGl0YWwgYW5kIE1jR2lsbCBVbml2ZXJz

aXR5LCBNb250cmVhbCwgUXVlYmVjLCBDYW5hZGEuJiN4RDtVbml2ZXJzaXR5IG9mIFBhZHVhLCBQ

YWR1YSwgSXRhbHkuJiN4RDtFdXJvcGVhbiBJbnN0aXR1dGUgb2YgT25jb2xvZ3ksIE1pbGFuLCBJ

dGFseS4mI3hEO0FicmFtc29uIENhbmNlciBDZW50ZXIgYXQgdGhlIFVuaXZlcnNpdHkgb2YgUGVu

bnN5bHZhbmlhLCBQaGlsYWRlbHBoaWEsIFBlbm5zeWx2YW5pYS4mI3hEO1VuaXZlcnNpdHkgb2Yg

Q2hpY2FnbyBNZWRpY2luZSwgQ2hpY2FnbywgSWxsaW5vaXMuJiN4RDtPc2xvIFVuaXZlcnNpdHkg

SG9zcGl0YWwgYW5kIFVuaXZlcnNpdHkgb2YgT3NsbywgT3NsbywgTm9yd2F5LiYjeEQ7VGVtcGxl

IFVuaXZlcnNpdHksIFBoaWxhZGVscGhpYSwgUGVubnN5bHZhbmlhLiYjeEQ7VW5pdmVyc2l0eSBv

ZiBMaWVnZSwgTGllZ2UsIEJlbGdpdW0uJiN4RDtNZW1vcmlhbCBTbG9hbi1LZXR0ZXJpbmcgQ2Fu

Y2VyIENlbnRlciwgTmV3IFlvcmssIE5ldyBZb3JrLiYjeEQ7U2FudGEgTWFyaWUgVW5pdmVyc2l0

eSBIb3NwaXRhbCwgTGlzYm9uLCBQb3J0dWdhbC4mI3hEO01lbnppZXMgUmVzZWFyY2ggSW5zdGl0

dXRlIFRhc21hbmlhLCBIb2JhcnQsIEF1c3RyYWxpYS4mI3hEO0NOUiBJbnN0aXR1dGUgb2YgQ2xp

bmljYWwgUGh5c2lvbG9neSwgUGlzYSwgSXRhbHkuJiN4RDtNYXlvIENsaW5pYywgUm9jaGVzdGVy

LCBNaW5uZXNvdGEuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+RXhwZXJ0IGNvbnNlbnN1

cyBmb3IgbXVsdGltb2RhbGl0eSBpbWFnaW5nIGV2YWx1YXRpb24gb2YgYWR1bHQgcGF0aWVudHMg

ZHVyaW5nIGFuZCBhZnRlciBjYW5jZXIgdGhlcmFweTogYSByZXBvcnQgZnJvbSB0aGUgQW1lcmlj

YW4gU29jaWV0eSBvZiBFY2hvY2FyZGlvZ3JhcGh5IGFuZCB0aGUgRXVyb3BlYW4gQXNzb2NpYXRp

b24gb2YgQ2FyZGlvdmFzY3VsYXIgSW1hZ2luZzwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5KIEFt

IFNvYyBFY2hvY2FyZGlvZ3I8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5KIEFtIFNvYyBFY2hvY2FyZGlvZ3I8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2Fs

PjxwYWdlcz45MTEtMzk8L3BhZ2VzPjx2b2x1bWU+Mjc8L3ZvbHVtZT48bnVtYmVyPjk8L251bWJl

cj48a2V5d29yZHM+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+Q2FyZGlvbG9neS9z

dGFuZGFyZHM8L2tleXdvcmQ+PGtleXdvcmQ+Q2hlbW9yYWRpb3RoZXJhcHkvKmFkdmVyc2UgZWZm

ZWN0cy8qc3RhbmRhcmRzPC9rZXl3b3JkPjxrZXl3b3JkPkV1cm9wZTwva2V5d29yZD48a2V5d29y

ZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8

L2tleXdvcmQ+PGtleXdvcmQ+TWVkaWNhbCBPbmNvbG9neS9zdGFuZGFyZHM8L2tleXdvcmQ+PGtl

eXdvcmQ+TXVsdGltb2RhbCBJbWFnaW5nLypzdGFuZGFyZHM8L2tleXdvcmQ+PGtleXdvcmQ+TmVv

cGxhc21zLypkaWFnbm9zaXMvKnRoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+UHJhY3RpY2UgR3Vp

ZGVsaW5lcyBhcyBUb3BpYzwva2V5d29yZD48a2V5d29yZD5SYWRpb2xvZ3kvc3RhbmRhcmRzPC9r

ZXl3b3JkPjxrZXl3b3JkPlVuaXRlZCBTdGF0ZXM8L2tleXdvcmQ+PGtleXdvcmQ+VmVudHJpY3Vs

YXIgRHlzZnVuY3Rpb24sIExlZnQvKmRpYWdub3Npcy8qZXRpb2xvZ3kvcHJldmVudGlvbiAmYW1w

OyBjb250cm9sPC9rZXl3b3JkPjxrZXl3b3JkPkJpb21hcmtlcnM8L2tleXdvcmQ+PGtleXdvcmQ+

Q2hlbW90aGVyYXB5PC9rZXl3b3JkPjxrZXl3b3JkPkRveG9ydWJpY2luPC9rZXl3b3JkPjxrZXl3

b3JkPkVhcmx5IGRldGVjdGlvbjwva2V5d29yZD48a2V5d29yZD5MZWZ0IHZlbnRyaWN1bGFyIGR5

c2Z1bmN0aW9uPC9rZXl3b3JkPjxrZXl3b3JkPlN0cmFpbjwva2V5d29yZD48a2V5d29yZD5UaHJl

ZS1kaW1lbnNpb25hbCBlY2hvY2FyZGlvZ3JhcGh5PC9rZXl3b3JkPjxrZXl3b3JkPlRyYXN0dXp1

bWFiPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMTQ8L3llYXI+PHB1Yi1kYXRl

cz48ZGF0ZT5TZXA8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xMDk3LTY3OTUgKEVs

ZWN0cm9uaWMpJiN4RDswODk0LTczMTcgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjI1

MTcyMzk5PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwczovL3d3

dy5uY2JpLm5sbS5uaWguZ292L3B1Ym1lZC8yNTE3MjM5OTwvdXJsPjwvcmVsYXRlZC11cmxzPjwv

dXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTAxNi9qLmVjaG8uMjAxNC4wNy4wMTI8

L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE.DATA (18) AnthracyclineYes Drop of 10 points to LVEF <53%LVEF measurement before each additional cycle after exceeding the dose of 240 mg/m2**Cardiology consultationF/U at completion of therapy and 6 months laterTrastuzumab Yes Drop of 10 points to LVEF <53%LVEF every 3 months during therapyCardiology consultationFU 6 months after completion of therapy in patients that received an AC-based regimenASCOPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Bcm1lbmlhbjwvQXV0aG9yPjxZZWFyPjIwMTc8L1llYXI+

PFJlY051bT4xMTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMTkpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjExPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iemQ5ZmZ4cnMyMmRwZWJlNWZ0cXA1dzJqMHhzZjIyMHJkZHNyIiB0aW1lc3RhbXA9IjE1

MTA3NzY1NDYiPjExPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwg

QXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Bcm1l

bmlhbiwgUy4gSC48L2F1dGhvcj48YXV0aG9yPkxhY2NoZXR0aSwgQy48L2F1dGhvcj48YXV0aG9y

PkJhcmFjLCBBLjwvYXV0aG9yPjxhdXRob3I+Q2FydmVyLCBKLjwvYXV0aG9yPjxhdXRob3I+Q29u

c3RpbmUsIEwuIFMuPC9hdXRob3I+PGF1dGhvcj5EZW5kdWx1cmksIE4uPC9hdXRob3I+PGF1dGhv

cj5EZW50LCBTLjwvYXV0aG9yPjxhdXRob3I+RG91Z2xhcywgUC4gUy48L2F1dGhvcj48YXV0aG9y

PkR1cmFuZCwgSi4gQi48L2F1dGhvcj48YXV0aG9yPkV3ZXIsIE0uPC9hdXRob3I+PGF1dGhvcj5G

YWJpYW4sIEMuPC9hdXRob3I+PGF1dGhvcj5IdWRzb24sIE0uPC9hdXRob3I+PGF1dGhvcj5KZXNz

dXAsIE0uPC9hdXRob3I+PGF1dGhvcj5Kb25lcywgTC4gVy48L2F1dGhvcj48YXV0aG9yPkt5LCBC

LjwvYXV0aG9yPjxhdXRob3I+TWF5ZXIsIEUuIEwuPC9hdXRob3I+PGF1dGhvcj5Nb3NsZWhpLCBK

LjwvYXV0aG9yPjxhdXRob3I+T2VmZmluZ2VyLCBLLjwvYXV0aG9yPjxhdXRob3I+UmF5LCBLLjwv

YXV0aG9yPjxhdXRob3I+UnVkZHksIEsuPC9hdXRob3I+PGF1dGhvcj5MZW5paGFuLCBELjwvYXV0

aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPlNhcm8gSC4gQXJtZW5p

YW4sIENpdHkgb2YgSG9wZSwgRHVhcnRlLCBDQTsgQ2hyaXN0aW5hIExhY2NoZXR0aSwgQW1lcmlj

YW4gU29jaWV0eSBvZiBDbGluaWNhbCBPbmNvbG9neSwgQWxleGFuZHJpYTsgTmVlbGltYSBEZW5k

dWx1cmksIFZpcmdpbmlhIENhbmNlciBTcGVjaWFsaXN0cywgQXJsaW5ndG9uLCBWQTsgQW5hIEJh

cmFjLCBNZWRzdGFyIEhlYXJ0IEluc3RpdHV0ZSwgTWVkc3RhciBXYXNoaW5ndG9uIEhvc3BpdGFs

IENlbnRlciwgV2FzaGluZ3RvbiwgREM7IEpvc2VwaCBDYXJ2ZXIgYW5kIE1hcmllbGwgSmVzc3Vw

LCBVbml2ZXJzaXR5IG9mIFBlbm5zeWx2YW5pYTsgQm9ubmllIEt5LCBIb3NwaXRhbCBvZiB0aGUg

VW5pdmVyc2l0eSBvZiBQZW5uc3lsdmFuaWEsIFBoaWxhZGVscGhpYSwgUEE7IExvdWlzIFMuIENv

bnN0aW5lLCBVbml2ZXJzaXR5IG9mIFJvY2hlc3RlciBNZWRpY2FsIENlbnRlciwgUm9jaGVzdGVy

OyBMZWUgVy4gSm9uZXMgYW5kIEtldmluIE9lZmZpbmdlciwgTWVtb3JpYWwgU2xvYW4gS2V0dGVy

aW5nIENhbmNlciBDZW50ZXIsIE5ldyBZb3JrLCBOWTsgU3VzYW4gRGVudCwgVGhlIE90dGF3YSBI

b3NwaXRhbCBDYW5jZXIgQ2VudGVyLCBPdHRhd2EsIE9udGFyaW8sIENhbmFkYTsgUGFtZWxhIFMu

IERvdWdsYXMsIER1a2UgVW5pdmVyc2l0eSwgRHVyaGFtLCBOQzsgSmVhbi1CZXJuYXJkIER1cmFu

ZCBhbmQgTWljaGFlbCBFd2VyLCBUaGUgVW5pdmVyc2l0eSBvZiBUZXhhcyBNRCBBbmRlcnNvbiBD

YW5jZXIgQ2VudGVyLCBIb3VzdG9uLCBUWDsgQ2Fyb2wgRmFiaWFuLCBVbml2ZXJzaXR5IG9mIEth

bnNhcyBNZWRpY2FsIENlbnRlciwgS2Fuc2FzIENpdHksIEtTOyBNZWxpc3NhIEh1ZHNvbiwgU3Qg

SnVkZSBDaGlsZHJlbiZhcG9zO3MgUmVzZWFyY2ggSG9zcGl0YWwsIE1lbXBoaXM7IEphdmlkIE1v

c2xlaGkgYW5kIERhbmllbCBMZW5paGFuLCBWYW5kZXJiaWx0IFVuaXZlcnNpdHk7IEthdGhhcmlu

ZSBSYXksIFBhdGllbnQgUmVwcmVzZW50YXRpdmUsIE5hc2h2aWxsZSwgVE47IEVyaWNhIEwuIE1h

eWVyLCBEYW5hLUZhcmJlciBDYW5jZXIgSW5zdGl0dXRlLCBCb3N0b24sIE1BOyBhbmQgS2F0aHJ5

biBSdWRkeSwgTWF5byBDbGluaWMsIFJvY2hlc3RlciwgTU4uPC9hdXRoLWFkZHJlc3M+PHRpdGxl

cz48dGl0bGU+UHJldmVudGlvbiBhbmQgTW9uaXRvcmluZyBvZiBDYXJkaWFjIER5c2Z1bmN0aW9u

IGluIFN1cnZpdm9ycyBvZiBBZHVsdCBDYW5jZXJzOiBBbWVyaWNhbiBTb2NpZXR5IG9mIENsaW5p

Y2FsIE9uY29sb2d5IENsaW5pY2FsIFByYWN0aWNlIEd1aWRlbGluZTwvdGl0bGU+PHNlY29uZGFy

eS10aXRsZT5KIENsaW4gT25jb2w8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNh

bD48ZnVsbC10aXRsZT5KIENsaW4gT25jb2w8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdl

cz44OTMtOTExPC9wYWdlcz48dm9sdW1lPjM1PC92b2x1bWU+PG51bWJlcj44PC9udW1iZXI+PGtl

eXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkhlYXJ0LypwaHlzaW9wYXRo

b2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+SGVhcnQgRGlzZWFzZXMvKmV0aW9sb2d5L3BoeXNpb3Bh

dGhvbG9neS8qcHJldmVudGlvbiAmYW1wOyBjb250cm9sPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFu

czwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbXMvKnBoeXNpb3BhdGhvbG9neS8qdGhlcmFweTwv

a2V5d29yZD48a2V5d29yZD5TdXJ2aXZvcnM8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHll

YXI+MjAxNzwveWVhcj48cHViLWRhdGVzPjxkYXRlPk1hciAxMDwvZGF0ZT48L3B1Yi1kYXRlcz48

L2RhdGVzPjxpc2JuPjE1MjctNzc1NSAoRWxlY3Ryb25pYykmI3hEOzA3MzItMTgzWCAoTGlua2lu

Zyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+Mjc5MTg3MjU8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJl

bGF0ZWQtdXJscz48dXJsPmh0dHBzOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzI3OTE4

NzI1PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4x

MC4xMjAwL0pDTy4yMDE2LjcwLjU0MDA8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3Jk

PjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Bcm1lbmlhbjwvQXV0aG9yPjxZZWFyPjIwMTc8L1llYXI+

PFJlY051bT4xMTwvUmVjTnVtPjxEaXNwbGF5VGV4dD4oMTkpPC9EaXNwbGF5VGV4dD48cmVjb3Jk

PjxyZWMtbnVtYmVyPjExPC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBk

Yi1pZD0iemQ5ZmZ4cnMyMmRwZWJlNWZ0cXA1dzJqMHhzZjIyMHJkZHNyIiB0aW1lc3RhbXA9IjE1

MTA3NzY1NDYiPjExPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwg

QXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5Bcm1l

bmlhbiwgUy4gSC48L2F1dGhvcj48YXV0aG9yPkxhY2NoZXR0aSwgQy48L2F1dGhvcj48YXV0aG9y

PkJhcmFjLCBBLjwvYXV0aG9yPjxhdXRob3I+Q2FydmVyLCBKLjwvYXV0aG9yPjxhdXRob3I+Q29u

c3RpbmUsIEwuIFMuPC9hdXRob3I+PGF1dGhvcj5EZW5kdWx1cmksIE4uPC9hdXRob3I+PGF1dGhv

cj5EZW50LCBTLjwvYXV0aG9yPjxhdXRob3I+RG91Z2xhcywgUC4gUy48L2F1dGhvcj48YXV0aG9y

PkR1cmFuZCwgSi4gQi48L2F1dGhvcj48YXV0aG9yPkV3ZXIsIE0uPC9hdXRob3I+PGF1dGhvcj5G

YWJpYW4sIEMuPC9hdXRob3I+PGF1dGhvcj5IdWRzb24sIE0uPC9hdXRob3I+PGF1dGhvcj5KZXNz

dXAsIE0uPC9hdXRob3I+PGF1dGhvcj5Kb25lcywgTC4gVy48L2F1dGhvcj48YXV0aG9yPkt5LCBC

LjwvYXV0aG9yPjxhdXRob3I+TWF5ZXIsIEUuIEwuPC9hdXRob3I+PGF1dGhvcj5Nb3NsZWhpLCBK

LjwvYXV0aG9yPjxhdXRob3I+T2VmZmluZ2VyLCBLLjwvYXV0aG9yPjxhdXRob3I+UmF5LCBLLjwv

YXV0aG9yPjxhdXRob3I+UnVkZHksIEsuPC9hdXRob3I+PGF1dGhvcj5MZW5paGFuLCBELjwvYXV0

aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPlNhcm8gSC4gQXJtZW5p

YW4sIENpdHkgb2YgSG9wZSwgRHVhcnRlLCBDQTsgQ2hyaXN0aW5hIExhY2NoZXR0aSwgQW1lcmlj

YW4gU29jaWV0eSBvZiBDbGluaWNhbCBPbmNvbG9neSwgQWxleGFuZHJpYTsgTmVlbGltYSBEZW5k

dWx1cmksIFZpcmdpbmlhIENhbmNlciBTcGVjaWFsaXN0cywgQXJsaW5ndG9uLCBWQTsgQW5hIEJh

cmFjLCBNZWRzdGFyIEhlYXJ0IEluc3RpdHV0ZSwgTWVkc3RhciBXYXNoaW5ndG9uIEhvc3BpdGFs

IENlbnRlciwgV2FzaGluZ3RvbiwgREM7IEpvc2VwaCBDYXJ2ZXIgYW5kIE1hcmllbGwgSmVzc3Vw

LCBVbml2ZXJzaXR5IG9mIFBlbm5zeWx2YW5pYTsgQm9ubmllIEt5LCBIb3NwaXRhbCBvZiB0aGUg

VW5pdmVyc2l0eSBvZiBQZW5uc3lsdmFuaWEsIFBoaWxhZGVscGhpYSwgUEE7IExvdWlzIFMuIENv

bnN0aW5lLCBVbml2ZXJzaXR5IG9mIFJvY2hlc3RlciBNZWRpY2FsIENlbnRlciwgUm9jaGVzdGVy

OyBMZWUgVy4gSm9uZXMgYW5kIEtldmluIE9lZmZpbmdlciwgTWVtb3JpYWwgU2xvYW4gS2V0dGVy

aW5nIENhbmNlciBDZW50ZXIsIE5ldyBZb3JrLCBOWTsgU3VzYW4gRGVudCwgVGhlIE90dGF3YSBI

b3NwaXRhbCBDYW5jZXIgQ2VudGVyLCBPdHRhd2EsIE9udGFyaW8sIENhbmFkYTsgUGFtZWxhIFMu

IERvdWdsYXMsIER1a2UgVW5pdmVyc2l0eSwgRHVyaGFtLCBOQzsgSmVhbi1CZXJuYXJkIER1cmFu

ZCBhbmQgTWljaGFlbCBFd2VyLCBUaGUgVW5pdmVyc2l0eSBvZiBUZXhhcyBNRCBBbmRlcnNvbiBD

YW5jZXIgQ2VudGVyLCBIb3VzdG9uLCBUWDsgQ2Fyb2wgRmFiaWFuLCBVbml2ZXJzaXR5IG9mIEth

bnNhcyBNZWRpY2FsIENlbnRlciwgS2Fuc2FzIENpdHksIEtTOyBNZWxpc3NhIEh1ZHNvbiwgU3Qg

SnVkZSBDaGlsZHJlbiZhcG9zO3MgUmVzZWFyY2ggSG9zcGl0YWwsIE1lbXBoaXM7IEphdmlkIE1v

c2xlaGkgYW5kIERhbmllbCBMZW5paGFuLCBWYW5kZXJiaWx0IFVuaXZlcnNpdHk7IEthdGhhcmlu

ZSBSYXksIFBhdGllbnQgUmVwcmVzZW50YXRpdmUsIE5hc2h2aWxsZSwgVE47IEVyaWNhIEwuIE1h

eWVyLCBEYW5hLUZhcmJlciBDYW5jZXIgSW5zdGl0dXRlLCBCb3N0b24sIE1BOyBhbmQgS2F0aHJ5

biBSdWRkeSwgTWF5byBDbGluaWMsIFJvY2hlc3RlciwgTU4uPC9hdXRoLWFkZHJlc3M+PHRpdGxl

cz48dGl0bGU+UHJldmVudGlvbiBhbmQgTW9uaXRvcmluZyBvZiBDYXJkaWFjIER5c2Z1bmN0aW9u

IGluIFN1cnZpdm9ycyBvZiBBZHVsdCBDYW5jZXJzOiBBbWVyaWNhbiBTb2NpZXR5IG9mIENsaW5p

Y2FsIE9uY29sb2d5IENsaW5pY2FsIFByYWN0aWNlIEd1aWRlbGluZTwvdGl0bGU+PHNlY29uZGFy

eS10aXRsZT5KIENsaW4gT25jb2w8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNh

bD48ZnVsbC10aXRsZT5KIENsaW4gT25jb2w8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdl

cz44OTMtOTExPC9wYWdlcz48dm9sdW1lPjM1PC92b2x1bWU+PG51bWJlcj44PC9udW1iZXI+PGtl

eXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3JkPjxrZXl3b3JkPkhlYXJ0LypwaHlzaW9wYXRo

b2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+SGVhcnQgRGlzZWFzZXMvKmV0aW9sb2d5L3BoeXNpb3Bh

dGhvbG9neS8qcHJldmVudGlvbiAmYW1wOyBjb250cm9sPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFu

czwva2V5d29yZD48a2V5d29yZD5OZW9wbGFzbXMvKnBoeXNpb3BhdGhvbG9neS8qdGhlcmFweTwv

a2V5d29yZD48a2V5d29yZD5TdXJ2aXZvcnM8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHll

YXI+MjAxNzwveWVhcj48cHViLWRhdGVzPjxkYXRlPk1hciAxMDwvZGF0ZT48L3B1Yi1kYXRlcz48

L2RhdGVzPjxpc2JuPjE1MjctNzc1NSAoRWxlY3Ryb25pYykmI3hEOzA3MzItMTgzWCAoTGlua2lu

Zyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+Mjc5MTg3MjU8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJl

bGF0ZWQtdXJscz48dXJsPmh0dHBzOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvcHVibWVkLzI3OTE4

NzI1PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4x

MC4xMjAwL0pDTy4yMDE2LjcwLjU0MDA8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3Jk

PjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE.DATA (19)- AC **(eg doxorubicin >250 mg/m2); - RT (>/= 30 Gy where the heart is in the tx field)- low dose AC (<250mg/m2)+ low dose RT (< 30Gy)- AC + Trast- low dose AC or trast+ RF***YesAdjudication to Stage B Heart FailureFrequency to be determined by health care providers based on clinical judgment and patient circumstancesWeighing risk/benefit and decision of cancer treatment at the discretion of the oncologistFU may be considered 6 to 12 months after completion of treatment among patients at increased riskNCCN = national comprehensive cancer network; FDA = Federal Drug Administration; ASE = American Society of Echocardiography; ASCO = American Society of Clinical OncologyTx = treatment; AC = anthracycline; RT = radiation therapy; trast = trastuzumab; LLN = lower limit of normal; RF = risk factors; FU = follow-up* Replaced cardiac monitoring at baseline, 3, 6, 9 months with “Evaluate LVEF prior to and during treatment” in the recent NCCN guideline update. ** Doxorubicin equivalent*** Risk factors included age ≥ 60, compromise cardiac function (eg history of myocardial infarction, moderate valvular disease, borderline LVEF) or ≥ 2 cardiovascular risk factors (smoking, HTN, DM, hyperlipidemia)References ADDIN EN.REFLIST 1.Wang L, Tan TC, Halpern EF, Neilan TG, Francis SA, Picard MH, et al. Major Cardiac Events and the Value of Echocardiographic Evaluation in Patients Receiving Anthracycline-Based Chemotherapy. Am J Cardiol. 2015;116(3):442-6.2.Romond EH, Jeong JH, Rastogi P, Swain SM, Geyer CE, Jr., Ewer MS, et al. Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer. J Clin Oncol. 2012;30(31):3792-9.3.Negishi K, Negishi T, Hare JL, Haluska BA, Plana JC, Marwick TH. Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity. J Am Soc Echocardiogr. 2013;26(5):493-8.4.Mousavi N, Tan TC, Ali M, Halpern EF, Wang L, Scherrer-Crosbie M. Echocardiographic parameters of left ventricular size and function as predictors of symptomatic heart failure in patients with a left ventricular ejection fraction of 50-59% treated with anthracyclines. Eur Heart J Cardiovasc Imaging. 2015;16(9):977-84.5.Ali MT, Yucel E, Bouras S, Wang L, Fei HW, Halpern EF, et al. Myocardial Strain Is Associated with Adverse Clinical Cardiac Events in Patients Treated with Anthracyclines. J Am Soc Echocardiogr. 2016;29(6):522-7 e3.6.Perez EA, Suman VJ, Davidson NE, Sledge GW, Kaufman PA, Hudis CA, et al. Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol. 2008;26(8):1231-8.7.Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, et al. Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med. 2011;365(14):1273-83.8.Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015;131(22):1981-8.9.Procter M, Suter TM, de Azambuja E, Dafni U, van Dooren V, Muehlbauer S, et al. Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial. J Clin Oncol. 2010;28(21):3422-8.10.Bosch X, Rovira M, Sitges M, Domenech A, Ortiz-Perez JT, de Caralt TM, et al. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies). J Am Coll Cardiol. 2013;61(23):2355-62.11.Seicean S, Seicean A, Alan N, Plana JC, Budd GT, Marwick TH. Cardioprotective effect of beta-adrenoceptor blockade in patients with breast cancer undergoing chemotherapy: follow-up study of heart failure. Circ Heart Fail. 2013;6(3):420-6.12.Lipshultz SE, Lipsitz SR, Sallan SE, Dalton VM, Mone SM, Gelber RD, et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol. 2005;23(12):2629-36.13.Armstrong GT, Joshi VM, Ness KK, Marwick TH, Zhang N, Srivastava D, et al. Comprehensive Echocardiographic Detection of Treatment-Related Cardiac Dysfunction in Adult Survivors of Childhood Cancer: Results From the St. Jude Lifetime Cohort Study. J Am Coll Cardiol. 2015;65(23):2511-22.14.Narayan HK, Finkelman B, French B, Plappert T, Hyman D, Smith AM, et al. Detailed Echocardiographic Phenotyping in Breast Cancer Patients: Associations With Ejection Fraction Decline, Recovery, and Heart Failure Symptoms Over 3 Years of Follow-Up. Circulation. 2017;135(15):1397-412.15.Food and Drug Administration. Adriamycin (DOXOrubicin HCl) for Injection. Version 2.0, 2012. Available online . Accessed November 15, 2017.16.Food and Drug Administration. HERCEPTIN (trastuzumab) Label. 2010. Available Online Comprehensive Cancer Network. NCCN Guidelines Version 2.2017. Anthracycline-Induced Cardiac Toxicity. Available online: JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014;27(9):911-39.19.Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, et al. Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017;35(8):893-911. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download